0001161697-11-000838.txt : 20110913 0001161697-11-000838.hdr.sgml : 20110913 20110913074931 ACCESSION NUMBER: 0001161697-11-000838 CONFORMED SUBMISSION TYPE: 10-Q/A PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20110630 FILED AS OF DATE: 20110913 DATE AS OF CHANGE: 20110913 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HASCO Medical, Inc. CENTRAL INDEX KEY: 0001131675 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 650924471 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-52422 FILM NUMBER: 111086871 BUSINESS ADDRESS: STREET 1: 1416 WEST 1-65 STREET 2: SERVICE ROAD SOUTH CITY: MOBILE STATE: AL ZIP: 36693 BUSINESS PHONE: (251) 633-4133 MAIL ADDRESS: STREET 1: 1416 WEST 1-65 STREET 2: SERVICE ROAD SOUTH CITY: MOBILE STATE: AL ZIP: 36693 FORMER COMPANY: FORMER CONFORMED NAME: BBC GRAPHICS OF PALM BEACH INC DATE OF NAME CHANGE: 20010108 10-Q/A 1 form_10-q.htm FORM 10-Q/A1 FOR 06-30-2011

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q/A
Amendment No. 1

(Mark One)

[X] QUARTERLY REPORT UNDER SECTION 13 OR 15 (D) OF THE SECURITIES AND EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2011

[ ] TRANSITION REPORT UNDER SECTION 13 OR 15 (D) OF THE EXCHANGE ACT

For the transition period from __________ to __________

COMMISSION FILE NUMBER: 000-52422

HASCO Medical, Inc.

(Name of Registrant as specified in its charter)


Florida	65-0924471
(State or other jurisdiction of	(I.R.S. Employer
incorporation of organization)	Identification No.)

1416 West I-65 Service Road S., Mobile, AL 36693

(Address of principal executive office)

(251) 633-4133

(Registrant’s telephone number)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [√] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [√] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer	[ ]	Accelerated filer	[ ]

Non-accelerated filer (Do not check if smaller reporting company)	[ ]	Smaller reporting company	[√]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes [ ] No [√]

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. 763,102,390 shares of common stock are issued and outstanding as of August 15, 2011.

EXPLANATORY NOTE

We are filing this Form 10-Q/A Amendment No. 1 for the quarterly period ended June 30, 2011, for the sole purpose of submitting the Interactive Data Files in Exhibit 101 relating to the Form 10-Q for the quarterly period ended June 30, 2011 that was filed on August 15, 2011. In accordance with Regulation S-T, the Interactive Data Files in Exhibit 101 have been listed under the heading PART II, ITEM 6. EXHIBITS and shall be deemed “furnished” and not “filed.”

Except for the item described above, no information contained in our original filing on Form 10-Q has been updated, modified or revised. This Amendment No. 1 also contains currently dated certifications as Exhibits 31.1, 31.2, 32.1 and 32.2. This Amendment No. 1 does not reflect events occurring after the filing of the original Form 10-Q or modify or update those disclosures that may be affected by subsequent events.

HASCO MEDICAL, INC.

Form 10-Q

Quarterly period ended June 30, 2011

Index


Part I.	Financial Information
	Item 1.	Financial Statements	3
		Consolidated Balance Sheets as of June 30, 2011 (Unaudited) and as of December 31, 2010 (Audited)	3
		Consolidated Statements of Operations for the three months ended June 30, 2011 and 2010 (Unaudited)	4
		Consolidated Statements of Cash Flows for the six months ended June 30, 2011 and 2010 (Unaudited)	5
		Notes to Unaudited Consolidated Financial Statements	6
	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	17
	Item 3.	Quantitative and Qualitative Disclosures About Market Risk	28
	Item 4.	Controls and Procedures	28

Part II.	Other Information
	Item 1.	Legal Proceedings	29
	Item 1A.	Risk Factors	29
	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	29
	Item 3.	Defaults Upon Senior Securities	29
	Item 4.	Submission of Matters to a Vote of Security Holders	29
	Item 5.	Other Information	29
	Item 6.	Exhibits	30

FORWARD LOOKING STATEMENTS

This report contains forward-looking statements regarding our business, financial condition, results of operations and prospects. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements, but are not deemed to represent an all-inclusive means of identifying forward-looking statements as denoted in this report. Additionally, statements concerning future matters are forward-looking statements.

Although forward-looking statements in this report reflect the good faith judgment of our management, such statements can only be based on facts and factors currently known by us. Consequently, forward-looking statements are inherently subject to risks and uncertainties and actual results and outcomes may differ materially from the results and outcomes discussed in or anticipated by the forward-looking statements. Factors that could cause or contribute to such differences in results and outcomes include, without limitation, those specifically addressed under the headings “Risks Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our annual report on Form 10-K, in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in this Form 10-Q and in other reports that we file with the SEC. You are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this report.

We file reports with the SEC. The SEC maintains a website (www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC, including us. You can also read and copy any materials we file with the SEC at the SEC’s Public Reference Room at 100 F Street, NE, Washington, DC 20549. You can obtain additional information about the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330.

We undertake no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this report, except as required by law. Readers are urged to carefully review and consider the various disclosures made throughout the entirety of this quarterly report, which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects.

PART I. FINANCIAL INFORMATION


Item 1.	Financial Statements

Hasco Medical, Inc. & Subsidiaries

Consolidated Balance Sheets


	June 30, 2011			December 31, 2010
	(unaudited)			(audited)
ASSETS
CURRENT ASSETS:
Cash and cash equivalents	$	362,190		$	423
Accounts receivable, net		334,840			254,362
Inventory		2,382,394			76,356
Prepaid expenses and other current asset		23,963			18,845

Total Current Assets		3,103,387			349,986

LONG-TERM ASSETS:
Property and equipment, net		757,309			147,769
Sales Team & infrastructure, net		1,635,045			—
Customer List, net		1,095,649			—
Other		38,019			420

Total Assets	$	6,629,409		$	498,175

LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES:
Accounts payable and accrued liabilities	$	1,753,877		$	612,282
Overdraft liabilities		—			46,023
Customer deposits		55,026			—
Notes payable		227,857			18,005
Other Liabilities		69,158			30,000

Total Current Liabilities		2,105,918			706,310

Long Term Debt		4,300,000			152,509

STOCKHOLDERS' EQUITY:
Preferred stock, $.001 par value; 3,000,000 shares authorized, none issued and outstanding		—			—
Common stock, $.001 par value; 1,000,000,000 shares authorized; 757,586,910 and 746,436,909 shares issued and outstanding, respectively.		757,587			746,437
Additional paid in capital		3,611,432			3,217,602
Accumulated deficit		(4,145,528	)		(4,324,683	)

Total Stockholders' Equity (Deficit)		223,491			(360,644	)

Total Liabilities and Stockholders' Deficit	$	6,629,409		$	498,175

See accompanying notes to audited financial statements

Hasco Medical, Inc. & Subsidiaries

Consolidated Statements of Operations

(unaudited)*


	Three Months Ended June 30,						Six Months Ended June 30,
	2011			2010			2011			2010

Net revenues	$	3,724,153		$	3,253,492		$	6,439,186		$	6,086,987

Cost of sales (1)		2,394,395			1,985,800			3,984,923			4,039,849

Gross profit		1,329,757			1,267,692			2,454,262			2,047,138

Operating expenses:
General and administrative		1,133,747			1,111,541			2,202,749			2,222,832
Depreciation		51,270			58,950			102,128			117,900

Total operating expenses		1,185,018			1,170,491			2,304,878			2,340,732

Income from operations		144,740			97,201			149,385			(293,594	)

Other income (expenses):
Other income		46,246			—			80,072			—
Interest expense		(36,188	)		(28,225	)		(67,833	)		(55,693	)

Total other expenses		10,057			(28,225	)		12,239			(55,693	)

Income (Loss) before income taxes		154,797			68,976			161,623			(349,287	)

Income tax (expense)		—			—			—			(15,846	)

Net Income	$	154,797		$	68,976		$	161,623		$	(365,133	)

* Statements of operation include Freedom Mobility for periods prior to acquisition for comparability.

See accompanying notes to audited financial statements

Hasco Medical, Inc. & Subsidiaries

Consolidated Statements of Cash Flows

(unaudited)


	Six Months Ended June 30,
	2011			2010

Cash flows from operating activities:
Net loss	$	161,624		$	(261,837	)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation & Amortization		186,375			1,823,666
Stock based compensation		17,880			20,074
Sales team & infrastructure, net		(1,635,045	)		(258,604	)
Customer list		(1,095,649	)		—
Purchase price adjustment		(20,328	)		19,541
Changes in operating assets and liabilities:
Accounts receivable		(80,478	)		4,236
Prepaid expenses and other current assets		(5,118	)		(16,405	)
Inventory		(2,306,038	)		303,319
Other assets		(37,599	)		—

Net cash (used in) provided by operating activities		(3,624,620	)		1,633,990

Cash flows from investing activities:
Disposal (Purchase) of property and equipment		(758,056	)		11,691

Net cash used in investing activities		(758,056	)		11,691

Cash flows from financing activities:
Proceeds from note payable		4,147,491			—
Proceeds from sale of common stock		387,100			150,096
Repayments (proceeds) of notes payable		209,852			(1,563,778	)

Net cash provided by financing activities		4,744,443			(1,413,682	)

Net increase (decrease) in cash		361,767			231,999

Cash, Beginning of period		423			28,217

Cash, End of period	$	362,190		$	260,216

Supplemental disclosures of cash flow information:
Cash paid for:
Interest	$	—		$	—
Income taxes	$	—		$	—

Non-Cash transactions:
Vehicles acquired through financing	$	—		$	21,759

See accompanying notes to unaudited consolidated financial statements

HASCO MEDICAL, INC. AND SUBSIDIARY

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2011 and 2010

NOTE 1 - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NATURE OF OPERATIONS

HASCO Medical, Inc. (“HASCO” or the “Company”), formerly BBC Graphics of Palm Beach Inc, was incorporated in May 2009 under the laws of the State of Florida. The Company operated as a provider of advertising and graphic design services. In June 2009, the Company changed its name to HASCO Medical, Inc.

On May 12, 2009, HASCO completed the acquisition of Southern Medical & Mobility, Inc. (SMM”) pursuant to the terms of the Agreement and Plan of Merger (the “Merger Agreement”) among HASCO, SMM and Southern Medical Acquisition, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company. Under the terms of the Merger Agreement Southern Medical Acquisition, Inc. was merged into Southern Medical & Mobility, Inc., and Southern Medical & Mobility, Inc. became a wholly-owned subsidiary of HASCO. The shareholder of Southern Medical & Mobility, Inc. was issued a total of 554,676,000 shares of the Company’s common stock in exchange for their Southern Medical & Mobility, Inc. share.

After the merger and transactions that occurred at the same time as the merger, there were 642,176,000 shares of the Company’s common stock outstanding, of which 620,000,000, approximately 96.5%, were held by HASCO Holdings, LLC, the former sole shareholder of Southern Medical & Mobility, Inc.

Prior to the merger, the Company was a shell company with no business operations.

Southern Medical & Mobility, Inc. provides home health care services and products consisting primarily of the rental and sale of home medical equipment and home health care supplies. These services and products are paid for primarily by Medicare, Medicaid, and other third-party payors.

For accounting purposes, HASCO Medical, Inc. has accounted for the transaction as a reverse acquisition and HASCO will be the surviving entity as a publicly-traded company under the name HASCO Medical Inc. or together with its subsidiaries. The Company did not recognize goodwill or any intangible assets in connection with this transaction.

The Merger was accounted for as a reverse acquisition, with Southern Medical & Mobility, Inc, as the accounting acquirer. Therefore, the Company’s historical financial statements reflect those of Southern Medical & Mobility, Inc. Accordingly, the reverse acquisition is being accounted for as a capital transaction in substance, rather than a business combination. For accounting purposes, the net liabilities of HASCO Medical, Inc. were recorded at fair value as of the Closing Date, with an adjustment to additional paid-in capital. The deficit accumulated by HASCO was carried forward after the Merger.

Effective with the reverse merger, all previously outstanding common stock owned by HASCO Medical, Inc.’s shareholders were exchanged for the Company’s common stock. The value of the Company’s common stock that was issued to HASCO Medical, Inc.’s shareholders was the historical cost of the Company’s net tangible assets, which did not differ materially from its fair value.

All references to common stock, share and per share amounts have been retroactively restated to reflect the reverse acquisition as if the transaction had taken place as of the beginning of the earliest period presented.

On May 13, 2011 Hasco Medical, Inc. completed the acquisition of Mobility Freedom, Inc and Wheel Chair Vans of America. Mobility Freedom was founded 1999 in Clermont, Florida, by Mr. Jeff Connors, who continues to serve as its President. With over 30 years experience in the van conversion industry, Mr. Connors formed Mobility Freedom in response to his identification of a need in the fast growing Central Florida area for a quality full service dealership of conversion vans and other mobility products that would help the disabled become mobile. A few years after the business started, Mr. Connors had an opportunity to purchase a van rental company, which now does business under the name “Wheelchair Vans of America.” Wheelchair Vans of America specializes in renting conversion vans to the disabled individuals visiting the State of Florida. This business unit has proven to be an effective complement to Mobility Freedom and is anticipated to be expanded to other areas of the country.

HASCO MEDICAL, INC. AND SUBSIDIARY

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2011 and 2010

Mobility Freedom caters to individuals with physical limitations that need specialty equipment to drive as well as families with members who are disabled that need to be transported. In certain circumstances, both the van itself as well as its specialty equipment is paid for, directly to Mobility Freedom, by a federal or state agency. As an example, approximately 45% of Mobility Freedom’s customers are veterans receiving benefits from the United States Department of Veterans Affairs (the “VA”). As part of the VA’s mission “to provided veterans the world-class benefits and services they have earned”, the VA pays for a van for disabled veterans. As a result, Mobility Freedom is both a VA and Vocational Rehabilitation (VR) state certified vendor. In addition, Mobility Freedom is an exclusive vendor for certain Florida state funded agencies, including the Florida Birth-Related Neurological Injury Compensation Association (NICA).

Mobility Freedom provides mobility solutions to its client base with disabilities through both the sale and rental of wheelchair accessible vans. It sales operations are conducted as an authorized dealer for a number of OEM handicap van manufacturers including:


	•	The Braun Corporation, which offers a variety of wheelchair accessible van conversions of popular minivan models including the Dodge Grand Caravan, the Chrysler Town & Country, the Toyota Sienna and the Honda Odyssey;

	•	Vantage Mobility International; and

	•	ElDorado National Company, a THOR company.

These OEM manufacturers provide chassis conversions to traditional minivans and full size vans in order to make them handicap accessible. These conversions traditionally include lowering the floors in order to increase head room, the addition of side entry or rear entry ramps and the installation of a wheelchair lift. Upon the selection by a customer of its base van, Mobility Freedom provides custom conversion services.

Mobility Freedom’s mobility services revolve around an analysis of each individual’s use of the van as well as individual physical limitations. In those instances where it is the passenger and not the driver who requires a wheelchair, Mobility Freedom provides full installation of EZ Lock Tie Down Systems to secure the wheelchair during movement. In connection with meeting the needs of a handicapped driver, the Company utilizes an independent evaluator who evaluates the needs of the driver and recommends the appropriate Driver Adaptive Equipment (“DAE”).

DAE installed by Mobility Freedom covers a broad array of products designed to allow a motorist with disabilities to drive despite his or her physical limitations. The equipment, the cost of which in certain circumstances can exceed $100,000, includes:


	•	hand controls;

	•	spinner knob to aid in turning the steering wheel;

	•	a transfer seat;

	•	electronic driving controls such as a touch screen which controls various electronic equipment in an auto such as the ignition; and

	•	reduced effort steering and braking.

Mobility Freedom also offers another unique solution with the option of a wheelchair accessible truck or truck conversion. Offered by Ryno Mobility a wheelchair truck conversion offers the ability to retain the style and performance of a truck while the handicap truck conversion allows wheelchair access.

Mobility Freedom has four corporate owned stores which are located in Orlando, Largo, Clermont and Palm Coast/Bunell, and three affiliates which are located in Edgewater, Pensacola and Ocala for a total of seven operations centers in Florida. We believe that many of the demographics factors in North Central Florida make it an ideal location for Mobility Freedom’s operations including:

HASCO MEDICAL, INC. AND SUBSIDIARY

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2011 and 2010


	•	an older and aging population;

	•	the numerous tourist destinations that define the greater Orlando are; and

	•	a significant population of military veterans attracted by the Orlando VA Medical Center. Currently the new Orlando VA Medical Center is under construction and will be located on a 65-acre campus in southeast Orange County. The 1.2 million square foot facility, scheduled to open in fall of 2012, will have a large multispecialty outpatient clinic, 134-inpatient beds, 120-community living center beds, a 60-bed domiciliary and administrative and support services. The VA will be co-located with the University of Central Florida College of Medicine, the Burnham Institute, the University of Florida Academic and Research Center and Nemours Children’s Hospital in the Lake Nona area known as the “Medical City.”

Mobility Freedom’s Our agreements with the vehicle manufacturers permit it to sell the vehicles within certain specific territories and it is not authorized to sell all brands in all of these areas. The agreements with the affiliates provide that Mobility Freedom holds the territory rights to sell vehicles and the affiliate provides the location. The affiliate is entitled to receive 50% of the profit on each van sold as consideration for providing the location. We expect that Mobility Freedom’s operations will represent a material portion of our business in the future.

Historically, our operations were focused on the provision of a diversified range of home health care services and products. Following our May 2011 acquisition of Mobility Freedom, our operations are conducted within two business units:


	•	Mobility Freedom, including its rental operations conducted under the trade name Wheelchair Vans of America located in Northern Florida, and

	•	Southern Medical & Mobility located in Mobile Alabama.

Our objective is to continue to grow both intrinsically and through acquisitions in areas that we currently offer products and services in, as well in areas that are complementary. As Mobility Freedom is significantly larger than Southern Mobility, we anticipate that Mobility Freedom will drive our near term financial results.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8-03 of Regulation S-X. Accordingly, the consolidated financial statements do not include all of the information and footnotes required by US GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and such adjustments are of a normal recurring nature. These consolidated financial statements should be read in conjunction with the consolidated financial statements for the year ended December 31, 2010 and notes thereto and other pertinent information contained in Form 10-K of HASCO Medical, Inc. (the “Company”, “we”, “us”. Or “our”) as filed with the Securities and Exchange Commission (the “Commission”). All significant intercompany transactions and balances have been eliminated in consolidation.

Use of Estimates

The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheets and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Significant estimates in 2011 and 2010 include the allowance for doubtful accounts, the valuation of inventory, the useful life of property and equipment and the assumptions used to calculate stock-based compensation.

HASCO MEDICAL, INC. AND SUBSIDIARY

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2011 and 2010

Reclassification

Certain amounts in the 2010 consolidated financial statements have been reclassified to conform to the 2011 presentation. Such reclassifications had no effect on the reported net loss.

Fair Value of Financial Instruments

Effective January 1, 2008, the Company adopted FASB ASC 820, “Fair Value Measurements and Disclosures” (“ASC 820”), for assets and liabilities measured at fair value on a recurring basis. ASC 820 establishes a common definition for fair value to be applied to existing generally accepted accounting principles that require the use of fair value measurements, and establishes a framework for measuring fair value and expands disclosure about such fair value measurements. The adoption of ASC 820 did not have an impact on the Company’s financial position or operating results, but did expand certain disclosures.

ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below:


	Level 1:	Observable inputs such as quoted market prices in active markets for identical assets or liabilities

	Level 2:	Observable market-based inputs or unobservable inputs that are corroborated by market data

	Level 3:	Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.

Cash and cash equivalents include money market securities that are considered to be highly liquid and easily tradable as of June 30, 2011 and December 31, 2010. These securities are valued using inputs observable in active markets for identical securities and are therefore classified as Level 1 within our fair value hierarchy.

In addition, FASB ASC 825-10-25 Fair Value Option was effective for January 1, 2008. ASC 825-10-25 expands opportunities to use fair value measurements in financial reporting and permits entities to choose to measure many financial instruments and certain other items at fair value. The Company did not elect the fair value options for any of its qualifying financial instruments.

The carrying amounts of financial instruments, including cash, accounts receivable, accounts payable and accrued liabilities, and promissory note, approximated fair value as of June 30, 2011 and December 31, 2010 , because of the relatively short-term maturity of these instruments and their market interest rates.

Revenue Recognition and Concentration of Credit Risk

Revenues are recognized under fee for service arrangements through equipment that the Company rents to patients, sales of equipment, supplies, and other items the Company sells to patients. Revenue generated from equipment that the Company rents to patients is recognized over the rental period and commences on delivery of the equipment to the patients. Revenue related to sales of equipment, and supplies is recognized on the date of delivery to the patients. All revenues are recorded at amounts estimated to be received under reimbursement arrangements with third-party payors, including private insurers, prepaid health plans, Medicare and Medicaid.

Revenues are recognized on an accrual basis at the time services and related products are provided to patients and collections are reasonably assured, and are recorded at amounts estimated to be received under healthcare contracts with third-party payers, including private insurers, Medicaid, and Medicare. Insurance benefits are assigned to us by patients receiving medical treatments and related products and, accordingly, we bill on behalf of our patients/customers. Under these contracts, we provide healthcare services, medical equipment and supplies to patients pursuant to a physician’s prescription. The insurance company reimburses us for these services and products at agreed upon rates. The balance remaining for product or service costs becomes the responsibility of the patient. A systematic process is employed to ensure that sales are recorded at net realizable value and that any required adjustments are recorded on a timely basis. We have established an allowance to account for contractual sales adjustments that result from differences between

HASCO MEDICAL, INC. AND SUBSIDIARY

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2011 and 2010

the amount remitted for reimbursement and the expected realizable amount. Due to the nature of the industry and the reimbursement environment in which we operate, certain estimates are required to record net revenue and accounts receivable at their net realizable values at the time products and/or services are provided. Inherent in these estimates is the risk that they will have to be revised or updated as additional information becomes available. Specifically, the complexity of many third party billing arrangements and the uncertainty of reimbursement amounts for certain services from certain payors may result in adjustments to amounts originally recorded. Such adjustments are typically identified and recorded at the point of cash application, claim denial or account review. The Company reports revenues in our financial statements net of such adjustments. The Company recorded contractual adjustments of $176,864 and $182,807 during the six months ended June 30, 2011 and 2010, respectively.

Certain items provided by the Company are reimbursed under rental arrangements that generally provide for fixed monthly payments established by fee schedules for as long as the patient is using the equipment and medical necessity continues (subject to capped rental arrangements which limit the rental payment periods in some instances and which may result in a transfer of title to the patient at the end of the rental payment period). Once initial delivery of rental equipment is made to the patient, a monthly billing cycle is established based on the initial date of delivery. The Company recognizes rental arrangement revenues ratably over the monthly service period and defers revenue for the portion of the monthly bill that is unearned. No separate payment is earned from the initial equipment delivery and setup process. During the rental period, the Company is responsible for servicing the equipment and providing routine maintenance, if necessary.

The Company follows the guidance of the FASB ASC 605-10-S99 “Revenue Recognition Overall – SEC Materials. The Company records revenue when persuasive evidence of an arrangement exists, services have been rendered or product delivery has occurred, the sales price to the customer is fixed or determinable, and collectability is reasonably assured.

Included in accounts receivable are earned but unbilled receivables. Unbilled accounts receivable represent charges for equipment and supplies delivered to customers for which invoices have not yet been generated by the billing system. Prior to the delivery of equipment and supplies to customers, the Company performs certain certification and approval procedures to ensure collection is reasonably assured and that unbilled accounts receivable are recorded at net amounts expected to be paid by customers and third-party payors. Billing delays, generally ranging from several days to several weeks, can occur due to delays in obtaining certain required payor-specific documentation from internal and external sources, interim transactions occurring between cycle billing dates established for each customer within the billing system and business acquisitions awaiting assignment of new provider enrollment identification numbers. In the event that a third-party payor does not accept the claim for payment, the customer is ultimately responsible.

The Company performs analyses to evaluate the net realizable value of accounts receivable. Specifically, the Company considers historical realization data, accounts receivable aging trends, other operating trends and relevant business conditions. Because of continuing changes in the health care industry and third-party reimbursement, it is possible that our estimates could change, which could have a material impact on the Company’s operations and cash flows.

Cash and Cash Equivalents

The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company places its cash with a high credit quality financial institution. The Company’s account at this institution is insured by the Federal Deposit Insurance Corporation ("FDIC") up to $250,000. For the six months ended June 30, 2011, the Company has not reached bank balances exceeding the FDIC insurance limit. To reduce its risk associated with the failure of such financial institution, the Company evaluates at least annually the rating of the financial institution in which it holds deposits.

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable, and notes payable. The Company's investment policy is to invest in low risk, highly liquid investments. The Company does not believe it is exposed to any significant credit risk in its cash investment.

The Company performs on-going credit evaluations of its customer base including those included in accounts receivable at June 30, 2011 and December 31, 2010, and, generally, does not require collateral. The Company maintains reserves for potential credit losses and such losses have been within management’s expectations.

HASCO MEDICAL, INC. AND SUBSIDIARY

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2011 and 2010

Accounts Receivable

Accounts receivable of Southern Medical and Mobility consists primarily of receivables due from Medicare, Medicaid, and third party payers. The Company recorded a bad debt allowance of $303,177 and $327,697 as of June 30, 2011 and December 31, 2010, respectively. Management performs ongoing evaluations of its accounts receivable.

Due to the nature of the industry and the reimbursement environment in which the Company operates, certain estimates are required to record net revenues and accounts receivable at their net realizable values. Inherent in these estimates is the risk that they will have to be revised or updated as additional information becomes available. Specifically, the complexity and uncertainty of reimbursement amounts for certain services from certain payors may result in adjustments to amounts originally recorded. Such adjustments are typically identified and recorded at the point of cash application, claim denial or account review.

Management performs periodic analyses to evaluate accounts receivable balances to ensure that recorded amounts reflect estimated net realizable value. Specifically, management considers historical realization data, accounts receivable aging trends, and other operating trends. Also considered are relevant business conditions such as governmental and managed care payor claims processing procedures and system changes.

Accounts receivable are reduced by an allowance for doubtful accounts which provides for those accounts from which payment is not expected to be received, although services were provided and revenue was earned. Upon determination that an account is uncollectible, it is written-off and charged to the allowance.

Accounts receivable balance concentrations by major payor category as of June 30, 2011 and December 31, 2010 were as follows:


Percentage of Accounts Receivable Outstanding:	June 30, 2011	December 31, 2010

Medicare	23.8%	36.6%
Medicaid/Other Government	20.2%	3.6%
Private Insurance/Other	56.0%	59.8%
Total	100.0%	100.0%

Inventory

Inventory is valued at the lower of cost or market, on an average cost basis and includes primarily finished goods.

Advertising

Advertising, marketing and selling is expensed as incurred. Such expenses for the six months ended June 30, 2011 and 2010, and totaled $25,107 and $3,348, respectively.

Shipping and Handling Costs

The Company classifies costs related to freight as costs of sales.

Property and Equipment

Property and equipment, including rental equipment are carried at cost and are depreciated on a straight-line basis over the estimated useful lives of the assets. Depreciation of rental equipment is computed using the straight-line method over the estimated useful lives, generally one to three years. Such depreciation of rental equipment is charged to cost of sales. The cost of repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition. The Company examines the possibility of decreases in the value of fixed assets when events or changes in circumstances reflect the fact that their recorded value may not be recoverable.

HASCO MEDICAL, INC. AND SUBSIDIARY

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2011 and 2010

Impairment of Long-Lived Assets

The Company reviews, long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable, or at least annually. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset’s estimated fair value and its book value. The Company did not record any impairment charges for the six months ended June 30, 2011 and 2010.

Income Taxes

Deferred income tax assets and liabilities are computed for differences between the carrying amounts of assets and liabilities for financial statement and tax purposes. Deferred income tax assets are required to be reduced by a valuation allowance when it is determined that it is more likely than not that all or a portion of a deferred tax asset will not be realized. In determining the necessity and amount of a valuation allowance, management considers current and past performance, the operating market environment, tax planning strategies and the length of tax benefit carry forward periods.

Pursuant to accounting standards related to the accounting for uncertainty in income taxes, the evaluation of a tax position is a two-step process. The first step is to determine whether it is more likely than not that a tax position will be sustained upon examination, including the resolution of any related appeals or litigation based on the technical merits of that position. The second step is to measure a tax position that meets the more-likely-than-not threshold to determine the amount of benefit to be recognized in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50% likelihood of being realized upon ultimate settlement. Tax positions that previously failed to meet the more-likely-than-not recognition threshold should be recognized in the first subsequent period in which the threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not criteria should be de-recognized in the first subsequent financial reporting period in which the threshold is no longer met. The accounting standard also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosures, and transition. The adoption had no effect on the Company’s consolidated financial statements.

Subsequent Events

For purposes of determining whether a post-balance sheet event should be evaluated to determine whether it has an effect on the financial statements for the six months ended June 30, 2011, subsequent events were evaluated by the Company as of the date on which the consolidated financial statements for the three and six months ended June 30, 2011 and 2010 were available to be issued.

Stock Based Compensation

In December 2004, the Financial Accounting Standards Board, or FASB, issued FASB ASC Topic 718: Compensation – Stock Compensation (“ASC 718”). Under ASC 718, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share-based compensation arrangements include stock options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans. Companies may elect to apply this statement either prospectively, or on a modified version of retrospective application under which financial statements for prior periods are adjusted on a basis consistent with the pro forma disclosures required for those periods under ASC 718. Upon adoption of ASC 718, the Company elected to value employee stock options using the Black-Scholes option valuation method that uses assumptions that relate to the expected volatility of the Company’s common stock, the expected dividend yield of our stock, the expected life of the options and the risk free interest rate. Such compensation amounts, if any, are amortized over the respective vesting periods or period of service of the option grant.

Related Parties

Parties are considered to be related to the Company if the parties that, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of

HASCO MEDICAL, INC. AND SUBSIDIARY

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2011 and 2010

the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. The Company discloses all related party transactions. All transactions shall be recorded at fair value of the goods or services exchanged. Property purchased from a related party is recorded at the cost to the related party and any payment to or on behalf of the related party in excess of the cost is reflected as a distribution to related party.

Recently Issued Accounting Pronouncements

We have reviewed the FASB issued Accounting Standards Update (“ASU”) accounting pronouncements and interpretations thereof that have effectiveness dates during the periods reported and in future periods. The Company has carefully considered the new pronouncements that alter previous generally accepted accounting principles and does not believe that any new or modified principles will have a material impact on the corporation’s reported financial position or operations in the near term. The applicability of any standard is subject to the formal review of our financial management and certain standards are under consideration. Reference is made to these recent accounting pronouncements as if they are set forth therein in their entirety.

Earnings (Loss) Per Share

Earnings per common share are calculated under the provisions of a FASB issued new guidance,” which established new accounting standards for computing and presenting earnings per share. The accounting standard requires the Company to report both basic earnings per share, which is based on the weighted-average number of common shares outstanding, and diluted earnings per share, which is based on the weighted-average number of common shares outstanding plus all potential dilutive common shares outstanding. The computation of diluted net loss per share does not include dilutive common stock equivalents in the weighted average shares outstanding as they would be anti-dilutive. As of June 30, 2011, there were 3,075,000 stock options which could potentially dilute future earnings per share.

NOTE 2 – GOING CONCERN CONSIDERATIONS

The accompanying consolidated financial statements are prepared assuming the Company will continue as a going concern. At June 30, 2011, the Company had an accumulated deficit of approximately $3.9 million. The ability of the Company to continue as a going concern is dependent upon increasing sales and obtaining additional capital and financing to support its recent acquisition. During the quarter ended June 30, 2011, the Company secured a working capital line of credit in the amount of $400,000. Management intends to attempt to raise additional funds by way of a public or private offering. While the Company believes in the viability of its strategy to increase sales volume and in its ability to raise additional funds, there can be no assurances to that effect.

NOTE 3 – PROPERTY AND EQUIPMENT

Property and equipment consisted of the following:


	Estimated Life	June 30, 2011			December 31, 2010
Building improvements	15-39 years	$	60,110		$	—
Office equipment	5 years		108,434			38,979
Rental equipment	13 - 36 months		1,521,767			468,646
Vehicles	5 years		114,775			71,656
Computer equipment	5 years		53,086			31,483
			1,582,172			610,764
Less: accumulated depreciation			(1,100,863	)		(462,995	)

		$	757,309		$	147,769

For the six months ended June 30, 2011 and 2010, depreciation expense amounted to $148,516 and $185,967, respectively of which $46,388 and $68,067 is included in cost of sales, respectively.

HASCO MEDICAL, INC. AND SUBSIDIARY

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2011 and 2010

The Company has entered into various financing arrangements in connection with the acquisition of three delivery vehicles (see Note 4 below).

NOTE 4 – NOTES PAYABLE

Between December 2008 and January 2009, the Company issued notes payable amounting to $52,979 in connection with the acquisition of three delivery vehicles. The notes payable bear approximately 2% interest per annum and are secured by a lien of all three delivery vehicles. These notes shall be payable in thirty-six equal monthly payments of $1,516 beginning in January 2009 through December 2011. As of June 30, 2011, the current and long term portion of these notes amounted to $15,176. As of December 31, 2010, the current and long term portion of these notes amounted to $18,005 and $2,509, respectively.

On June 29, 2011 Hasco Medical, Inc. entered into a $400,000 revolving line of credit agreement with Whitney Bank, which includes an annual renewal. An annual facility fee of .25% was charged. Interest at the Wall Street Journal prime rate plus 1.0% on the used facility will be paid monthly. At June 30, 2011 the aforementioned interest rate was 4.25%. As of June 30, 2011 there remains $100,000 available on the line of credit.

On May 13, 2011, the Company issued a promissory note, payable to the Sellers of Mobility Freedom Inc (the Acquisition), in the amount of $3,850,000, in exchange for all the shares of acquired company. The terms of the agreement included an employment agreement with the seller. The acquisition price consists of two notes:


	1.	Note for $2,000,000 ($1,850,000 cash proceeds to seller and consolidation of $150,000 previously advanced for working capital) to Hal Compton, Sr, our Chairman. The note bears interest at 5% annually with monthly payments of interest and principal of $21,213, commencing August 15, 2011 for 120 months;

	2.	Promissory note to seller note in the amount of $2,000,000, secured by grantee from the majority shareholder, with interest at 6% per annum and equal monthly installments of interest and principal of $16,877.14.

NOTE 5 – LOANS PAYABLE – RELATED PARTY

In February 2011, HASCO Holdings, LLC, the largest shareholder of the Company, loaned $50,000 to the Company. These loans are non interest bearing and are due on demand.

In February 2011, one of the Company’s directors loaned $135,000 to the Company. These loans are non interest bearing and are due on demand.

NOTE 6 – EQUITY

On May 12, 2009 HASCO Medical, Inc. (“HASCO”) completed the acquisition of Southern Medical & Mobility, Inc. (SMM”) pursuant to the terms of the Agreement and Plan of Merger (the “Merger Agreement”) among HASCO, SMM and Southern Medical Acquisition, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company. Under the terms of the Merger Agreement Southern Medical Acquisition, Inc. was merged into Southern Medical & Mobility, Inc., and Southern Medical & Mobility, Inc. became a wholly-owned subsidiary of HASCO. The shareholder of Southern Medical & Mobility, Inc. was issued a total of 554,676,000 shares of the Company’s common stock in exchange for their Southern Medical & Mobility, Inc. share.

Prior to the merger, the Company was a shell company with no business operations.

HASCO MEDICAL, INC. AND SUBSIDIARY

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2011 and 2010

In January 2011, in connection with the sale of the Company’s common stock, the Company issued 2,000,000 shares of common stock for net proceeds of approximately $20,000.

In February 2011, the Company entered into a placement agent agreement whereby the Company engaged that firm to assist us in a best efforts private offering of the Company’s securities. Under the terms of the agreement, the Company paid the firm an upfront retainer of 150,000 shares of the Company’s common stock as compensation for services. The Company shall pay 2% commissions based on the proceeds received by the Company from the offering. The Company valued these common shares at the fair market value on the date of grant at $0.02 per share or $3,000 and was recorded as stock-based consulting expense.

In March 2011, the Company issued 9,000,000 shares in connection with the payment of accrued management fees of $180,000 to HASCO Holdings, LLC. The Company valued these common shares at the fair market value on the date of grant at $0.02 per share or $180,000.

NOTE 7 – STOCK OPTION PLAN

Under the Company’s stock option plan, adopted on July 9, 2009, 20,000,000 shares of common stock were reserved for issuance upon exercise of options granted to directors, officers and employees of the Company. The Company is authorized to issue Incentive Stock Options (“ISOs”), which meet the requirements of Section 422 of the Internal Revenue Code of 1986. At its discretion, the Company can also issue Non Statutory Options (“NSOs”). When an ISO is granted, the exercise price shall be equal to the fair market value per share of the common stock on the date of the grant. The exercise price of an NSO shall not be less than fair market value of one share of the common stock on the date the option is granted. The vesting period will be determined on the date of grant.

On November 1, 2009, the Company granted an aggregate of 4,075,000 5-year option to purchase shares of common stock at $0.007 per share which vests at the end of two years, to four officers and three directors of the Company. The 4,075,000 options were valued on the grant date at $0.0064 per option or a total of $26,080 using a Black-Scholes option pricing model with the following assumptions: stock price of $0.007 per share, volatility of 150%, expected term of five years, and a risk free interest rate of 2.33%.

Stock option activity for the three months ended June 30, 2011 is summarized as follows:


	Number of shares		Weighted average exercise price
Outstanding at December 31, 2010	4,075,000		$	0.007
Granted	—			—
Exercised	—			—
Cancelled	(1,000,000	)		—
Outstanding at June 30, 2011			$

Options exercisable at end of year	—		$	—
Weighted average fair value of options granted during the year			$	—

Stock options outstanding at June 30, 2011 as disclosed in the above table have $29,212 intrinsic value at the end of the year.

HASCO MEDICAL, INC. AND SUBSIDIARY

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2011 and 2010

The following table summarizes the Company's stock options outstanding at June 30, 2011:


Options Outstanding						Options Exercisable
	Range of Exercise Price	Number Outstanding	Weighted Average Remaining Contractual Life		Weighted Average Exercise Price	Number Exercisable		Weighted Average Exercise Price
$	0.007	3,075,000	3.58 Years	$	0.007	—	$	—
		3,075,000		$	0.007	—	$	—

NOTE 8 – COMMITMENTS

Operating Lease

The Company leases office space in Mobile, Alabama, and several sites in Florida under two- five-year operating leases that expire on April 30, 2014. The office lease agreements have certain escalation clauses and renewal options. Additionally, the Company has lease agreements for computer equipment, including an office copier and fax machine. Future minimum rental payments required under these operating leases are as follows:


Period ending June 30:
2011		145,311
2012		277,120
2013 and thereafter		309,431
	$	731,862

Rent expense was $128,575 and $98,506 for the six months ended June 30, 2011 and 2010, respectively.

In April 2011, the Company received approximately $80,000 from Hasco Holdings, LLC. In March 2011, Hasco Holdings LLC. entered into a settlement and release agreement with the former owners of Southern Medical & Mobility, Inc. (“SMM”). The former owners agreed to reimburse Hasco Holdings LLC for all the refunds made to third party payors associated with billings prior to the acquisition of Hasco Holdings LLC of SMM in June 2008.

NOTE 9 – SEGMENT REPORTING

Pursuant to accounting standards related to the Disclosure about Segments of an Enterprise and Related Information which establishes standards for the reporting by business enterprises of information about operating segments, products and services, geographic areas, and major customers. The method for determining what information to report is based on the way that management organizes the operations of the Company for making operational decisions and assessments of financial performance.

The Company’s operating decision-maker is considered to be the chief executive officer (CEO). The CEO reviews financial information for purposes of making operating decisions and assessing financial performance. The financial information reviewed by the CEO is identical to the information presented in the accompanying statements of operations. Therefore, the Company has determined that it operates in a single operating segment. For the periods ended December 31, 2010 and 2009 all material assets and revenues of the Company were in the United States.

NOTE 10 – RELATED PARTY TRANSACTIONS

Management Fee


Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our financial statements and related notes appearing elsewhere in this report. This discussion and analysis contains forward-looking statements that involve risks, uncertainties, and assumptions. The actual results may differ materially from those anticipated in these forward-looking statements as a result of certain factors, including but not limited to the risks discussed in this report.

Overview

From our formation in May 1999 through April 2006, we were in the business of providing advertising and graphic design services to our clients. On October 1, 2004, we were administratively dissolved by the State of Florida pursuant to Sections 607.1420 and 607.1421 of the Florida Business Corporation Act. On April 29, 2006, we were reinstated as an active Florida corporation pursuant to Section 607.1422 of the Florida Business Corporation Act. As of that date, we discontinued our advertising and graphics design business.

We were organized under the laws of the State of Florida in May 1999. Our principal executive offices are located at 1416 West I-65 Service Road S., Mobile, AL 36693, and our telephone number is (251) 633-4133.

On January 12, 2009 HASCO Holdings, LLC acquired 65,324,000 shares of HASCO Medical, Inc. common stock for total consideration of $150,000. HASCO Holdings, LLC thereby purchased beneficial ownership of 75% of the outstanding shares of common stock of the Company. HASCO Holdings, LLC acquired the common shares of the Company from two shareholders, Robert Druzak, and John R. Signorello.

On May 12, 2009, HASCO Medical, Inc. (i) closed a share exchange transaction, pursuant to which HASCO Medical, Inc. became the 100% parent of SOUTHERN MEDICAL & MOBILITY, and (ii) assumed the operations of SOUTHERN MEDICAL & MOBILITY.

On May 12, 2009, we completed the acquisition of Southern Medical & Mobility, Inc. (SMM”) pursuant to the terms of the Agreement and Plan of Merger (the “Merger Agreement”) among HASCO, SMM and Southern Medical Acquisition, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company. Under the terms of the Merger Agreement Southern Medical Acquisition, Inc. was merged into Southern Medical & Mobility, Inc., and Southern Medical & Mobility, Inc. became our wholly-owned subsidiary. The shareholder of Southern Medical & Mobility, Inc. was issued a total of 554,676,000 shares of our common stock in exchange for their Southern Medical & Mobility, Inc. share.

After the merger and transactions that occurred at the same time as the merger, there were 642,176,000 shares of our common stock outstanding, of which 620,000,000, approximately 96.5%, were held by HASCO Holdings, LLC, the former sole shareholder of Southern Medical & Mobility, Inc.

Prior to the merger, we were a shell company with no business operations.

HASCO Medical, Inc., through the reverse merger of its wholly-owned subsidiary with and into Southern Medical & Mobility, is a low cost, quality provider of a broad range of home healthcare services that serve patients in Alabama, Florida, and Mississippi. We have two major service lines: home respiratory equipment and durable/ home medical equipment. Our objective is to be a leading provider of home health care products and services in the markets we operate.

For accounting purposes, the Merger was treated as a reverse acquisition with Southern Medical & Mobility, Inc. being the accounting acquirer. Therefore, the Company’s historical financial statements reflect those of Southern Medical & Mobility, Inc.

Historically, our operations were focused on the provision of a diversified range of home health care services and products. Following our May 13, 2011 acquisition of Mobility Freedom, our operations are conducted within two business units:


	•	Mobility Freedom, including its rental operations conducted under the trade name Wheelchair Vans of America located in Northern Florida, and

	•	Southern Medical & Mobility located in Mobile Alabama.

Critical Accounting Policies

The discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. Significant estimates in 2011 and 2010 include the allowance for doubtful accounts, the valuation of inventory, the useful life of property and equipment and the assumptions used to calculate stock-based compensation.

A summary of significant accounting policies is included in Note 1 to the audited consolidated financial statements included for the year ended December 31, 2010 and notes thereto contained in this report as filed with the Securities and Exchange Commission. Management believes that the application of these policies on a consistent basis enables us to provide useful and reliable financial information about the Company’s operating results and financial condition.

Our consolidated financial statements include a summary of the significant accounting policies and methods used in the preparation of our consolidated financial statements. Management believes the following critical accounting policies affect the significant judgments and estimates used in the preparation of the consolidated financial statements.

Use of Estimates - Management’s Discussion and Analysis or Plan of Operations is based upon our audited consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these consolidated financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, management evaluates these estimates, including those related to allowances for doubtful accounts receivable and the carrying value of and equipment and long-lived assets. Management bases these estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis of making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

Revenue Recognition - The Company follows the guidance of the FASB ASC 605-10-S99 “Revenue Recognition Overall – SEC Materials. The Company records revenue when persuasive evidence of an arrangement exists, services have been rendered or product delivery has occurred, the sales price to the customer is fixed or determinable, and collectability is reasonably assured. The following policies reflect specific criteria for the various revenues streams of the Company:


	•	Revenues are recognized under fee for service arrangements through vans that the Company rents to disabled individuals visiting Florida. Revenue generated from vans that the Company rents to individuals is recognized over the rental period and commences on delivery of the van to the customer. Revenue related to sales of vans, and supplies is recognized on the date of delivery to the customer.

	•	Revenues from sales of products are generally recognized when products are shipped unless the Company has obligations remaining under sales or licensing agreements, in which case revenue is either deferred until all obligations are satisfied or recognized ratably over the term of the contract.

	•	Revenue from services is recorded as it is earned. Customers are generally billed every two weeks based on the units of production for the project. Each project has an estimated total which is based on the estimated units of production and agreed upon billing rates.

	•	Amounts billed in advance of services being provided are recorded as deferred revenues and recognized in the consolidated statement of operations as services are provided.

Stock Based Compensation - In December 2004, the Financial Accounting Standards Board, or FASB, issued FASB ASC Topic 718: Compensation – Stock Compensation (“ASC 718”). Under ASC 718, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share-based compensation arrangements include stock options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans. Companies may elect to apply this statement either prospectively, or on a modified version of retrospective application under which financial statements for prior periods are adjusted on a basis consistent with the pro forma disclosures required for those periods under ASC 718. Upon adoption of ASC 718, the Company elected to value employee stock options using the Black-Scholes option valuation method that uses assumptions that relate to the expected volatility of the Company’s common stock, the expected dividend yield of our stock, the expected life of the options and the risk free interest rate. Such compensation amounts, if any, are amortized over the respective vesting periods or period of service of the option grant.

Accounts Receivable - Management performs ongoing evaluations of its accounts receivable. Due to the nature of the industry and the reimbursement environment in which the Company operates, certain estimates are required to record net revenues and accounts receivable at their net realizable values. Inherent in these estimates is the risk that they will have to be revised or updated as additional information becomes available. Specifically, the complexity and uncertainty of reimbursement amounts for certain services from certain payors may result in adjustments to amounts originally recorded. Such adjustments are typically identified and recorded at the point of cash application, claim denial or account review. Management performs periodic analyses to evaluate accounts receivable balances to ensure that recorded amounts reflect estimated net realizable value. Specifically, management considers historical realization data, accounts receivable aging trends, and other operating trends. Also considered are relevant business conditions such as governmental and managed care payor claims processing procedures and system changes. Accounts receivable are reduced by an allowance for doubtful accounts which provides for those accounts from which payment is not expected to be received, although services were provided and revenue was earned. Upon determination that an account is uncollectible, it is written-off and charged to the allowance.

Inventory is valued at the lower of cost or market, on an average cost basis and includes primarily finished goods.

Long-Lived Assets - The Company reviews for impairment whenever events or circumstances indicate that the carrying amount of assets may not be recoverable, pursuant to guidance established in ASC 360-10-35-15, “Impairment or Disposal of Long-Lived Assets” . The Company reviews, long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable, or at least annually. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset’s estimated fair value and its book value.

Reimbursement by Third Party Payors

With the acquisition of Mobility Freedom & Wheelchairs of America on May 13, 2011 the revenue mix has changed significantly. Mobility Freedom revenues are recognized under fee for service arrangements through vans that the Company rents to disabled individuals visiting Florida. Revenue generated from vans that the Company rents to individuals is recognized over the rental period and commences on delivery of the van to the customer. Revenue related to sales of vans, and supplies is recognized on the date of delivery to the customer.

We no longer derive substantially all of our revenues from reimbursement by third party payors, including Medicare, Medicaid, and private insurers. However, our business has been, and may continue to be, significantly impacted by changes mandated by Medicare legislation

Under existing Medicare laws and regulations, the sale and rental of our products generally are reimbursed by the Medicare program according to prescribed fee schedule amounts calculated using statutorily-prescribed formulas. The Balanced Budget Act of 1997 (BBA) granted authority to the Secretary of the Department of Health and Human Services (DHHS) to increase or reduce the reimbursement for home medical equipment, including oxygen, by up to 15% each year under an inherent reasonableness procedure. The regulation implementing the inherent reasonableness authority establishes a process for adjusting payments for certain items and services covered by Medicare Part B when the existing payment amount is determined to be grossly excessive or deficient. The regulation lists factors that may be used by the Centers for Medicare and Medicaid Services (CMS), the agency within the DHHS responsible for administering the Medicare program, and its contractors to determine whether an existing reimbursement rate is grossly excessive or deficient and to determine what a realistic and equitable payment amount is. Also, under the regulation, CMS and its contractors will not consider a payment amount to be grossly excessive or deficient and make an adjustment if they determine that an overall payment adjustment of less than 15% is necessary to produce a realistic and equitable payment amount. The implementation of the inherent reasonableness procedure itself does not trigger payment adjustments for any items or services and to date, no payment adjustments have occurred or been proposed under this inherent reasonableness procedure.

In addition to its inherent reasonableness authority, CMS has the discretion to reduce the reimbursement for home medical equipment (HME) to an amount based on the payment amount for the least costly alternative (LCA) treatment that meets the Medicare beneficiary’s medical needs. LCA determinations may be applied to particular products and services by CMS and its contractors through the informal notice and comment process used in establishing local coverage policies for HME. Using either its inherent reasonableness authority or LCA determinations, CMS and its contractors may reduce reimbursement levels for certain items and services covered by Medicare Part B, including products and services we offer which could have a material adverse effect on our revenues, profit margins, profitability, operating cash flows and results of operations. With respect to its LCA policies, on October 16, 2008, a U.S. District Court in the District of Columbia held that CMS did not have the authority to implement LCA determinations in setting payment amounts for covered inhalation drugs. DHHS filed its notice of appeal on December 10, 2008. We cannot predict whether this court decision will be overturned or whether CMS or its contractors will continue to apply LCA policies in the future to inhalation drugs or other HME products we offer to Medicare beneficiaries.

Recent legislation, each of which has been signed into law, including the Patient Protection and Affordable Care Act (“PPACA”), Medicare Improvement for Patients and Providers Act of 2008 (MIPPA), Medicare, Medicaid and State Children’s Health Insurance Program Extension Act of 2007 (“SCHIP Extension Act”), the Deficit Reduction Act of 2005 (DRA) and the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA), contain provisions that negatively impact reimbursement for the primary HME products that we provide. MIPPA retroactively delayed the implementation of competitive bidding for eighteen months and decreased the 2009 fee schedule payment amounts by 9.5 percent for product categories included in competitive bidding. The SCHIP Extension Act reduced Medicare reimbursement amounts for covered Medicare Part B drugs, including inhalation drugs that we provide, beginning April 1, 2008. The DRA caps the Medicare rental period for oxygen equipment at 36 months of continuous use, after which time title of the equipment would transfer to the beneficiary. For purposes of this cap, the DRA provides for a new 36-month rental period that began January 1, 2006 for all oxygen equipment. With the passage of MIPPA, transfer of title of oxygen equipment at the end of the 36-month rental cap was repealed, although the rental cap remained in place. The MMA significantly reduced reimbursement for inhalation drug therapies beginning in 2005, reduced payment amounts for five categories of HME, including oxygen, beginning in 2005, froze payment amounts for other covered HME items through 2007, established a competitive acquisition program for HME and implemented quality standards and accreditation requirements for HME suppliers. PPACA was signed into law on March 23, 2010. Together with the Health Care and Education Reconciliation Act of 2010 (signed into law on March 30, 2010) which amended the statute, PPACA is a comprehensive health care law that is intended to expand access to health insurance, reform the health insurance market to provide additional consumer protections, and improve the health care delivery system to reduce costs and produce better outcomes through a combination of cost controls, subsidies and mandates. These legislative provisions, as currently in effect and when fully implemented, have had and will have a material adverse effect on our business, financial condition, operating results and cash flows. We cannot predict the impact that any federal legislation enacted in the future will have on our revenues, profit margins, profitability, operating cash flows and results of operations.

Changes in the law or new interpretations of existing laws could have a dramatic effect on permissible activities, the relative costs associated with doing business and the amount of reimbursement by government and other third-party payors. Reimbursement from Medicare and other government programs is subject to federal and state statutory and regulatory requirements, administrative rulings, interpretations of policy, implementation of reimbursement procedures, retroactive payment adjustments and governmental funding restrictions. Our levels of revenue and profitability, like those of other health care companies, are affected by the continuing efforts of government payors to contain or reduce the costs of health care, including competitive bidding initiatives, measures that impose quality standards as a prerequisite to payment, policies reducing certain HME payment rates and restricting coverage and payment for inhalation drugs, and refinements to payments for oxygen and oxygen equipment.

(1) Competitive Bidding Program for HME. On April 2, 2007, CMS issued its final rule implementing a competitive bidding program for certain HME products under Medicare Part B. This nationwide competitive bidding program is designed to replace the existing fee schedule payment methodology. Under the competitive bidding program, suppliers compete for the right to provide items to beneficiaries in a defined region. CMS selects contract suppliers that agree to receive as payment the “single payment amount” calculated by CMS after bids are submitted. Round one of the competitive bidding program began on July 1, 2008 in ten high-population competitive bidding areas (CBAs). On July 15, 2008, Congress enacted the MIPPA legislation which retroactively delayed the implementation of competitive bidding and reduced Medicare prices nationwide by 9.5% beginning in 2009 for the product categories, including oxygen, that were initially included in competitive bidding. As a result of the delay, CMS cancelled all contract awards retroactively to June 30, 2008. In 2009, CMS reinstituted the bidding process in the nine largest MSA markets. Reimbursement rates from the re-bidding process were publicly released by CMS on June 30, 2010. CMS announced average savings of approximately 32% off the current payment rates in effect for the product categories included in competitive bidding. These payment rates are now in effect in the nine markets only, as of January 1, 2011. CMS will undertake a second round of competitive

bidding in up to 91 additional markets, with contracts expected to be effective as of January 1, 2013. It is not certain at this time whether CMS intends to implement competitive bidding in all 91 markets simultaneously, or whether the program will be phased in over several years. The PPACA legislation requires CMS to expand competitive bidding further to all geographic markets (certain markets may be excluded at the discretion of CMS) or to use competitive bid pricing information to adjust the payment amounts otherwise in effect for areas that are not competitive acquisition areas by January 1, 2016. We will continue to monitor developments regarding the implementation of the competitive bidding program. While we cannot predict the outcome of the competitive bidding program on our business when fully implemented nor the Medicare payment rates that will be in effect in future years for the items subjected to competitive bidding, it is likely that the program will materially adversely affect our financial position and operating results.

On July 15, 2008, Congress enacted the MIPPA legislation which reduced Medicare payment rates nationwide for certain DME items, including oxygen equipment, by 9.5% beginning in 2009. In addition to the 9.5% reduction, CMS subjected the monthly payment amount for stationary oxygen equipment to additional cuts of 2.3% in 2009, thereby reducing the monthly payment rate from $199.28 in 2008 to $175.79 in 2009. The monthly payment amount was reduced by 1.5% in 2010, to $173.17. We estimate that this reduction negatively impacted our revenues in 2010. The stationary oxygen payment rate for 2011 has been established by CMS at $173.31 per month, an increase of 0.1%.

(2) Certain Clinical Conditions, Accreditation Requirements and Quality Standards. The MMA required establishment and implementation of new clinical conditions of coverage for HME products and quality standards for HME suppliers. Some clinical conditions have been implemented, such as the requirement for a face-to-face visit by treating physicians for beneficiaries seeking power mobility devices. CMS published its quality standards and criteria for accrediting organizations for HME suppliers in 2006 and revised some of these standards in October 2008. As an entity that bills Medicare and receives payment from the program, we are subject to these standards. We have revised our policies and procedures to ensure compliance in all material respects with the quality standards. These standards, which are applied by independent accreditation organizations, include business-related standards, such as financial and human resources management requirements, which would be applicable to all HME suppliers, and product-specific quality standards, which focus on product specialization and service standards. The product specific standards address several of our products, including oxygen and oxygen equipment, CPAP and power and manual wheelchairs and other mobility equipment.

Currently, we are accredited by the Accreditation Commission for Health Care, Inc. (ACHC) for Medical Supply Provider Services. The ACHC is a CMS recognized accrediting organization. Round one competitive bid suppliers will now be required to be accredited by September 30, 2009.

On January 25, 2008, CMS published a proposed rule to clarify, expand and add to the existing enrollment requirements that Durable Medical Equipment and Prosthetics, Orthotics, and Supplies (DMEPOS) suppliers must satisfy to establish and maintain billing privileges in the Medicare program. Included in the proposed rule are revised or clarified requirements regarding contracting with an individual or entity to provide licensed services, record retention, clarification of the term “appropriate site” as set forth in the regulation (which may be expanded to include a minimum square footage requirement), use of cell phones and beepers/pagers as a method of receiving calls from the public or beneficiaries, comprehensive liability insurance, patient solicitation, maintenance of ordering and referring documentation, sharing of a practice location with another Medicare provider, and minimum operating hours. At this time, we cannot predict the impact that this proposed rule, if implemented, would have on our business.

On January 2, 2009, CMS published its final rule on surety bond requirements for DMEPOS suppliers, effective March 3, 2009. The amount of the surety bond has been set at $50,000 and must be obtained for each National Provider Identifier (NPI) number subject to Medicare billing privileges. We are required to have our own NPI number. There may be an upward adjustment for suppliers that have had adverse legal actions imposed on them in the past. DMEPOS suppliers already enrolled in Medicare must obtain a surety bond by October 2, 2009, and newly enrolled suppliers or those changing ownership will be subject to the provisions of the new rule on May 4, 2009. We obtained a surety bond on October 2, 2009 and still currently maintaining such surety bond.

(3) Reduction in Payments for HME and Inhalation Drugs. The MMA changes also included a reduction in reimbursement rates beginning in January 2005 for oxygen equipment and certain other items of home medical equipment (including wheelchairs, nebulizers, hospital beds and air mattresses) based on the percentage difference between the amount of payment otherwise determined for 2002 and the 2002 median reimbursement amount under the Federal Employee Health Benefits Program (FEHBP) as determined by the Office of the Inspector General of the DHHS. The FEHBP adjusted payments remained “frozen” through 2008. With limited exceptions, items that were not included in competitive bidding received a 5% update for 2009. As discussed above, for 2009, MIPPA included a 9.5% nationwide reduction in reimbursement for the product categories included in competitive bidding, as a budget neutrality offset for the eighteen month delay.

(4) Reductions in Payments for Oxygen and Oxygen Equipment. The DRA which was signed into law on February 8, 2006, has made certain changes to the way Medicare Part B pays for certain of our HME products, including oxygen and oxygen equipment. For oxygen equipment, prior to the DRA, Medicare made monthly rental payments indefinitely, provided medical need continued. The DRA capped the Medicare rental period for oxygen equipment at 36 months of continuous use, after which time ownership of the equipment would transfer to the beneficiary. For purposes of this cap, the DRA provides for a new 36-month rental period that began January 1, 2006 for all oxygen equipment. In addition to the changes in the duration of the rental period for capped rental items and oxygen equipment, the DRA permits payments for servicing and maintenance of the products after ownership transfers to the beneficiary.

On November 1, 2006, CMS released a final rule to implement the DRA changes, which went into effect January 1, 2007. Under the rule, CMS clarified the DRA’s 36-month rental cap on oxygen equipment. CMS also revised categories and payment amounts for the oxygen equipment and contents during the rental period and for oxygen contents after equipment ownership by the beneficiary as described below. With the passage of MIPPA on July 15, 2008, transfer of title to oxygen equipment at the end of the 36-month rental cap was repealed, although the rental cap remained in place. Effective January 1, 2009, after the 36th continuous month during which payment is made for the oxygen equipment, the equipment is to continue to be furnished during any period of medical need for the remainder of the reasonable useful lifetime of the equipment. After the 36-month rental cap, payment is made only for oxygen contents and for certain reasonable and necessary maintenance and servicing (for parts and labor not covered by the supplier’s or manufacturer’s warranty)

In its November 1, 2006 final rule, CMS also acknowledged certain other payments after the 36-month rental cap, including payment for supplies such as tubing and masks. In addition, CMS detailed several requirements regarding a supplier’s responsibility to maintain and service capped rental items and provided for a general maintenance and servicing payment for certain oxygen-generating equipment beginning six months after the 36-month rental cap. On October 30, 2008, CMS issued new oxygen payment rules and supplier responsibilities to address changes to the transfer of title under MIPPA. In the final rule, CMS determined that for liquid or gaseous oxygen (stationary or portable), after the 36-month rental cap, there will be no additional Medicare payment for the maintenance and servicing of such equipment for the remainder of the useful lifetime of the equipment. CMS also determined that for 2009 only, Medicare will pay for in-home, maintenance and servicing visits for oxygen concentrators and transfilling equipment every six months, beginning six months after the end of the 36-month rental cap. This payment will be made if the supplier visits the beneficiary’s home, performs any necessary maintenance and servicing, and inspects the equipment to ensure that it will function safely for the next six months. CMS also solicited public comments on whether to continue such maintenance and servicing payments after 2009. Finally, CMS clarified that though it retains title to the equipment, a supplier is required to continue to furnish needed oxygen equipment and contents for liquid or gaseous equipment after the 36-month rental cap until the end of the equipment’s reasonable useful lifetime. CMS determined the reasonable useful lifetime for oxygen equipment to be five years provided there are no breaks in service due to medical necessity, computed based on the date the equipment is delivered to the beneficiary. On January 27, 2009, CMS posted further instructions on the implementation of the 36-month rental cap, including guidance on payment for oxygen contents after month 36 and the replacement of oxygen equipment that has been in continuous use by the patient for the equipment’s reasonable useful lifetime (as defined above). In accordance with these instructions, and consistent with the final rule published on October 30, 2008, suppliers may bill for oxygen contents on a monthly basis after the 36-month rental cap, and the supplier can deliver up to a maximum of three months of oxygen contents at one time. Additionally, in accordance with these instructions, and consistent with the final rule published on October 30, 2008, we now provide replacement equipment to our patients that exceed five years of continuous use.

The financial impact of the 36-month rental cap will depend upon a number of variables, including, (i) the number of Medicare oxygen customers reaching 36 months of continuous service, (ii) the number of patients receiving oxygen contents beyond the 36-month rental period and the coverage and billing requirements established by CMS for suppliers to receive payment for such oxygen contents, (iii) the mortality rates of patients on service beyond 36 months, (iv) the incidence of patients with equipment deemed to be beyond its reasonable useful life that may be eligible for new equipment and therefore a new rental episode and the coverage and billing requirements established by CMS for suppliers to receive payment for a new rental period, (v) any breaks in continuous use due to medical necessity, and (vi) payment amounts established by CMS to reimburse suppliers for maintenance of oxygen equipment. We cannot predict the impact that any future rulemaking by CMS will have on our business. If payment amounts for oxygen equipment and contents are further reduced in the future, this could have an adverse effect on our revenues, profit margins, profitability, operating cash flows and results of operations.

Results of Operations

The following table provides an overview of certain key factors of our results of operations for the three and six months ended June 30, 2011 as compared to June 30, 2010:


	Three months ended June30,					Six months ended June 30,
	2011		2010			2011		2010
Net Revenues	$	3,724,153	$	3,253,492		$	6,439,186	$	6,086,987
Cost of sales		2,394,395		1,985,800			3,984,923		4,039,849
Operating Expenses:
Marketing and selling		31,766		3,628			43,188		29,607
Depreciation		51,270		58,950			102,128		117,900
General and administrative		1,101,982		1,107,913			2,159,562		2,193,225
Total operating expenses		1,185,018		1.118,843			2,304,878		2,237,436
Income (loss) from operations		144,740		148,849			149,385		(190,298)
Total other income (expense)		10,057		(28,225	)		12,239		(55,693)
Provision for income taxes		—		—			—		(15,846)
Net income (loss)	$	154,797	$	120,624		$	161,624	$	(261,837)

Other Key Indicators:


	Three months ended June 30,		Six months ended June 30,
	2011	2010	2011	2010
Cost of sales as a percentage of revenues	64.3%	61.0%	61.9%	66.4%
Gross profit margin	35.7%	39.0%	38.1%	33.6%
General and administrative expenses as a percentage of revenues	29.6%	34.1%	33.5%	36.0%
Total operating expenses as a percentage of revenues	31.8%	34.4%	35.8%	36.8%

The following table provides comparative data regarding the source of our net revenues in each of these periods:


	Three months ended June 30,				Six months ended June 30,
	2011		2010		2011		2010
Product Sales	$	3,123,202	$	2,257,427	$	5,642,227	$	4,866,267
Rental Revenue		600,951		996,065		796,959		1,220,720
Total Net Revenues:	$	3,724,153	$	3,253,492	$	6,439,186	$	6,086,987


	Three months ended June 30,		Six months ended June 30,
Gross profit as a Percentage of Net Revenues	2011	2010	2011	2010
Product sales	83.9%	69.4%	87.6%	79.9%
Rental Revenue	16.1%	30.6%	12.4%	20.1%

Six Month Period ended June 30, 2011 and 2010

Net Revenues

For the six months ended June 30, 2011, we reported revenues of $6,439,186 as compared to revenues of $6,086,987 for the six months ended June 30, 2010, an increase of $352,199 or approximately 5.8 % Product sales for the six months ended June 30, 2011 increased by $775,960 or approximately 15.9 % as compared to the six months ended June 30, 2010. Rental revenue for the six months ended June 30, 2011 decreased by $423,761 or approximately 34.7% as compared to the six months ended June 30, 2010. The overall decrease of product sales and rental revenue is due to the impact of the 9.5% MIPAA reduction, lower reimbursement rates from third party payors and lower hospital census levels.

Cost of Sales

Our cost of sales consists of the depreciation of rental assets and products purchased for resale. For the six months ended June 30, 2011, cost of sales was $3,984,923 or approximately 61.9% of revenues, compared to $4,039,849, or approximately 66.4% of revenues, for the six months ended June 30, 2010. During the six months ended June 30, 2010, cost of sales decreased due to decreased revenues as compared to the six months ended June 30, 2009. During the six months ended June 30, 2011, cost of sales as a percentage of net revenues decreased due to an improved product mix as compared to the six months ended June 30, 2010.

Gross Profit

During the six months ended June 30, 2011, our gross profit for our product sale as a percentage of net revenues increased by approximately 4.5% as compared to the six months ended June 30, 2010.

During the six months ended June 30, 2011, our gross profit for our rental revenue as a percentage of net revenues decreased by approximately 8% as compared to the six months ended June 30, 2010. The decrease in gross profit of rental revenue is primarily attributable to a decrease in rental revenues during the six months ended June 30, 2011.

Total Operating Expenses

Our total operating expenses decreased slightly at approximately 1% to $2,304,878 for the six months ended June 30, 2011 as compared to $2,237,436 for the six months ended June 30, 2010. These changes include:

• Marketing and Selling. For the six months ended June 30, 2011, marketing and selling costs were $43,188 as compared to $29,607 for the six months ended June 30, 2010, an increase of $13,581. The increase was due to marketing, advertising and print advertising programs initiatives that have resulted in revenue growth.

• Depreciation and amortization expense. For the six months ended June 30, 2010, depreciation expense amounted to $102,128 as compared to $117,900 for the six months ended June 30, 2010, a decrease of $15,772 or 13.4% due to a decrease in rental van & rental equipment purchases.

• General and administrative expense. For the six months ended June 30, 2011, general and administrative expenses were $2,159,562 as compared to $2,193,225 for the six months ended June 30, 2010, a decrease of $33,663. For the six months ended June 30, 2011 and 2010 general and administrative expenses consisted of the following:


	Six Months Ended June 30, Fiscal Q1
	2011		2010
Rent	$	128,575	$	98,506
Employee compensation		1,341,483		1,241,952
Professional fees		189,323		117,502
Internet/Phone		42,346		38,569
Travel/Entertainment		39,077		38,262
Bad debt expense		-43,042		142,174
Insurance		125,381		80,566
Management fee		0		180,000
Other general and administrative		336,419		254,694
	$	2,159,562	$	2,193,225


	•	For the six months ended June 30, 2011, Rent expense increased by $30,069 or 30.5% over the same period in 2010. The increase is due to the market leases on the Mobility Freedom locations

	•	For the six months ended June 30, 2011, employee compensation, related taxes and stock-based compensation expenses increased to $1,341,483 as compared to $1,241,952, a 8%. The increase relates to the addition of several key positions in anticipation of the Mobility Freedom acquisition.

	•	For the six months ended June 30, 2011, professional fees increased to $189,323 as compared to $117,502, an increase of $71,821 or 61.1%. The increase is primarily related to increase in audit and accounting fees related to the Mobility Freedom acquisition.


	•	For the six months ended June 30, 2011, internet/telephone expense slightly increased to $42,346 as compared to $38,569, an increase of $3,777 or less than 1%.

	•	For the six months ended June 30, 2011, travel and entertainment expense increased to $39,077 as compared to $38,262 was essentially unchanged.

	•	For the six months ended June 30, 2011 bad debt expense was reduced by $43,042 as compared to $142,174 for the six months ended June 30, 2010, a decrease of $185,216 or 130.2%. The decrease was due to a detailed review of Accounts Receivable aging by senior management, which determined that the provision for bad debt was overstated.

	•	For the six months ended June 30, 2011 Insurance expense increased to $125,381 as compared to $80,566 for the six months ended June 30, 2010, an increase of $44,815or 55.6%. Insurance expense increased due to added coverage and higher sales related premiums as compared to 2010.

	•	For the six months ended June 30, 2011 Management fee expense slightly increased to $180,000 as compared to $171,654 for the six months ended June 30, 2010.

	•	For the six months ended June 30, 2011 other general and administrative expense decreased to $0 as compared to $180,000 for the six months ended June 30, 2010. In January 2011, in consultation with Senior Management, the Chairman & principal investor voluntarily chose to forego contractual binding management fees.

INCOME (LOSS) FROM OPERATIONS

We reported income from operations of $149,385 for the six months ended June 30, 2011 as compared to a loss from operations of $(293,594) for the six months ended June 30, 2010.

OTHER INCOME (EXPENSES)

Interest expense. For the six months ended June 30, 2011, interest expense amounted to $67,833 as compared to $55,693 for the six months ended June 30, 2010, an increase of $12,140 or 21.8%.

NET INCOME (LOSS)

Our net income was $161,623 for the six months ended June 30, 2011 compared to net loss of $(365,133) for the six months ended June 30, 2010.

Three Month Period ended June 30, 2011 and 2010

Net Revenues

For the three months ended June 30, 2011, we reported revenues of $3,724,153 as compared to revenues of $3,253,492 for the three months ended June 30, 2010, an increase of $470,661 or approximately 14.5%. Product sales for the three months ended June 30, 2011 increased by $865,775 or approximately 38.4% as compared to the six months ended June 30, 2010. Rental revenue for the three months ended June 30, 2011 decreased by $395,114 or 39.7% approximately as compared to the six months ended June 30, 2010. The product revenues increase in 2011 are directly attributable to increased van sales at Mobility Freedom. The overall decrease of rental revenue is due to the impact of the 9.5% MIPAA reduction, lower reimbursement rates from third party payors and lower hospital census levels.

Cost of Sales

Our cost of sales consists of the depreciation of rental assets and products purchased for resale. For the three months ended June 30, 2011, cost of sales was $2,394,395, or approximately 35.7% of revenues, compared to $1,985,800, or approximately 39% of revenues, for the three months ended June 30, 2010. During the three months ended June 30, 2011, cost of sales increased due to increased revenues as compared to the three months ended June 30, 2010. During the three months ended June 30, 2011, cost of sales as a percentage of net revenues increased due to the revenue mix as compared to the three months ended June 30, 2010.

Total Operating Expenses

Our total operating expenses increased approximately 5.9% to $1,185,018 for the three months ended June 30, 2011 as compared to $1,118,843 for the three months ended June 30, 2010. These changes include:

• Marketing and Selling. For the three months ended June 30, 2011, marketing and selling costs were $31,766 as compared to $3,628 for the three months ended June 30, 2010, an increase of $28,138. The increase was due to marketing, advertising and print advertising programs initiated during the three months ended June 30, 2011.

• Depreciation and amortization expense. For the three months ended June 30, 2011, depreciation expense amounted to $51,270 as compared to $58,950 for the three months ended June 30, 2010, a decrease of $7,680 or 13% related to the decrease in rental equipment in 2011.

• General and administrative expense. For the three months ended June 30, 2011, general and administrative expenses were $1,101,982 as compared to $1,107,913 for the three months ended June 30, 2010, a slight decrease of $5,931. For the three months ended June 30, 2011 and 2010 general and administrative expenses consisted of the following:


	Three Months Ended June 30, Fiscal Q1
	2011		2010
Rent	$	63,980	$	48,768
Employee compensation		687,738		605,522
Professional fees		128,843		61,935
Internet/Phone		19,132		19,456
Travel/Entertainment		28,025		20,381
Bad debt expense		-49,298		134,426
Insurance		50,259		35,101
Management fee		90,000		90,000
Other general and administrative		83,303		92,323
	$	1,101,982	$	1.107,913


	•	For the three months ended June 30, 2011, Rent expense increased to $63,980 as compared to $48,768 for the three months ended June 30, 2010 . The change relates to new leases on the Mobility Freedom locations.

	•	For the three months ended June 30, 2011, employee compensation, related taxes and stock-based compensation expenses increased to $687,738 as compared to $605,522 for the three months ended June 30, 2010, an increase of $82,216 or 13.6%. The increase reflects Senior Management additions in anticipation of the acquisition of Mobility Freedom.

	•	For the three months ended June 30, 2011, professional fees increased to $128,843 as compared to $61,935 for the three months ended June 30, 2010, an increase of $66,908 or 108%. The increase is primarily related to increase in audit and accounting fees.

	•	For the three months ended June 30, 2011, internet/telephone expense slightly increased to $19,132 as compared to $19,456 for the three months ended June 30, 2010, essentially no change.

	•	For the three months ended June 30, 2011, travel and entertainment expense increased to $28,025 as compared to $20,381 for the three months ended June 30, 2010. The $7,644 or 37.5% increase is primarily due to the Mobility Freedom acquisition.

	•	For the three months ended June 30, 2011 bad debt expense was reduced by $49,298 as compared to a provision of $134,426 for the three months ended June 30, 2010, a change of $183,724 or 136.7% The decrease was due to a detailed review of Accounts Receivable aging by senior management, which determined that the provision for bad debt was overstated.

	•	For the three months ended June 30, 2011 Insurance expense increased to $50,259 as compared to $35,101 for the three months ended June 30, 2010, an increase of $15,158, or 43.2%. Insurance expense increased due to added coverage and higher sales related premiums as compared to 2010.

	•	For the three months ended June 30, 2011 other general and administrative expense decreased $8,520 or 9.2% to $83,803 as compared to $92,323 for the three months ended June 30, 2010. The decrease is primarily attributable to Sr. Management’s decision to reduce unnecessary costs.

INCOME FROM OPERATIONS

We reported income from operations of $144,740 for the three months ended June 30, 2011 as compared to income from operations of $97,201 for the three months ended June 30, 2010.

NET INCOME

Net income was $154,797 and $161,623 for the three months ended June 30, 2011 compared to net income of $68,976 for the three months ended June 30, 2010.

LIQUIDITY AND CAPITAL RESOURCES

Liquidity is the ability of a company to generate funds to support its current and future operations, satisfy its obligations and otherwise operate on an ongoing basis. The following table provides an overview of certain selected balance sheet comparisons between June 30, 2011 and December 31, 2010:


	June 30, 2011		December 31, 2010		$ Change

Working capital surplus (deficit)	1,349,510		-262,296		1,611,806

Cash	362,190		423		361,767
Accounts receivable, net	334,840		254,362		80,478
Inventory	2,382,394		76,356		2,306,038
Total current assets	3,103,387		349,986		2,753,401
Property and equipment, net	757,309		147,769		609,540
Total assets	6,629,409		498,175		6,131,234

Accounts payable and accrued liabilities	1,753,877		612,282		1,141,595
Notes payable-current	227,857		18,005		209,852
Total current liabilities	2,105,918		706,310		1,399,608
Notes payable-long term	4,300,000		152,509		4,147,491
Total liabilities	6,405,918		858,819		5,547,099
Accumulated deficit	(4,145,528	)	(4,324,683	)	179,155
Stockholders’ equity (deficit)	223,491		(360,644	)	584,135

Net cash used in operating activities was $3,624,620 for the six months ended June 30, 2011 as compared to net cash provided by operating activities of $1,633,990 for the six months ended June 30, 2010, a decrease of $5,258,610, primarily attributable to the acquisition in the current quarter. For the six months ended June 30, 2011, we had net income of $161,624 offset by non-cash items such as depreciation and amortization expense of $186,375 and stock-based compensation of $17,880 and decreases from changes in assets and liabilities of $1,239,477. During the six months ended June 30, 2011.

Net cash used in investing activities for the six months ended June 30, 2011 was $758,056 as compared to net cash used in investing activities of $11,691 for the six months ended June 30, 2010. During the six months ended June 30, 2011 and 2010, we used cash for property and equipment purchases.

Net cash provided by financing activities for the six months ended June 30, 2011 was $4,744,443 as compared to net cash used in financing activities of $(1,413,682) for the six months ended June 30, 2010. For the six months ended June 30, 2011, net cash provided by financing activities related to payments on notes payable of $528,897offset by proceeds from sale of common stock of $387,100 and proceeds from issuance of debts of $4,147,491. For the six months ended June 30, 2010, net cash used in financing activities included payments on notes payable of $1,563,778, offset by proceeds from sale of common stock of 150,096.

At June 30, 2011 we had a working capital surplus of $1,349,510 and accumulated deficit of $(4,145,528).

Contractual Obligations and Off-Balance Sheet Arrangements

Contractual Obligations

The following tables summarize our contractual obligations as of June 30, 2011.


	Payments Due by Period
	Total		Less than 1 year		1-3 Years		3-5 Years		5 Years +
Contractual Obligations :
Operating Lease	$	731,862	$	145,311	$	520,552	$	65,999	$	—

Line of Credit		300,000		300,000		—		—		—
Notes payable		227,857		227,857		—		—		—
Notes payable – related party		4,000,000		242,982		526,672		586,067		2,644,279

Total Contractual Obligations:	$	5,259,719	$	916,150	$	1,047,224	$	652,066	$	2,644,279

Off-balance Sheet Arrangements

We have not entered into any other financial guarantees or other commitments to guarantee the payment obligations of any third parties. We have not entered into any derivative contracts that are indexed to our shares and classified as stockholder’s equity or that are not reflected in our consolidated financial statements. Furthermore, we do not have any retained or contingent interest in assets transferred to an unconsolidated entity that serves as credit, liquidity or market risk support to such entity. We do not have any variable interest in any unconsolidated entity that provides financing, liquidity, market risk or credit support to us or engages in leasing, hedging or research and development services with us.

Recently Issued Accounting Pronouncements


Item 3.	Quantitative and Qualitative Disclosures About Market Risk

Not required for smaller reporting companies.


Item 4.	Controls and Procedures

Disclosure Controls and Procedures

Our management, including Hal Compton, Jr., our chief executive officer, and James C. Thomas, our chief financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2011.

Disclosure controls and procedures refer to controls and other procedures designed to ensure that information required to be disclosed in the reports we file or submit under the Securities Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating and implementing possible controls and procedures.

Management conducted its evaluation of disclosure controls and procedures under the supervision of our chief executive officer and our chief financial officer. Based on that evaluation, our management, including Mr. Compton and Mr. Thomas, concluded that because of the significant deficiencies in internal control over financial reporting described below, our disclosure controls and procedures were not effective as of June 30, 2011.

Management’s Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(F) and 15d-15(F) under the Securities Exchange Act. Our management is also required to assess and report on the effectiveness of our internal control over financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act of 2002 (“Section 404”) on an annual basis. As previously reported on our Form 10-K for the year ended December 31, 2010, management identified significant deficiencies related to (i) our internal audit functions and (ii) a lack of segregation of duties within accounting functions.

Management has determined that our internal audit function is significantly deficient due to insufficient qualified resources to perform internal audit functions.

Due to our size and nature, segregation of all conflicting duties may not always be possible and may not be economically feasible. However, to the extent possible, we will implement procedures to assure that the initiation of transactions, the custody of assets and the recording of transactions will be performed by separate individuals.

We believe that the foregoing steps will remediate the material weaknesses identified above, and we will continue to monitor the effectiveness of these steps and make any changes that our management deems appropriate. Due to the nature of these material weaknesses in our internal control over financial reporting, there is more than a remote likelihood that misstatements which could be material to our annual or interim financial statements could occur that would not be prevented or detected.

Changes in Internal Controls over Financial Reporting

There were no changes in our internal controls over financial reporting during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION


Item 1.	Legal Proceedings

None.


Item 1A.	Risk Factors

Not required for smaller reporting companies.


Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds

None.


Item 3.	Defaults Upon Senior Securities

None.


Item 4.	Submission of Matters to a Vote of Security Holders

None.


Item 5.	Other Information

None.


Item 6.	Exhibits


Exhibit Number	Description

31.1	Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
31.2	Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
32.1	Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
32.2	Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
101	Interactive Data Files of Financial Statements and Notes contained in this Quarterly Report on Form 10-Q.**

* Filed herein

** In accordance with Regulation S-T, the Interactive Data Files in Exhibit 101 to the Quarterly Report on Form 10-Q shall be deemed "furnished" and not "filed."

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant has caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	HASCO MEDICAL, INC.

	By: /s/ Hal Compton, Jr.
September 13, 2011	Hal Compton, Jr.,
	Chief Executive Officer, principal executive officer

	By: /s/ James C. Thomas
September 13, 2011	James C. Thomas
	Chief Financial Officer, principal financial and accounting officer

EX-31 2 ex_31-1.htm CERTIFICATION OF THE CEO

EXHIBIT 31.1

Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Hal Compton, Jr., certify that:

1. I have reviewed this quarterly report on Form 10-Q of HASCO Medical, Inc.;

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly for the period in which this quarterly report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

a) all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: August 18, 2011

By: /s/ Hal Compton, Jr.

Hal Compton, Jr.

Chief Executive Officer, principal executive officer

EX-31 3 ex_31-2.htm CERTIFICATION OF THE CFO

EXHIBIT 31.2

Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, James C. Thomas, certify that:

1. I have reviewed this quarterly report on Form 10-Q of HASCO Medical, Inc.;

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: August 18, 2011

By: /s/ James C. Thomas

James C. Thomas,

Chief Financial Officer, principal financial and accounting officer

EX-32 4 ex_32-1.htm CERTIFICATION OF THE CEO

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of HASCO Medical, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Hal Compton, Jr., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002, that:


	(1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

	(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

August 18, 2011

By: /s/ Hal Compton, Jr.

Hal Compton, Jr.,

Chief Executive Officer, principal executive officer

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32 5 ex_32-2.htm CERTIFICATION OF THE CFO

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of HASCO Medical, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), James Thomas, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002, that:


	(1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

	(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

August 18, 2011

By: /s/ James C. Thomas

James C. Thomas,

Chief Financial Officer, principal financial and accounting officer

EX-101.INS 6 hasc-20110630.xml XBRL INSTANCE FILE false --12-31 Q2 2011 2011-06-30 10-Q 0001131675 763102390 Smaller Reporting Company HASCO Medical, Inc. 1095649 1635045 258604 1095649  <div> <div style="WIDTH: 720px"> NOTE 2 - GOING CONCERN CONSIDERATIONS The accompanying consolidated financial statements are prepared assuming the Company will continue as a going concern.  At June 30, 2011, the Company had an accumulated deficit of approximately $3.9 million. The ability of the Company to continue as a going concern is dependent upon increasing sales and obtaining additional capital and financing to support its recent acquisition.  During the quarter ended June 30, 2011, the Company secured a working capital line of credit in the amount of $400,000.  Management intends to attempt to raise additional funds by way of a public or private offering.  While the Company believes in the viability of its strategy to increase sales volume and in its ability to raise additional funds, there can be no assurances to that effect. </div> </div>  <div> <div style="WIDTH: 720px"> NOTE 5 - LOANS PAYABLE - RELATED PARTY In February 2011, HASCO Holdings, LLC, the largest shareholder of the Company, loaned $50,000 to the Company. These loans are non interest bearing and are due on demand. In February 2011, one of the Company's directors loaned $135,000 to the Company. These loans are non interest bearing and are due on demand. </div> </div> 1635045

1753877

612282

334840

254362

3611432

3217602

6629409

498175

3103387

349986

46023

<div> <div style="WIDTH: 720px"> NOTE 1 - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES   NATURE OF OPERATIONS HASCO Medical, Inc. ("HASCO" or the "Company"), formerly BBC Graphics of Palm Beach Inc, was incorporated in May 2009 under the laws of the State of Florida. The Company operated as a provider of advertising and graphic design services.  In June 2009, the Company changed its name to HASCO Medical, Inc. On May 12, 2009, HASCO completed the acquisition of Southern Medical & Mobility, Inc. (SMM") pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement") among HASCO, SMM and Southern Medical Acquisition, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company. Under the terms of the Merger Agreement Southern Medical Acquisition, Inc. was merged into Southern Medical & Mobility, Inc., and Southern Medical & Mobility, Inc. became a wholly-owned subsidiary of HASCO. The shareholder of Southern Medical & Mobility, Inc. was issued a total of 554,676,000 shares of the Company's common stock in exchange for their Southern Medical & Mobility, Inc. share. After the merger and transactions that occurred at the same time as the merger, there were 642,176,000 shares of the Company's common stock outstanding, of which 620,000,000, approximately 96.5%, were held by HASCO Holdings, LLC, the former sole shareholder of Southern Medical & Mobility, Inc. Prior to the merger, the Company was a shell company with no business operations. Southern Medical & Mobility, Inc. provides home health care services and products consisting primarily of the rental and sale of home medical equipment and home health care supplies. These services and products are paid for primarily by Medicare, Medicaid, and other third-party payors. For accounting purposes, HASCO Medical, Inc. has accounted for the transaction as a reverse acquisition and HASCO will be the surviving entity as a publicly-traded company under the name HASCO Medical Inc. or together with its subsidiaries. The Company did not recognize goodwill or any intangible assets in connection with this transaction.   The Merger was accounted for as a reverse acquisition, with Southern Medical & Mobility, Inc, as the accounting acquirer. Therefore, the Company's historical financial statements reflect those of Southern Medical & Mobility, Inc. Accordingly, the reverse acquisition is being accounted for as a capital transaction in substance, rather than a business combination. For accounting purposes, the net liabilities of HASCO Medical, Inc. were recorded at fair value as of the Closing Date, with an adjustment to additional paid-in capital. The deficit accumulated by HASCO was carried forward after the Merger.   Effective with the reverse merger, all previously outstanding common stock owned by HASCO Medical, Inc.'s shareholders were exchanged for the Company's common stock. The value of the Company's common stock that was issued to HASCO Medical, Inc.'s shareholders was the historical cost of the Company's net tangible assets, which did not differ materially from its fair value. All references to common stock, share and per share amounts have been retroactively restated to reflect the reverse acquisition as if the transaction had taken place as of the beginning of the earliest period presented.    On May 13, 2011 Hasco Medical, Inc. completed the acquisition of Mobility Freedom, Inc and Wheel Chair Vans of America.   Mobility Freedom was founded 1999 in Clermont, Florida, by Mr. Jeff Connors, who continues to serve as its President.  With over 30 years experience in the van conversion industry, Mr. Connors formed Mobility Freedom in response to his identification of a need in the fast growing Central Florida area for a quality full service dealership of conversion vans and other mobility products that would help the disabled become mobile. A few years after the business started, Mr. Connors had an opportunity to purchase a van rental company, which now does business under the name "Wheelchair Vans of America." Wheelchair Vans of America specializes in renting conversion vans to the disabled individuals visiting the State of Florida. This business unit has proven to be an effective complement to Mobility Freedom and is anticipated to be expanded to other areas of the country. Mobility Freedom caters to individuals with physical limitations that need specialty equipment to drive as well as families with members who are disabled that need to be transported. In certain circumstances, both the van itself as well as its specialty equipment is paid for, directly to Mobility Freedom, by a federal or state agency. As an example, approximately 45% of Mobility Freedom's customers are veterans receiving benefits from the United States Department of Veterans Affairs (the "VA").  As part of the VA's mission "to provided veterans the world-class benefits and services they have earned", the VA pays for a van for disabled veterans. As a result, Mobility Freedom is both a VA and Vocational Rehabilitation (VR) state certified vendor.  In addition, Mobility Freedom is an exclusive vendor for certain Florida state funded agencies, including the Florida Birth-Related Neurological Injury Compensation Association (NICA). Mobility Freedom provides mobility solutions to its client base with disabilities through both the sale and rental of wheelchair accessible vans. It sales operations are conducted as an authorized dealer for a number of OEM handicap van manufacturers including: <table style="MARGIN-TOP: 0px; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0"> <tr style="FONT-SIZE: 1pt"> <td width="24"> </td> <td width="24"> </td> <td width="672"> </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="24"> • </td> <td style="MARGIN-TOP: 0px" valign="top" width="672"> The Braun Corporation, which offers a variety of wheelchair accessible van conversions of popular minivan models including the Dodge Grand Caravan, the Chrysler Town & Country, the Toyota Sienna and the Honda Odyssey; </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="672">   </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="24"> • </td> <td style="MARGIN-TOP: 0px" valign="top" width="672"> Vantage Mobility International; and </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="672">   </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="24"> • </td> <td style="MARGIN-TOP: 0px" valign="top" width="672"> ElDorado National Company, a THOR company. </td> </tr> </table> These OEM manufacturers provide chassis conversions to traditional minivans and full size vans in order to make them handicap accessible.  These conversions traditionally include lowering the floors in order to increase head room, the addition of side entry or rear entry ramps and the installation of a wheelchair lift.  Upon the selection by a customer of its base van, Mobility Freedom provides custom conversion services. Mobility Freedom's mobility services revolve around an analysis of each individual's use of the van as well as individual physical limitations. In those instances where it is the passenger and not the driver who requires a wheelchair, Mobility Freedom provides full installation of EZ Lock Tie Down Systems to secure the wheelchair during movement. In connection with meeting the needs of a handicapped driver, the Company utilizes an independent evaluator who evaluates the needs of the driver and recommends the appropriate Driver Adaptive Equipment ("DAE"). DAE installed by Mobility Freedom covers a broad array of products designed to allow a motorist with disabilities to drive despite his or her physical limitations. The equipment, the cost of which in certain circumstances can exceed $100,000, includes: <table style="MARGIN-TOP: 0px; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0"> <tr style="FONT-SIZE: 1pt"> <td width="24"> </td> <td width="24"> </td> <td width="672"> </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="24"> • </td> <td style="MARGIN-TOP: 0px" valign="top" width="672"> hand controls; </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="672">   </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="24"> • </td> <td style="MARGIN-TOP: 0px" valign="top" width="672"> spinner knob to aid in turning the steering wheel; </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="672">   </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="24"> • </td> <td style="MARGIN-TOP: 0px" valign="top" width="672"> a transfer seat; </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="672">   </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="24"> • </td> <td style="MARGIN-TOP: 0px" valign="top" width="672"> electronic driving controls such as a touch screen which controls various electronic equipment in an auto such as the ignition; and </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="672">   </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="24"> • </td> <td style="MARGIN-TOP: 0px" valign="top" width="672"> reduced effort steering and braking. </td> </tr> </table> Mobility Freedom also offers another unique solution with the option of a wheelchair accessible truck or truck conversion. Offered by Ryno Mobility a wheelchair truck conversion offers the ability to retain the style and performance of a truck while the handicap truck conversion allows wheelchair access.   Mobility Freedom has four corporate owned stores which are located in Orlando, Largo, Clermont and Palm Coast/Bunell, and three affiliates which are located in Edgewater, Pensacola and Ocala for a total of seven operations centers in Florida.  We believe that many of the demographics factors in North Central Florida make it an ideal location for Mobility Freedom's operations including: <table style="MARGIN-TOP: 0px; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0"> <tr style="FONT-SIZE: 1pt"> <td width="24"> </td> <td width="24"> </td> <td width="672"> </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="24"> • </td> <td style="MARGIN-TOP: 0px" valign="top" width="672"> an older and aging population; </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="672">   </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="24"> • </td> <td style="MARGIN-TOP: 0px" valign="top" width="672"> the numerous tourist destinations that define the greater Orlando are; and </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="672">   </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="24"> • </td> <td style="MARGIN-TOP: 0px" valign="top" width="672"> a significant population of military veterans attracted by the Orlando VA Medical Center. Currently the new Orlando VA Medical Center is under construction and will be located on a 65-acre campus in southeast Orange County.  The 1.2 million square foot facility, scheduled to open in fall of 2012, will have a large multispecialty outpatient clinic, 134-inpatient beds, 120-community living center beds, a 60-bed domiciliary and administrative and support services.  The VA will be co-located with the University of Central Florida College of Medicine, the Burnham Institute, the University of Florida Academic and Research Center and Nemours Children's Hospital in the Lake Nona area known as the "Medical City." </td> </tr> </table> Mobility Freedom's Our agreements with the vehicle manufacturers permit it to sell the vehicles within certain specific territories and it is not authorized to sell all brands in all of these areas. The agreements with the affiliates provide that Mobility Freedom holds the territory rights to sell vehicles and the affiliate provides the location. The affiliate is entitled to receive 50% of the profit on each van sold as consideration for providing the location.  We expect that Mobility Freedom's operations will represent a material portion of our business in the future. Historically, our operations were focused on the provision of a diversified range of home health care services and products.  Following our May 2011 acquisition of Mobility Freedom, our operations are conducted within two business units: <table style="MARGIN-TOP: 0px; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0"> <tr style="FONT-SIZE: 1pt"> <td width="24"> </td> <td width="24"> </td> <td width="672"> </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="24"> • </td> <td style="MARGIN-TOP: 0px" valign="top" width="672"> Mobility Freedom, including its rental operations conducted under the trade name Wheelchair Vans of America located in Northern Florida, and </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="672">   </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="24"> • </td> <td style="MARGIN-TOP: 0px" valign="top" width="672"> Southern Medical & Mobility located in Mobile Alabama. </td> </tr> </table> Our objective is to continue to grow both intrinsically and through acquisitions in areas that we currently offer products and services in, as well in areas that are complementary. As Mobility Freedom is significantly larger than Southern Mobility, we anticipate that Mobility Freedom will drive our near term financial results. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("US GAAP") for interim financial information and with the instructions to Form 10-Q and Article 8-03 of Regulation S-X. Accordingly, the consolidated financial statements do not include all of the information and footnotes required by US GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and such adjustments are of a normal recurring nature. These consolidated financial statements should be read in conjunction with the consolidated financial statements for the year ended December 31, 2010 and notes thereto and other pertinent information contained in Form 10-K of HASCO Medical, Inc. (the "Company", "we", "us". Or "our") as filed with the Securities and Exchange Commission (the "Commission"). All significant intercompany transactions and balances have been eliminated in consolidation.  Use of Estimates The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheets and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Significant estimates in 2011 and 2010 include the allowance for doubtful accounts, the valuation of inventory, the useful life of property and equipment and the assumptions used to calculate stock-based compensation. Reclassification Certain amounts in the 2010 consolidated financial statements have been reclassified to conform to the 2011 presentation. Such reclassifications had no effect on the reported net loss. Fair Value of Financial Instruments Effective January 1, 2008, the Company adopted FASB ASC 820, "Fair Value Measurements and Disclosures" ("ASC 820"), for assets and liabilities measured at fair value on a recurring basis. ASC 820 establishes a common definition for fair value to be applied to existing generally accepted accounting principles that require the use of fair value measurements, and establishes a framework for measuring fair value and expands disclosure about such fair value measurements. The adoption of ASC 820 did not have an impact on the Company's financial position or operating results, but did expand certain disclosures. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below: <table style="MARGIN-TOP: 0px; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0"> <tr style="FONT-SIZE: 1pt" > <td width="24"> </td> <td width="72"> </td> <td width="624"> </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="72"> Level 1: </td> <td style="MARGIN-TOP: 0px" valign="top" width="624"> Observable inputs such as quoted market prices in active markets for identical assets or liabilities </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="72">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="624">   </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="72"> Level 2: </td> <td style="MARGIN-TOP: 0px" valign="top" width="624"> Observable market-based inputs or unobservable inputs that are corroborated by market data </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="72">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="624">   </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="72"> Level 3: </td> <td style="MARGIN-TOP: 0px" valign="top" width="624"> Unobservable inputs for which there is little or no market data, which require the use of the reporting entity's own assumptions. </td> </tr> </table> Cash and cash equivalents include money market securities that are considered to be highly liquid and easily tradable as of June 30, 2011 and December 31, 2010. These securities are valued using inputs observable in active markets for identical securities and are therefore classified as Level 1 within our fair value hierarchy. In addition, FASB ASC 825-10-25 Fair Value Option was effective for January 1, 2008. ASC 825-10-25 expands opportunities to use fair value measurements in financial reporting and permits entities to choose to measure many financial instruments and certain other items at fair value. The Company did not elect the fair value options for any of its qualifying financial instruments. The carrying amounts of financial instruments, including cash, accounts receivable, accounts payable and accrued liabilities, and promissory note, approximated fair value as of June 30, 2011 and December 31, 2010 , because of the relatively short-term maturity of these instruments and their market interest rates. Revenue Recognition and Concentration of Credit Risk  Revenues are recognized under fee for service arrangements through equipment that the Company rents to patients, sales of equipment, supplies, and other items the Company sells to patients. Revenue generated from equipment that the Company rents to patients is recognized over the rental period and commences on delivery of the equipment to the patients. Revenue related to sales of equipment, and supplies is recognized on the date of delivery to the patients. All revenues are recorded at amounts estimated to be received under reimbursement arrangements with third-party payors, including private insurers, prepaid health plans, Medicare and Medicaid. Revenues are recognized on an accrual basis at the time services and related products are provided to patients and collections are reasonably assured, and are recorded at amounts estimated to be received under healthcare contracts with third-party payers, including private insurers, Medicaid, and Medicare. Insurance benefits are assigned to us by patients receiving medical treatments and related products and, accordingly, we bill on behalf of our patients/customers. Under these contracts, we provide healthcare services, medical equipment and supplies to patients pursuant to a physician's prescription.  The insurance company reimburses us for these services and products at agreed upon rates. The balance remaining for product or service costs becomes the responsibility of the patient.  A systematic process is employed to ensure that sales are recorded at net realizable value and that any required adjustments are recorded on a timely basis. We have established an allowance to account for contractual sales adjustments that result from differences between the amount remitted for reimbursement and the expected realizable amount. Due to the nature of the industry and the reimbursement environment in which we operate, certain estimates are required to record net revenue and accounts receivable at their net realizable values at the time products and/or services are provided. Inherent in these estimates is the risk that they will have to be revised or updated as additional information becomes available. Specifically, the complexity of many third party billing arrangements and the uncertainty of reimbursement amounts for certain services from certain payors may result in adjustments to amounts originally recorded. Such adjustments are typically identified and recorded at the point of cash application, claim denial or account review. The Company reports revenues in our financial statements net of such adjustments.  The Company recorded contractual adjustments of $176,864 and $182,807 during the six months ended June 30, 2011 and 2010, respectively. Certain items provided by the Company are reimbursed under rental arrangements that generally provide for fixed monthly payments established by fee schedules for as long as the patient is using the equipment and medical necessity continues (subject to capped rental arrangements which limit the rental payment periods in some instances and which may result in a transfer of title to the patient at the end of the rental payment period). Once initial delivery of rental equipment is made to the patient, a monthly billing cycle is established based on the initial date of delivery. The Company recognizes rental arrangement revenues ratably over the monthly service period and defers revenue for the portion of the monthly bill that is unearned. No separate payment is earned from the initial equipment delivery and setup process. During the rental period, the Company is responsible for servicing the equipment and providing routine maintenance, if necessary. The Company follows the guidance of the FASB ASC 605-10-S99 "Revenue Recognition Overall - SEC Materials. The Company records revenue when persuasive evidence of an arrangement exists, services have been rendered or product delivery has occurred, the sales price to the customer is fixed or determinable, and collectability is reasonably assured. Included in accounts receivable are earned but unbilled receivables. Unbilled accounts receivable represent charges for equipment and supplies delivered to customers for which invoices have not yet been generated by the billing system. Prior to the delivery of equipment and supplies to customers, the Company performs certain certification and approval procedures to ensure collection is reasonably assured and that unbilled accounts receivable are recorded at net amounts expected to be paid by customers and third-party payors. Billing delays, generally ranging from several days to several weeks, can occur due to delays in obtaining certain required payor-specific documentation from internal and external sources, interim transactions occurring between cycle billing dates established for each customer within the billing system and business acquisitions awaiting assignment of new provider enrollment identification numbers. In the event that a third-party payor does not accept the claim for payment, the customer is ultimately responsible. The Company performs analyses to evaluate the net realizable value of accounts receivable. Specifically, the Company considers historical realization data, accounts receivable aging trends, other operating trends and relevant business conditions. Because of continuing changes in the health care industry and third-party reimbursement, it is possible that our estimates could change, which could have a material impact on the Company's operations and cash flows. Cash and Cash Equivalents The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company places its cash with a high credit quality financial institution. The Company's account at this institution is insured by the Federal Deposit Insurance Corporation ("FDIC") up to $250,000. For the six months ended June 30, 2011, the Company has not reached bank balances exceeding the FDIC insurance limit. To reduce its risk associated with the failure of such financial institution, the Company evaluates at least annually the rating of the financial institution in which it holds deposits. Concentrations of Credit Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable, and notes payable. The Company's investment policy is to invest in low risk, highly liquid investments. The Company does not believe it is exposed to any significant credit risk in its cash investment. The Company performs on-going credit evaluations of its customer base including those included in accounts receivable at June 30, 2011 and December 31, 2010, and, generally, does not require collateral.  The Company maintains reserves for potential credit losses and such losses have been within management's expectations. Accounts Receivable     Accounts receivable of Southern Medical and Mobility consists primarily of receivables due from Medicare, Medicaid, and third party payers. The Company recorded a bad debt allowance of $303,177 and $327,697 as of June 30, 2011 and December 31, 2010, respectively. Management performs ongoing evaluations of its accounts receivable.   Due to the nature of the industry and the reimbursement environment in which the Company operates, certain estimates are required to record net revenues and accounts receivable at their net realizable values. Inherent in these estimates is the risk that they will have to be revised or updated as additional information becomes available. Specifically, the complexity and uncertainty of reimbursement amounts for certain services from certain payors may result in adjustments to amounts originally recorded. Such adjustments are typically identified and recorded at the point of cash application, claim denial or account review.   Management performs periodic analyses to evaluate accounts receivable balances to ensure that recorded amounts reflect estimated net realizable value. Specifically, management considers historical realization data, accounts receivable aging trends, and other operating trends. Also considered are relevant business conditions such as governmental and managed care payor claims processing procedures and system changes. Accounts receivable are reduced by an allowance for doubtful accounts which provides for those accounts from which payment is not expected to be received, although services were provided and revenue was earned. Upon determination that an account is uncollectible, it is written-off and charged to the allowance. Accounts receivable balance concentrations by major payor category as of June 30, 2011 and December 31, 2010 were as follows: <table style="MARGIN-TOP: 0px; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" align="center"> <tr style="FONT-SIZE: 1pt"> <td width="283"> </td> <td width="9"> </td> <td width="103"> </td> <td width="15"> </td> <td width="114"> </td> <td width="7"> </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="283"> Percentage of Accounts Receivable Outstanding: </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="9">   </td> <td style="BORDER-BOTTOM: #000000 1px solid; MARGIN-TOP: 0px" valign="bottom" width="103"> June 30,  2011 </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="15">   </td> <td style="BORDER-BOTTOM: #000000 1px solid; MARGIN-TOP: 0px" valign="bottom" width="114"> December 31,  2010 </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="7">   </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="283">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="9">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="103">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="15">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="114">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="7">   </td> </tr> <tr> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="top" width="283"> Medicare </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="9">   </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="103"> 23.8% </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="15">   </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="114"> 36.6% </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="7">   </td> </tr> <tr> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="top" width="283"> Medicaid/Other Government </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="9">   </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="103"> 20.2% </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="15">   </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="114"> 3.6% </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="7">   </td> </tr> <tr> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="top" width="283"> Private Insurance/Other </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="9">   </td> <td style="BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="103"> 56.0% </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="15">   </td> <td style="BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="114"> 59.8% </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="7">   </td> </tr> <tr> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="top" width="283"> Total </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="9">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="103"> 100.0% </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="15">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="114"> 100.0% </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="7">   </td> </tr> </table> Inventory Inventory is valued at the lower of cost or market, on an average cost basis and includes primarily finished goods. Advertising Advertising, marketing and selling is expensed as incurred.  Such expenses for the six months ended June 30, 2011 and 2010, and totaled $25,107 and $3,348, respectively. Shipping and Handling Costs The Company classifies costs related to freight as costs of sales. Property and Equipment   Property and equipment, including rental equipment are carried at cost and are depreciated on a straight-line basis over the estimated useful lives of the assets. Depreciation of rental equipment is computed using the straight-line method over the estimated useful lives, generally one to three years. Such depreciation of rental equipment is charged to cost of sales. The cost of repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized.  When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition. The Company examines the possibility of decreases in the value of fixed assets when events or changes in circumstances reflect the fact that their recorded value may not be recoverable. Impairment of Long-Lived Assets The Company reviews, long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable, or at least annually. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset's estimated fair value and its book value. The Company did not record any impairment charges for the six months ended June 30, 2011 and 2010. Income Taxes   Deferred income tax assets and liabilities are computed for differences between the carrying amounts of assets and liabilities for financial statement and tax purposes. Deferred income tax assets are required to be reduced by a valuation allowance when it is determined that it is more likely than not that all or a portion of a deferred tax asset will not be realized. In determining the necessity and amount of a valuation allowance, management considers current and past performance, the operating market environment, tax planning strategies and the length of tax benefit carry forward periods. Pursuant to accounting standards related to the accounting for uncertainty in income taxes, the evaluation of a tax position is a two-step process. The first step is to determine whether it is more likely than not that a tax position will be sustained upon examination, including the resolution of any related appeals or litigation based on the technical merits of that position. The second step is to measure a tax position that meets the more-likely-than-not threshold to determine the amount of benefit to be recognized in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50% likelihood of being realized upon ultimate settlement. Tax positions that previously failed to meet the more-likely-than-not recognition threshold should be recognized in the first subsequent period in which the threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not criteria should be de-recognized in the first subsequent financial reporting period in which the threshold is no longer met. The accounting standard also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosures, and transition.  The adoption had no effect on the Company's consolidated financial statements. Subsequent Events For purposes of determining whether a post-balance sheet event should be evaluated to determine whether it has an effect on the financial statements for the six months ended June 30, 2011, subsequent events were evaluated by the Company as of the date on which the consolidated financial statements for the three and six months ended June 30, 2011 and 2010 were available to be issued. Stock Based Compensation In December 2004, the Financial Accounting Standards Board, or FASB, issued FASB ASC Topic 718: Compensation - Stock Compensation ("ASC 718"). Under ASC 718, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share-based compensation arrangements include stock options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans. Companies may elect to apply this statement either prospectively, or on a modified version of retrospective application under which financial statements for prior periods are adjusted on a basis consistent with the pro forma disclosures required for those periods under ASC 718. Upon adoption of ASC 718, the Company elected to value employee stock options using the Black-Scholes option valuation method that uses assumptions that relate to the expected volatility of the Company's common stock, the expected dividend yield of our stock, the expected life of the options and the risk free interest rate. Such compensation amounts, if any, are amortized over the respective vesting periods or period of service of the option grant. Related Parties Parties are considered to be related to the Company if the parties that, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. The Company discloses all related party transactions. All transactions shall be recorded at fair value of the goods or services exchanged. Property purchased from a related party is recorded at the cost to the related party and any payment to or on behalf of the related party in excess of the cost is reflected as a distribution to related party. Recently Issued Accounting Pronouncements We have reviewed the FASB issued Accounting Standards Update ("ASU") accounting pronouncements and interpretations thereof that have effectiveness dates during the periods reported and in future periods. The Company has carefully considered the new pronouncements that alter previous generally accepted accounting principles and does not believe that any new or modified principles will have a material impact on the corporation's reported financial position or operations in the near term.  The applicability of any standard is subject to the formal review of our financial management and certain standards are under consideration.  Reference is made to these recent accounting pronouncements as if they are set forth therein in their entirety. Earnings (Loss) Per Share Earnings per common share are calculated under the provisions of a FASB issued new guidance," which established new accounting standards for computing and presenting earnings per share. The accounting standard requires the Company to report both basic earnings per share, which is based on the weighted-average number of common shares outstanding, and diluted earnings per share, which is based on the weighted-average number of common shares outstanding plus all potential dilutive common shares outstanding. The computation of diluted net loss per share does not include dilutive common stock equivalents in the weighted average shares outstanding as they would be anti-dilutive. As of June 30, 2011, there were 3,075,000 stock options which could potentially dilute future earnings per share. </div> </div>

362190

423

28217

260216

361767

231999

<div> <div style="WIDTH: 720px"> NOTE 8 - COMMITMENTS Operating Lease The Company leases office space in Mobile, Alabama, and several sites in Florida under two- five-year operating leases that expire on April 30, 2014. The office lease agreements have certain escalation clauses and renewal options. Additionally, the Company has lease agreements for computer equipment, including an office copier and fax machine. Future minimum rental payments required under these operating leases are as follows: <table style="MARGIN-TOP: 0px; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" align="center"> <tr style="FONT-SIZE: 1pt"> <td width="169"> </td> <td width="13"> </td> <td width="61"> </td> <td width="10"> </td> </tr> <tr> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="169"> Period ending June 30: </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="13">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="61">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="10">   </td> </tr> <tr> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="169"> 2011 </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="13">   </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="61"> 145,311 </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="top" width="10">   </td> </tr> <tr> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="169"> 2012 </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="13">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="61"> 277,120 </td> <td style="MARGIN-TOP: 0px" valign="top" width="10">   </td> </tr> <tr> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="169"> 2013 and thereafter </td> <td style="BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="13">   </td> <td style="BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="61"> 309,431 </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="top" width="10">   </td> </tr> <tr> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="169">   </td> <td style="BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="13"> $ </td> <td style="BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="61"> 731,862 </td> <td style="MARGIN-TOP: 0px" valign="top" width="10">   </td> </tr> </table>   Rent expense was $128,575 and $98,506 for the six months ended June 30, 2011 and 2010, respectively. In April 2011, the Company received approximately $80,000 from Hasco Holdings, LLC.  In March 2011, Hasco Holdings LLC. entered into a settlement and release agreement with the former owners of Southern Medical & Mobility, Inc. ("SMM"). The former owners agreed to reimburse Hasco Holdings LLC for all the refunds made to third party payors associated with billings prior to the acquisition of Hasco Holdings LLC of SMM in June 2008. </div> </div>

0.001

1000000000

757586910

746436909

757586910

746436909

757587

746437

2394395

1985800

3984923

4039849

55026

<div> <div style="WIDTH: 720px"> NOTE 4 - NOTES PAYABLE Between December 2008 and January 2009, the Company issued notes payable amounting to $52,979 in connection with the acquisition of three delivery vehicles. The notes payable bear approximately 2% interest per annum and are secured by a lien of all three delivery vehicles. These notes shall be payable in thirty-six equal monthly payments of $1,516 beginning in January 2009 through December 2011. As of June 30, 2011, the current and long term portion of these notes amounted to $15,176. As of December 31, 2010, the current and long term portion of these notes amounted to $18,005 and $2,509, respectively. On June 29, 2011 Hasco Medical, Inc. entered into a $400,000 revolving line of credit agreement with Whitney Bank, which includes an annual renewal.  An annual facility fee of .25% was charged. Interest at the Wall Street Journal prime rate plus 1.0% on the used facility will be paid monthly.  At June 30, 2011 the aforementioned interest rate was 4.25%.   As of June 30, 2011 there remains $100,000 available on the line of credit. On May 13, 2011, the Company issued a promissory  note, payable to the Sellers of Mobility Freedom Inc (the Acquisition), in the amount of $3,850,000, in exchange for all the shares of acquired company.  The terms of the agreement included an employment agreement with the seller.  The acquisition price consists of two notes: <table style="MARGIN-TOP: 0px; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0"> <tr style="FONT-SIZE: 1pt"> <td width="24"> </td> <td width="24"> </td> <td width="672"> </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="24"> 1. </td> <td style="MARGIN-TOP: 0px" valign="top" width="672"> Note for $2,000,000 ($1,850,000 cash proceeds to seller and consolidation of $150,000 previously advanced for working capital)  to Hal Compton, Sr, our Chairman.  The note bears interest at 5% annually with monthly payments of interest and principal of $21,213, commencing August 15, 2011 for 120 months; </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="672">   </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="top" width="24">   </td> <td style="MARGIN-TOP: 0px" valign="top" width="24"> 2. </td> <td style="MARGIN-TOP: 0px" valign="top" width="672"> Promissory note to seller note in the amount of $2,000,000, secured by grantee from the majority shareholder, with interest at 6% per annum and equal monthly installments of interest and principal of $16,877.14. </td> </tr> </table> </div> </div>

186375

1823666

51270

58950

102128

117900

<div> <div style="WIDTH: 720px"> NOTE 7 - STOCK OPTION PLAN   Under the Company's stock option plan, adopted on July 9, 2009, 20,000,000 shares of common stock were reserved for issuance upon exercise of options granted to directors, officers and employees of the Company. The Company is authorized to issue Incentive Stock Options ("ISOs"), which meet the requirements of Section 422 of the Internal Revenue Code of 1986. At its discretion, the Company can also issue Non Statutory Options ("NSOs"). When an ISO is granted, the exercise price shall be equal to the fair market value per share of the common stock on the date of the grant. The exercise price of an NSO shall not be less than fair market value of one share of the common stock on the date the option is granted. The vesting period will be determined on the date of grant. On November 1, 2009, the Company granted an aggregate of 4,075,000 5-year option to purchase shares of common stock at $0.007 per share which vests at the end of two years, to four officers and three directors of the Company. The 4,075,000 options were valued on the grant date at $0.0064 per option or a total of $26,080 using a Black-Scholes option pricing model with the following assumptions: stock price of $0.007 per share, volatility of 150%, expected term of five years, and a risk free interest rate of 2.33%. Stock option activity for the three months ended June 30, 2011 is summarized as follows: <table style="MARGIN-TOP: 0px; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" align="center"> <tr style="FONT-SIZE: 1pt" > <td width="333"> </td> <td width="109"> </td> <td width="31"> </td> <td width="19"> </td> <td width="97"> </td> <td width="18"> </td> <td width="13"> </td> </tr> <tr> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="333">   </td> <td style="BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="109"> Number of shares </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="31">   </td> <td style="BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="135" colspan="3"> Weighted average exercise price </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="13">   </td> </tr> <tr> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="333"> Outstanding at December 31, 2010 </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="109"> 4,075,000 </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="31">   </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="19"> $ </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="97"> 0.007 </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="32" colspan="2">   </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="bottom" width="333"> Granted </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="109"> - </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="31">   </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="19">   </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="97"> - </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="32" colspan="2">   </td> </tr> <tr> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="333"> Exercised </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="109"> - </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="31">   </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="19">   </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="97"> - </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="32" colspan="2">   </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="bottom" width="333"> Cancelled </td> <td style="BORDER-BOTTOM: #000000 1px solid; MARGIN-TOP: 0px" valign="bottom" width="109"> (1,000,000 </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="31"> ) </td> <td style="BORDER-BOTTOM: #000000 1px solid; MARGIN-TOP: 0px" valign="bottom" width="19">   </td> <td style="BORDER-BOTTOM: #000000 1px solid; MARGIN-TOP: 0px" valign="bottom" width="97"> - </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="32" colspan="2">   </td> </tr> <tr> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="333"> Outstanding at June 30, 2011 </td> <td style="BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="109">   </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="31">   </td> <td style="BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="19"> $ </td> <td style="BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="97">   </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="32" colspan="2">   </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="bottom" width="333">   </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="109">   </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="31">   </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="19">   </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="97">   </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="32" colspan="2">   </td> </tr> <tr> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="333"> Options exercisable at end of year </td> <td style="BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="109"> - </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="31">   </td> <td style="BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="19"> $ </td> <td style="BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="97"> - </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="32" colspan="2">   </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="bottom" width="333"> Weighted average fair value of options granted during the year </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="109">   </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="31">   </td> <td style="BORDER-BOTTOM: #000000 3px double; MARGIN-TOP: 0px" valign="bottom" width="19"> $ </td> <td style="BORDER-BOTTOM: #000000 3px double; MARGIN-TOP: 0px" valign="bottom" width="97"> - </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="32" colspan="2">   </td> </tr> </table> Stock options outstanding at June 30, 2011 as disclosed in the above table have $29,212 intrinsic value at the end of the year. The following table summarizes the Company's stock options outstanding at June 30, 2011: <table style="MARGIN-TOP: 0px; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" align="center"> <tr style="FONT-SIZE: 1pt"> <td width="19"> </td> <td width="83"> </td> <td width="19"> </td> <td width="100"> </td> <td width="19"> </td> <td width="122"> </td> <td width="23"> </td> <td width="96"> </td> <td width="18"> </td> <td width="90"> </td> <td width="28"> </td> <td width="96"> </td> </tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid; MARGIN-TOP: 0px" valign="bottom" width="486" colspan="8"> Options Outstanding </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="18">   </td> <td style="BORDER-BOTTOM: #000000 1px solid; MARGIN-TOP: 0px" valign="bottom" width="215" colspan="3"> Options Exercisable </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="bottom" width="19">   </td> <td style="BORDER-BOTTOM: #000000 1px solid; MARGIN-TOP: 0px" valign="bottom" width="83"> Range of Exercise Price </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="19">   </td> <td style="BORDER-BOTTOM: #000000 1px solid; MARGIN-TOP: 0px" valign="bottom" width="100"> Number Outstanding </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="19">   </td> <td style="BORDER-BOTTOM: #000000 1px solid; MARGIN-TOP: 0px" valign="bottom" width="122"> Weighted Average Remaining Contractual Life </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="23">   </td> <td style="BORDER-BOTTOM: #000000 1px solid; MARGIN-TOP: 0px" valign="bottom" width="96"> Weighted Average Exercise Price </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="18">   </td> <td style="BORDER-BOTTOM: #000000 1px solid; MARGIN-TOP: 0px" valign="bottom" width="90"> Number Exercisable </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="28">   </td> <td style="BORDER-BOTTOM: #000000 1px solid; MARGIN-TOP: 0px" valign="bottom" width="96"> Weighted Average Exercise Price </td> </tr> <tr> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="19"> $ </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="83"> 0.007 </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="19">   </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="100"> 3,075,000 </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="19">   </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="122"> 3.58 Years </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="23"> $ </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="96"> 0.007 </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="18">   </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="90"> - </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="28"> $ </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="96"> - </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="bottom" width="19">   </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="83">   </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="19">   </td> <td style="BORDER-BOTTOM: #000000 3px double; MARGIN-TOP: 0px; BORDER-TOP: #000000 1px solid" valign="bottom" width="100"> 3,075,000 </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="19">   </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="122">   </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="23"> $ </td> <td style="BORDER-BOTTOM: #000000 3px double; MARGIN-TOP: 0px; BORDER-TOP: #000000 1px solid" valign="bottom" width="96"> 0.007 </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="18">   </td> <td style="BORDER-BOTTOM: #000000 3px double; MARGIN-TOP: 0px; BORDER-TOP: #000000 1px solid" valign="bottom" width="90"> - </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="28"> $ </td> <td style="BORDER-BOTTOM: #000000 3px double; MARGIN-TOP: 0px; BORDER-TOP: #000000 1px solid" valign="bottom" width="96"> - </td> </tr> </table> </div> </div>

1133747

1111541

2202749

2222832

1329757

1267692

2454262

2047138

154797

68976

161623

-349287

15846

80478

-4236

2306038

-303319

37599

5118

16405

36188

28225

67833

55693

2382394

76356

6629409

498175

2105918

706310

4300000

152509

4744443

-1413682

-758056

11691

-3624620

1633990

154797

68976

161623

-365133

21759

10057

-28225

12239

-55693

227857

18005

1185018

1170491

2304878

2340732

144740

97201

149385

-293594

38019

420

69158

30000

20328

-19541

46246

80072

758056

-11691

0.001

3000000

23963

18845

387100

150096

4147491

209852

-1563778

161624

-261837

<div> <div style="WIDTH: 720px"> NOTE 3 - PROPERTY AND EQUIPMENT Property and equipment consisted of the following: <table style="MARGIN-TOP: 0px; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" align="center"> <tr style="FONT-SIZE: 1pt"> <td width="155"> </td> <td width="107"> </td> <td width="17"> </td> <td width="29"> </td> <td width="75"> </td> <td width="18"> </td> <td width="29"> </td> <td width="74"> </td> <td width="13"> </td> </tr> <tr> <td style="MARGIN-TOP: 0px" valign="bottom" width="155">   </td> <td style="BORDER-BOTTOM: #000000 1px solid; MARGIN-TOP: 0px" valign="bottom" width="107"> Estimated Life </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="17">   </td> <td style="BORDER-BOTTOM: #000000 1px solid; MARGIN-TOP: 0px" valign="bottom" width="105" colspan="2"> June 30, 2011 </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="18">   </td> <td style="BORDER-BOTTOM: #000000 1px solid; MARGIN-TOP: 0px" valign="bottom" width="104" colspan="2"> December 31, 2010 </td> <td style="MARGIN-TOP: 0px" valign="bottom" width="13">   </td> </tr> <tr> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="top" width="155"> Building improvements </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="107"> 15-39 years </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="17">   </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="29"> $ </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="75"> 60,110 </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="18">   </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="29"> $ </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="74"> - </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="13">   </td> </tr> <tr> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="top" width="155"> Office equipment </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="107"> 5 years </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="17">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="29">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="75"> 108,434 </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="18">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="29">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="74"> 38,979 </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="13">   </td> </tr> <tr> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="top" width="155"> Rental equipment </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="107"> 13 - 36 months </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="17">   </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="29">   </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="75"> 1,521,767 </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="18">   </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="29">   </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="74"> 468,646 </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="13">   </td> </tr> <tr> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="top" width="155"> Vehicles </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="107"> 5 years </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="17">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="29">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="75"> 114,775 </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="18">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="29">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="74"> 71,656 </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="13">   </td> </tr> <tr> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="top" width="155"> Computer equipment </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="107"> 5 years </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="17">   </td> <td style="BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="29">   </td> <td style="BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="75"> 53,086 </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="18">   </td> <td style="BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="29">   </td> <td style="BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="74"> 31,483 </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="13">   </td> </tr> <tr> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="top" width="155">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="107">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="17">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="29">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="75"> 1,582,172 </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="18">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="29">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="74"> 610,764 </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="13">   </td> </tr> <tr> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="top" width="155"> Less: accumulated depreciation </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="107">   </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="17">   </td> <td style="BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="29">   </td> <td style="BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="75"> (1,100,863 </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="18"> ) </td> <td style="BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="29">   </td> <td style="BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="74"> (462,995 </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="13"> ) </td> </tr> <tr> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="top" width="155">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="107">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="17">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="29">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="75">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="18">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="29">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="74">   </td> <td style="BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0px" valign="bottom" width="13">   </td> </tr> <tr> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="top" width="155">   </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="107">   </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="17">   </td> <td style="BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="29"> $ </td> <td style="BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="75"> 757,309 </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="18">   </td> <td style="BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="29"> $ </td> <td style="BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="74"> 147,769 </td> <td style="BACKGROUND-COLOR: #f3f3f3; MARGIN-TOP: 0px" valign="bottom" width="13">   </td> </tr> </table> For the six months ended June 30, 2011 and 2010, depreciation expense amounted to $148,516 and $185,967, respectively of which $46,388 and $68,067 is included in cost of sales, respectively. The Company has entered into various financing arrangements in connection with the acquisition of three delivery vehicles (see Note 4 below). </div> </div>

757309

147769

<div> <div style="WIDTH: 720px"> NOTE 10 - RELATED PARTY TRANSACTIONS Management Fee In March 2011, the Company issued 9,000,000 shares in connection with the payment of accrued management fees of $180,000 to HASCO Holdings, LLC. The Company valued these common shares at the fair market value on the date of grant at $0.02 per share or $180,000. The Company and HASCO Holdings, LLC agreed to terminate the management agreement in January 2011. </div> </div>

-4145528

-4324683

3724153

3253492

6439186

6086987

<div> <div style="WIDTH: 720px"> NOTE 9 - SEGMENT REPORTING Pursuant to accounting standards related to the Disclosure about Segments of an Enterprise and Related Information which establishes standards for the reporting by business enterprises of information about operating segments, products and services, geographic areas, and major customers. The method for determining what information to report is based on the way that management organizes the operations of the Company for making operational decisions and assessments of financial performance. The Company's operating decision-maker is considered to be the chief executive officer (CEO). The CEO reviews financial information for purposes of making operating decisions and assessing financial performance. The financial information reviewed by the CEO is identical to the information presented in the accompanying statements of operations. Therefore, the Company has determined that it operates in a single operating segment. For the periods ended December 31, 2010 and 2009 all material assets and revenues of the Company were in the United States. </div> </div>

17880

20074

223491

-360644

<div> <div style="WIDTH: 720px"> NOTE 6 - EQUITY   On May 12, 2009 HASCO Medical, Inc. ("HASCO") completed the acquisition of Southern Medical & Mobility, Inc. (SMM") pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement") among HASCO, SMM and Southern Medical Acquisition, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company. Under the terms of the Merger Agreement Southern Medical Acquisition, Inc. was merged into Southern Medical & Mobility, Inc., and Southern Medical & Mobility, Inc. became a wholly-owned subsidiary of HASCO. The shareholder of Southern Medical & Mobility, Inc. was issued a total of 554,676,000 shares of the Company's common stock in exchange for their Southern Medical & Mobility, Inc. share. After the merger and transactions that occurred at the same time as the merger, there were 642,176,000 shares of the Company's common stock outstanding, of which 620,000,000, approximately 96.5%, were held by HASCO Holdings, LLC, the former sole shareholder of Southern Medical & Mobility, Inc. Prior to the merger, the Company was a shell company with no business operations. For accounting purposes, HASCO Medical, Inc. has accounted for the transaction as a reverse acquisition and HASCO will be the surviving entity as a publicly-traded company under the name HASCO Medical Inc. or together with its subsidiaries. The Company did not recognize goodwill or any intangible assets in connection with this transaction. Effective with the reverse merger, all previously outstanding common stock owned by HASCO Medical, Inc.'s shareholders were exchanged for the Company's common stock. The value of the Company's common stock that was issued to HASCO Medical, Inc.'s shareholders was the historical cost of the Company's net tangible assets, which did not differ materially from its fair value. All references to common stock, share and per share amounts have been retroactively restated to reflect the reverse acquisition as if the transaction had taken place as of the beginning of the earliest period presented.  In January 2011, in connection with the sale of the Company's common stock, the Company issued 2,000,000 shares of common stock for net proceeds of approximately $20,000. In February 2011, the Company entered into a placement agent agreement whereby the Company engaged that firm to assist us in a best efforts private offering of the Company's securities. Under the terms of the agreement, the Company paid the firm an upfront retainer of 150,000 shares of the Company's common stock as compensation for services. The Company shall pay 2% commissions based on the proceeds received by the Company from the offering. The Company valued these common shares at the fair market value on the date of grant at $0.02 per share or $3,000 and was recorded as stock-based consulting expense. In March 2011, the Company issued 9,000,000 shares in connection with the payment of accrued management fees of $180,000 to HASCO Holdings, LLC. The Company valued these common shares at the fair market value on the date of grant at $0.02 per share or $180,000. </div> </div>

xbrli:shares ISO4217:USD ISO4217:USD shares 0001131675 2011-08-15 0001131675 2011-06-30 0001131675 2011-04-01 2011-06-30 0001131675 2011-01-01 2011-06-30 0001131675 2010-12-31 0001131675 2010-06-30 0001131675 2010-04-01 2010-06-30 0001131675 2010-01-01 2010-06-30 0001131675 2009-12-31

EX-101.SCH 7 hasc-20110630.xsd XBRL SCHEMA FILE 101 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 002 - Statement - Consolidated Balance Sheets link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 003 - Statement - Consolidated Balance Sheets (Parenthetical) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 109 - Disclosure - COMMITMENTS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 005 - Statement - Consolidated Statements of Cash Flows link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 004 - Statement - Consolidated Statements of Operations link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 001 - Document - Document and Entity Information link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 102 - Disclosure - GOING CONCERN CONSIDERATIONS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 105 - Disclosure - LOANS PAYABLE - RELATED PARTY link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 106 - Disclosure - NOTE PAYABLE - RELATED PARTY link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 104 - Disclosure - NOTES PAYABLE link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 103 - Disclosure - PROPERTY AND EQUIPMENT link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 111 - Disclosure - RELATED PARTY TRANSACTIONS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 110 - Disclosure - SEGMENT REPORTING link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 107 - Disclosure - EQUITY link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 108 - Disclosure - STOCK OPTION PLAN link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 112 - Disclosure - SUBSEQUENT EVENTS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink EX-101.CAL 8 hasc-20110630_cal.xml XBRL CALCULATION FILE EX-101.LAB 9 hasc-20110630_lab.xml XBRL LABEL FILE Amendment Flag Current Fiscal Year End Date Document And Entity Information [Abstract] Document And Entity Information [Abstract]. Document Fiscal Period Focus Document Fiscal Year Focus Document Period End Date Document Type Entity Central Index Key Entity Common Stock, Shares Outstanding Entity Filer Category Entity Registrant Name Accounts Payable and Accrued Liabilities, Current Accounts payable and accrued liabilities Accounts Receivable, Net, Current Accounts receivable, net Additional Paid in Capital Additional paid in capital Assets Total Assets Assets [Abstract] ASSETS Assets, Current Total Current Assets Assets, Current [Abstract] CURRENT ASSETS Assets, Noncurrent [Abstract] LONG-TERM ASSETS: Bank Overdrafts Overdraft liabilities Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Common Stock, Value, Issued Common stock, $.001 par value; 1,000,000,000 shares authorized; 757,586,910 and 746,436,909 shares issued and outstanding, respectively. Customer Deposits, Current Customer deposits Customer List Net Customer List, Net. Customer List, net Deposits Assets, Noncurrent Deposits Due to Related Parties, Current Loans payable - related party Equity [Abstract] STOCKHOLDERS' EQUITY: Interest Payable, Current Accrued interest payable Inventory, Net Inventory Liabilities Total Liabilities Liabilities and Equity Total Liabilities and Stockholders' Deficit Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities, Current Total Current Liabilities Liabilities, Current [Abstract] CURRENT LIABILITIES: Liabilities, Noncurrent Long Term Debt Liabilities, Noncurrent [Abstract] LONG-TERM LIABILITIES: Long-term Debt, Excluding Current Maturities Long Term Debt Notes Payable, Noncurrent Notes Payable Notes Payable, Current Notes payable Notes Payable, Related Parties, Noncurrent Note Payable - related party Other Assets [Abstract] OTHER ASSETS: Other Assets, Noncurrent Other Other Liabilities, Current Other Liabilities Preferred Stock, Value, Issued Preferred stock ($.001 par value; 3,000,000 shares authorized; none issued and outstanding) Prepaid Expense and Other Assets, Current Prepaid expenses and other current asset Property, Plant and Equipment, Net Property and equipment, net Retained Earnings (Accumulated Deficit) Accumulated deficit Sales Team And Iinfrastructure Net Sales Team And Iinfrastructure, Net. Sales Team and infrastructure, net Consolidated Balance Sheets [Abstract] Stockholders' Equity Attributable to Parent Total Stockholders' Equity (Deficit) Common Stock, Par or Stated Value Per Share Common stock, par value per share Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding Preferred Stock, Par or Stated Value Per Share Preferred stock, par value per share Preferred Stock, Shares Authorized Preferred stock, shares authorized Preferred Stock, Shares Issued Preferred stock, shares issued Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Cost of Revenue Cost of sales Depreciation, Nonproduction Depreciation Earnings Per Share [Abstract] Net loss per common shares: Earnings Per Share, Basic Basic Earnings Per Share, Diluted Diluted General and Administrative Expense General and administrative Gross Margin Percent Gross Margin Percent. Gross margin, percent Gross Profit Gross profit Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest Income (Loss) before income taxes Consolidated Statements of Operations [Abstract] Income Tax Expense (Benefit) Income tax (expense) Interest Expense Interest expense Net Income (Loss) Attributable to Parent Net Income Nonoperating Income (Expense) Total other expenses Nonoperating Income (Expense) [Abstract] Other income (expenses): Operating Expenses Total operating expenses Operating Expenses [Abstract] Operating expenses: Operating Expenses As Percent Of Net Revenues Operating Expenses As Percent Of Net Revenues. Operating expenses a a percent of net revenues Operating Income (Loss) Income from operations Other Nonoperating Income Other income Revenues Net revenues Selling and Marketing Expense Marketing and selling Weighted Average Number of Shares Outstanding, Diluted Diluted Weighted Average Number of Shares Outstanding, Diluted [Abstract] Weighted average common shares outstanding: Weighted Average Number of Shares Outstanding, Basic Basic Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash provided by (used in) operating activities: Cash, Beginning of period Cash, End of period Cash and Cash Equivalents, Period Increase (Decrease) Net increase (decrease) in cash Cash Used For Customer Lists Cash Used For Customer Lists. Customer list Cash Used For Sales Team And Infrastructure Net Cash Used For Sales Team And Infrastructure, Net. Sales team and infrastructure, net Depreciation, Depletion and Amortization Depreciation and Amortization Income Taxes Paid Income taxes Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable and accrued liabilities Increase (Decrease) in Accounts Receivable Accounts receivable Increase (Decrease) in Inventories Inventory Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Other Operating Assets Other assets Increase (Decrease) in Other Operating Liabilities Other liabilities Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense Prepaid expenses Interest Paid Interest Issuance of Stock and Warrants for Services or Claims Common stock issued for services Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Cash flows from financing activities: Net Cash Provided by (Used in) Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Cash flows from investing activities: Net Cash Provided by (Used in) Operating Activities Net cash (used in) provided by operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Cash flows from operating activities: Noncash Investing and Financing Items [Abstract] Non-Cash transactions: Noncash or Part Noncash Acquisition, Fixed Assets Acquired Vehicles acquired through financing Other Noncash Income (Expense) Purchase price adjustment Payments for (Proceeds from) Productive Assets Disposal (Purchase) of property and equipment Payments of Dividends Dividend payments Payments to Acquire Property, Plant, and Equipment Purchase of property and equipment Proceeds from Issuance of Common Stock Proceeds from sale of common stock Proceeds from Notes Payable Proceeds from note payable Proceeds from Related Party Debt Proceeds from loans payable - related party Proceeds from (Repayments of) Bank Overdrafts Overdraft liability Proceeds from (Repayments of) Notes Payable Repayments (proceeds) of notes payable Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Provision for Doubtful Accounts Bad debt expense Repayments of Related Party Debt Repayments of loan payable - related party Share-based Compensation Stock based compensation Consolidated Statements of Cash Flows [Abstract] Stock Issued Fair value of shares of common stock issued for accrued management fees Supplemental Cash Flow Information [Abstract] Supplemental disclosures of cash flow information: Supplemental Cash Flow Information Cash Paid For [Abstract] Cash Paid For: Supplemental Cash Flow Information: Cash Paid For: [Abstract]. Basis of Presentation and Significant Accounting Policies [Text Block] NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract] GOING CONCERN CONSIDERATIONS [Abstract] Going Concern Considerations Disclosure [Abstract]. Liquidity Disclosure Going Concern Note [Text Block] GOING CONCERN CONSIDERATIONS If there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date), disclose: (a) pertinent conditions and events giving rise to the assessment of substantial doubt about the entity's ability to continue as a going concern for a reasonable period of time, (b) the possible effects of such conditions and events, (c) management's evaluation of the significance of those conditions and events and any mitigating factors, (d) possible discontinuance of operations, (e) management's plans (including relevant prospective financial information), and (f) information about the recoverability or classification of recorded asset amounts or the amounts or classification of liabilities. PROPERTY AND EQUIPMENT [Abstract] Property, Plant and Equipment Disclosure [Text Block] PROPERTY AND EQUIPMENT NOTES PAYABLE [Abstract] Debt Disclosure [Text Block] NOTES PAYABLE LOANS PAYABLE - RELATED PARTY [Abstract] Loans Payable - Related Party Disclosure [Abstract] Loans Payable Related Party Disclosure [Text Block] LOANS PAYABLE - RELATED PARTY Loans Payable - Related Party Disclosure [Text Block]. NOTE PAYABLE - RELATED PARTY [Abstract] Note Payable - Related Party Disclosure [Abstract] Note Payable Related Party Disclosure [Text Block] NOTE PAYABLE - RELATED PARTY Note Payable - Related Party Disclosure [Text Block]. EQUITY [Abstract] Stockholders' Equity Note Disclosure [Text Block] EQUITY STOCK OPTION PLAN [Abstract] Disclosure of Compensation Related Costs, Share-based Payments [Text Block] STOCK OPTION PLAN COMMITMENTS [Abstract] Commitments Disclosure [Text Block] COMMITMENTS SEGMENT REPORTING [Abstract] Segment Reporting Disclosure [Text Block] SEGMENT REPORTING RELATED PARTY TRANSACTIONS [Abstract] Related Party Transactions Disclosure [Text Block] RELATED PARTY TRANSACTIONS SUBSEQUENT EVENTS [Abstract] Subsequent Events [Text Block] SUBSEQUENT EVENTS EX-101.PRE 10 hasc-20110630_pre.xml XBRL PRESENTATION FILE XML 11 R3.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets (Parenthetical) (USD $)	Jun. 30, 2011	Dec. 31, 2010
Consolidated Balance Sheets [Abstract]
Preferred stock, par value per share	$ 0.001	$ 0.001
Preferred stock, shares authorized	3,000,000	3,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value per share	$ 0.001	$ 0.001
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	757,586,910	746,436,909
Common stock, shares outstanding	757,586,910	746,436,909

- Definition

Total number of shares of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares represent the ownership interest of the common shareholders. Shares outstanding equals shares issued minus shares held in treasury and other adjustments, if any.

+ References+ Details

- Definition

Face amount or stated value per share of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.

+ References+ Details

XML 12 R4.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Operations (USD $)	3 Months Ended		6 Months Ended
Consolidated Statements of Operations (USD $)	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
Consolidated Statements of Operations [Abstract]
Net revenues	$ 3,724,153	$ 3,253,492	$ 6,439,186	$ 6,086,987
Cost of sales	2,394,395	1,985,800	3,984,923	4,039,849
Gross profit	1,329,757	1,267,692	2,454,262	2,047,138
Operating expenses:
General and administrative	1,133,747	1,111,541	2,202,749	2,222,832
Depreciation	51,270	58,950	102,128	117,900
Total operating expenses	1,185,018	1,170,491	2,304,878	2,340,732
Income from operations	144,740	97,201	149,385	(293,594)
Other income (expenses):
Other income	46,246		80,072
Interest expense	(36,188)	(28,225)	(67,833)	(55,693)
Total other expenses	10,057	(28,225)	12,239	(55,693)
Income (Loss) before income taxes	154,797	68,976	161,623	(349,287)
Income tax (expense)				(15,846)
Net Income	$ 154,797	$ 68,976	$ 161,623	$ (365,133)

XML 13 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information	6 Months Ended
Document and Entity Information	Jun. 30, 2011	Aug. 15, 2011
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2011
Entity Registrant Name	HASCO Medical, Inc.
Entity Central Index Key	0001131675
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2011
Document Fiscal Period Focus	Q2
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		763,102,390

XML 14 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'

'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'

'+ "\n"+' '+ "\n"+'

'+ "\n"+'

'+raw+'

'+ "\n"+'

'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } } XML 15 R12.htm IDEA: XBRL DOCUMENT

STOCK OPTION PLAN

6 Months Ended

Jun. 30, 2011

STOCK OPTION PLAN [Abstract]

STOCK OPTION PLAN

NOTE 7 - STOCK OPTION PLAN

Under the Company's stock option plan, adopted on July 9, 2009, 20,000,000 shares of common stock were reserved for issuance upon exercise of options granted to directors, officers and employees of the Company. The Company is authorized to issue Incentive Stock Options ("ISOs"), which meet the requirements of Section 422 of the Internal Revenue Code of 1986. At its discretion, the Company can also issue Non Statutory Options ("NSOs"). When an ISO is granted, the exercise price shall be equal to the fair market value per share of the common stock on the date of the grant. The exercise price of an NSO shall not be less than fair market value of one share of the common stock on the date the option is granted. The vesting period will be determined on the date of grant.

Stock option activity for the three months ended June 30, 2011 is summarized as follows:


	Number of shares		Weighted average exercise price
Outstanding at December 31, 2010	4,075,000		$	0.007
Granted	-			-
Exercised	-			-
Cancelled	(1,000,000	)		-
Outstanding at June 30, 2011			$

Options exercisable at end of year	-		$	-
Weighted average fair value of options granted during the year			$	-

Stock options outstanding at June 30, 2011 as disclosed in the above table have $29,212 intrinsic value at the end of the year.

The following table summarizes the Company's stock options outstanding at June 30, 2011:


Options Outstanding						Options Exercisable
	Range of Exercise Price	Number Outstanding	Weighted Average Remaining Contractual Life		Weighted Average Exercise Price	Number Exercisable		Weighted Average Exercise Price
$	0.007	3,075,000	3.58 Years	$	0.007	-	$	-
		3,075,000		$	0.007	-	$	-

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Statement of Position (SOP)
-Number 93-6
-Paragraph 53
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 14

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 123R
-Paragraph 64, 65, A240
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 40
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

XML 16 R8.htm IDEA: XBRL DOCUMENT

PROPERTY AND EQUIPMENT

6 Months Ended

Jun. 30, 2011

PROPERTY AND EQUIPMENT [Abstract]

PROPERTY AND EQUIPMENT

NOTE 3 - PROPERTY AND EQUIPMENT

Property and equipment consisted of the following:


	Estimated Life	June 30, 2011			December 31, 2010
Building improvements	15-39 years	$	60,110		$	-
Office equipment	5 years		108,434			38,979
Rental equipment	13 - 36 months		1,521,767			468,646
Vehicles	5 years		114,775			71,656
Computer equipment	5 years		53,086			31,483
			1,582,172			610,764
Less: accumulated depreciation			(1,100,863	)		(462,995	)

		$	757,309		$	147,769

For the six months ended June 30, 2011 and 2010, depreciation expense amounted to $148,516 and $185,967, respectively of which $46,388 and $68,067 is included in cost of sales, respectively.

The Company has entered into various financing arrangements in connection with the acquisition of three delivery vehicles (see Note 4 below).

- Definition

The entire disclosure for long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software. This disclosure may include property plant and equipment accounting policies and methodology, a schedule of property, plant and equipment gross, additions, deletions, transfers and other changes, depreciation, depletion and amortization expense, net, accumulated depreciation, depletion and amortization expense and useful lives, income statement disclosures, assets held for sale and public utility disclosures.

+ References+ Details

XML 17 R14.htm IDEA: XBRL DOCUMENT

SEGMENT REPORTING	6 Months Ended
SEGMENT REPORTING	Jun. 30, 2011
SEGMENT REPORTING [Abstract]
SEGMENT REPORTING	NOTE 9 - SEGMENT REPORTING Pursuant to accounting standards related to the Disclosure about Segments of an Enterprise and Related Information which establishes standards for the reporting by business enterprises of information about operating segments, products and services, geographic areas, and major customers. The method for determining what information to report is based on the way that management organizes the operations of the Company for making operational decisions and assessments of financial performance. The Company's operating decision-maker is considered to be the chief executive officer (CEO). The CEO reviews financial information for purposes of making operating decisions and assessing financial performance. The financial information reviewed by the CEO is identical to the information presented in the accompanying statements of operations. Therefore, the Company has determined that it operates in a single operating segment. For the periods ended December 31, 2010 and 2009 all material assets and revenues of the Company were in the United States.

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 131
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

+ Details

XML 18 R15.htm IDEA: XBRL DOCUMENT

RELATED PARTY TRANSACTIONS	6 Months Ended
RELATED PARTY TRANSACTIONS	Jun. 30, 2011
RELATED PARTY TRANSACTIONS [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 10 - RELATED PARTY TRANSACTIONS Management Fee In March 2011, the Company issued 9,000,000 shares in connection with the payment of accrued management fees of $180,000 to HASCO Holdings, LLC. The Company valued these common shares at the fair market value on the date of grant at $0.02 per share or $180,000. The Company and HASCO Holdings, LLC agreed to terminate the management agreement in January 2011.

- Definition

The entire disclosure for related party transactions, including the nature of the relationship(s), a description of the transactions, the amount of the transactions, the effects of any change in the method of establishing the terms of the transaction from the previous period, stated interest rate, expiration date, terms and manner of settlement per the agreement with the related party, and amounts due to or from related parties. If the entity and one or more other entities are under common ownership or management control and this control affects the operating results or financial position, disclosure includes the nature of the control relationship even if there are no transactions between the entities. Disclosure may also include the aggregate amount of current and deferred tax expense for each statement of earnings presented where the entity is a member of a group that files a consolidated tax return, the amount of any tax related balances due to or from affiliates as of the date of each statement of financial position presented, the principal provisions of the method by which the consolidated amount of current and deferred tax expense is allocated to the members of the group and the nature and effect of any changes in that method. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 3A
-Section 04
-Paragraph b

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 57
-Paragraph 1-4
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39678-107864

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 4
-Section 08
-Paragraph k

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864

+ Details

XML 19 R13.htm IDEA: XBRL DOCUMENT

COMMITMENTS

6 Months Ended

Jun. 30, 2011

COMMITMENTS [Abstract]

COMMITMENTS

NOTE 8 - COMMITMENTS

Operating Lease


Period ending June 30:
2011		145,311
2012		277,120
2013 and thereafter		309,431
	$	731,862

Rent expense was $128,575 and $98,506 for the six months ended June 30, 2011 and 2010, respectively.

In April 2011, the Company received approximately $80,000 from Hasco Holdings, LLC. In March 2011, Hasco Holdings LLC. entered into a settlement and release agreement with the former owners of Southern Medical & Mobility, Inc. ("SMM"). The former owners agreed to reimburse Hasco Holdings LLC for all the refunds made to third party payors associated with billings prior to the acquisition of Hasco Holdings LLC of SMM in June 2008.

- Definition

The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.

+ References+ Details

XML 20 R6.htm IDEA: XBRL DOCUMENT

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

6 Months Ended

Jun. 30, 2011

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 1 - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NATURE OF OPERATIONS

HASCO Medical, Inc. ("HASCO" or the "Company"), formerly BBC Graphics of Palm Beach Inc, was incorporated in May 2009 under the laws of the State of Florida. The Company operated as a provider of advertising and graphic design services. In June 2009, the Company changed its name to HASCO Medical, Inc.

On May 12, 2009, HASCO completed the acquisition of Southern Medical & Mobility, Inc. (SMM") pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement") among HASCO, SMM and Southern Medical Acquisition, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company. Under the terms of the Merger Agreement Southern Medical Acquisition, Inc. was merged into Southern Medical & Mobility, Inc., and Southern Medical & Mobility, Inc. became a wholly-owned subsidiary of HASCO. The shareholder of Southern Medical & Mobility, Inc. was issued a total of 554,676,000 shares of the Company's common stock in exchange for their Southern Medical & Mobility, Inc. share.

After the merger and transactions that occurred at the same time as the merger, there were 642,176,000 shares of the Company's common stock outstanding, of which 620,000,000, approximately 96.5%, were held by HASCO Holdings, LLC, the former sole shareholder of Southern Medical & Mobility, Inc.

Prior to the merger, the Company was a shell company with no business operations.

The Merger was accounted for as a reverse acquisition, with Southern Medical & Mobility, Inc, as the accounting acquirer. Therefore, the Company's historical financial statements reflect those of Southern Medical & Mobility, Inc. Accordingly, the reverse acquisition is being accounted for as a capital transaction in substance, rather than a business combination. For accounting purposes, the net liabilities of HASCO Medical, Inc. were recorded at fair value as of the Closing Date, with an adjustment to additional paid-in capital. The deficit accumulated by HASCO was carried forward after the Merger.

Effective with the reverse merger, all previously outstanding common stock owned by HASCO Medical, Inc.'s shareholders were exchanged for the Company's common stock. The value of the Company's common stock that was issued to HASCO Medical, Inc.'s shareholders was the historical cost of the Company's net tangible assets, which did not differ materially from its fair value.

On May 13, 2011 Hasco Medical, Inc. completed the acquisition of Mobility Freedom, Inc and Wheel Chair Vans of America. Mobility Freedom was founded 1999 in Clermont, Florida, by Mr. Jeff Connors, who continues to serve as its President. With over 30 years experience in the van conversion industry, Mr. Connors formed Mobility Freedom in response to his identification of a need in the fast growing Central Florida area for a quality full service dealership of conversion vans and other mobility products that would help the disabled become mobile. A few years after the business started, Mr. Connors had an opportunity to purchase a van rental company, which now does business under the name "Wheelchair Vans of America." Wheelchair Vans of America specializes in renting conversion vans to the disabled individuals visiting the State of Florida. This business unit has proven to be an effective complement to Mobility Freedom and is anticipated to be expanded to other areas of the country.

Mobility Freedom caters to individuals with physical limitations that need specialty equipment to drive as well as families with members who are disabled that need to be transported. In certain circumstances, both the van itself as well as its specialty equipment is paid for, directly to Mobility Freedom, by a federal or state agency. As an example, approximately 45% of Mobility Freedom's customers are veterans receiving benefits from the United States Department of Veterans Affairs (the "VA"). As part of the VA's mission "to provided veterans the world-class benefits and services they have earned", the VA pays for a van for disabled veterans. As a result, Mobility Freedom is both a VA and Vocational Rehabilitation (VR) state certified vendor. In addition, Mobility Freedom is an exclusive vendor for certain Florida state funded agencies, including the Florida Birth-Related Neurological Injury Compensation Association (NICA).


	•	The Braun Corporation, which offers a variety of wheelchair accessible van conversions of popular minivan models including the Dodge Grand Caravan, the Chrysler Town & Country, the Toyota Sienna and the Honda Odyssey;

	•	Vantage Mobility International; and

	•	ElDorado National Company, a THOR company.

Mobility Freedom's mobility services revolve around an analysis of each individual's use of the van as well as individual physical limitations. In those instances where it is the passenger and not the driver who requires a wheelchair, Mobility Freedom provides full installation of EZ Lock Tie Down Systems to secure the wheelchair during movement. In connection with meeting the needs of a handicapped driver, the Company utilizes an independent evaluator who evaluates the needs of the driver and recommends the appropriate Driver Adaptive Equipment ("DAE").


	•	hand controls;

	•	spinner knob to aid in turning the steering wheel;

	•	a transfer seat;

	•	electronic driving controls such as a touch screen which controls various electronic equipment in an auto such as the ignition; and

	•	reduced effort steering and braking.


	•	an older and aging population;

	•	the numerous tourist destinations that define the greater Orlando are; and

	•	a significant population of military veterans attracted by the Orlando VA Medical Center. Currently the new Orlando VA Medical Center is under construction and will be located on a 65-acre campus in southeast Orange County. The 1.2 million square foot facility, scheduled to open in fall of 2012, will have a large multispecialty outpatient clinic, 134-inpatient beds, 120-community living center beds, a 60-bed domiciliary and administrative and support services. The VA will be co-located with the University of Central Florida College of Medicine, the Burnham Institute, the University of Florida Academic and Research Center and Nemours Children's Hospital in the Lake Nona area known as the "Medical City."

Mobility Freedom's Our agreements with the vehicle manufacturers permit it to sell the vehicles within certain specific territories and it is not authorized to sell all brands in all of these areas. The agreements with the affiliates provide that Mobility Freedom holds the territory rights to sell vehicles and the affiliate provides the location. The affiliate is entitled to receive 50% of the profit on each van sold as consideration for providing the location. We expect that Mobility Freedom's operations will represent a material portion of our business in the future.


	•	Mobility Freedom, including its rental operations conducted under the trade name Wheelchair Vans of America located in Northern Florida, and

	•	Southern Medical & Mobility located in Mobile Alabama.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("US GAAP") for interim financial information and with the instructions to Form 10-Q and Article 8-03 of Regulation S-X. Accordingly, the consolidated financial statements do not include all of the information and footnotes required by US GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and such adjustments are of a normal recurring nature. These consolidated financial statements should be read in conjunction with the consolidated financial statements for the year ended December 31, 2010 and notes thereto and other pertinent information contained in Form 10-K of HASCO Medical, Inc. (the "Company", "we", "us". Or "our") as filed with the Securities and Exchange Commission (the "Commission"). All significant intercompany transactions and balances have been eliminated in consolidation.

Use of Estimates

Reclassification

Certain amounts in the 2010 consolidated financial statements have been reclassified to conform to the 2011 presentation. Such reclassifications had no effect on the reported net loss.

Fair Value of Financial Instruments

Effective January 1, 2008, the Company adopted FASB ASC 820, "Fair Value Measurements and Disclosures" ("ASC 820"), for assets and liabilities measured at fair value on a recurring basis. ASC 820 establishes a common definition for fair value to be applied to existing generally accepted accounting principles that require the use of fair value measurements, and establishes a framework for measuring fair value and expands disclosure about such fair value measurements. The adoption of ASC 820 did not have an impact on the Company's financial position or operating results, but did expand certain disclosures.


	Level 1:	Observable inputs such as quoted market prices in active markets for identical assets or liabilities

	Level 2:	Observable market-based inputs or unobservable inputs that are corroborated by market data

	Level 3:	Unobservable inputs for which there is little or no market data, which require the use of the reporting entity's own assumptions.

Revenue Recognition and Concentration of Credit Risk

Revenues are recognized on an accrual basis at the time services and related products are provided to patients and collections are reasonably assured, and are recorded at amounts estimated to be received under healthcare contracts with third-party payers, including private insurers, Medicaid, and Medicare. Insurance benefits are assigned to us by patients receiving medical treatments and related products and, accordingly, we bill on behalf of our patients/customers. Under these contracts, we provide healthcare services, medical equipment and supplies to patients pursuant to a physician's prescription. The insurance company reimburses us for these services and products at agreed upon rates. The balance remaining for product or service costs becomes the responsibility of the patient. A systematic process is employed to ensure that sales are recorded at net realizable value and that any required adjustments are recorded on a timely basis. We have established an allowance to account for contractual sales adjustments that result from differences between

The Company follows the guidance of the FASB ASC 605-10-S99 "Revenue Recognition Overall - SEC Materials. The Company records revenue when persuasive evidence of an arrangement exists, services have been rendered or product delivery has occurred, the sales price to the customer is fixed or determinable, and collectability is reasonably assured.

Cash and Cash Equivalents

The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company places its cash with a high credit quality financial institution. The Company's account at this institution is insured by the Federal Deposit Insurance Corporation ("FDIC") up to $250,000. For the six months ended June 30, 2011, the Company has not reached bank balances exceeding the FDIC insurance limit. To reduce its risk associated with the failure of such financial institution, the Company evaluates at least annually the rating of the financial institution in which it holds deposits.

Concentrations of Credit Risk

Accounts Receivable

Accounts receivable balance concentrations by major payor category as of June 30, 2011 and December 31, 2010 were as follows:


Percentage of Accounts Receivable Outstanding:	June 30, 2011	December 31, 2010

Medicare	23.8%	36.6%
Medicaid/Other Government	20.2%	3.6%
Private Insurance/Other	56.0%	59.8%
Total	100.0%	100.0%

Inventory

Inventory is valued at the lower of cost or market, on an average cost basis and includes primarily finished goods.

Advertising

Advertising, marketing and selling is expensed as incurred. Such expenses for the six months ended June 30, 2011 and 2010, and totaled $25,107 and $3,348, respectively.

Shipping and Handling Costs

The Company classifies costs related to freight as costs of sales.

Property and Equipment

Impairment of Long-Lived Assets

The Company reviews, long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable, or at least annually. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset's estimated fair value and its book value. The Company did not record any impairment charges for the six months ended June 30, 2011 and 2010.

Income Taxes

Subsequent Events

Stock Based Compensation

In December 2004, the Financial Accounting Standards Board, or FASB, issued FASB ASC Topic 718: Compensation - Stock Compensation ("ASC 718"). Under ASC 718, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share-based compensation arrangements include stock options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans. Companies may elect to apply this statement either prospectively, or on a modified version of retrospective application under which financial statements for prior periods are adjusted on a basis consistent with the pro forma disclosures required for those periods under ASC 718. Upon adoption of ASC 718, the Company elected to value employee stock options using the Black-Scholes option valuation method that uses assumptions that relate to the expected volatility of the Company's common stock, the expected dividend yield of our stock, the expected life of the options and the risk free interest rate. Such compensation amounts, if any, are amortized over the respective vesting periods or period of service of the option grant.

Related Parties

Recently Issued Accounting Pronouncements

We have reviewed the FASB issued Accounting Standards Update ("ASU") accounting pronouncements and interpretations thereof that have effectiveness dates during the periods reported and in future periods. The Company has carefully considered the new pronouncements that alter previous generally accepted accounting principles and does not believe that any new or modified principles will have a material impact on the corporation's reported financial position or operations in the near term. The applicability of any standard is subject to the formal review of our financial management and certain standards are under consideration. Reference is made to these recent accounting pronouncements as if they are set forth therein in their entirety.

Earnings (Loss) Per Share

Earnings per common share are calculated under the provisions of a FASB issued new guidance," which established new accounting standards for computing and presenting earnings per share. The accounting standard requires the Company to report both basic earnings per share, which is based on the weighted-average number of common shares outstanding, and diluted earnings per share, which is based on the weighted-average number of common shares outstanding plus all potential dilutive common shares outstanding. The computation of diluted net loss per share does not include dilutive common stock equivalents in the weighted average shares outstanding as they would be anti-dilutive. As of June 30, 2011, there were 3,075,000 stock options which could potentially dilute future earnings per share.

XML 21 R9.htm IDEA: XBRL DOCUMENT

NOTES PAYABLE

6 Months Ended

Jun. 30, 2011

NOTES PAYABLE [Abstract]

NOTES PAYABLE

NOTE 4 - NOTES PAYABLE


	1.	Note for $2,000,000 ($1,850,000 cash proceeds to seller and consolidation of $150,000 previously advanced for working capital) to Hal Compton, Sr, our Chairman. The note bears interest at 5% annually with monthly payments of interest and principal of $21,213, commencing August 15, 2011 for 120 months;

	2.	Promissory note to seller note in the amount of $2,000,000, secured by grantee from the majority shareholder, with interest at 6% per annum and equal monthly installments of interest and principal of $16,877.14.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References+ Details

XML 22 R10.htm IDEA: XBRL DOCUMENT

LOANS PAYABLE - RELATED PARTY	6 Months Ended
LOANS PAYABLE - RELATED PARTY	Jun. 30, 2011
LOANS PAYABLE - RELATED PARTY [Abstract]
LOANS PAYABLE - RELATED PARTY	NOTE 5 - LOANS PAYABLE - RELATED PARTY In February 2011, HASCO Holdings, LLC, the largest shareholder of the Company, loaned $50,000 to the Company. These loans are non interest bearing and are due on demand. In February 2011, one of the Company's directors loaned $135,000 to the Company. These loans are non interest bearing and are due on demand.

XML 23 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 24 R11.htm IDEA: XBRL DOCUMENT

EQUITY	6 Months Ended
EQUITY	Jun. 30, 2011
EQUITY [Abstract]
EQUITY	NOTE 6 - EQUITY On May 12, 2009 HASCO Medical, Inc. ("HASCO") completed the acquisition of Southern Medical & Mobility, Inc. (SMM") pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement") among HASCO, SMM and Southern Medical Acquisition, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company. Under the terms of the Merger Agreement Southern Medical Acquisition, Inc. was merged into Southern Medical & Mobility, Inc., and Southern Medical & Mobility, Inc. became a wholly-owned subsidiary of HASCO. The shareholder of Southern Medical & Mobility, Inc. was issued a total of 554,676,000 shares of the Company's common stock in exchange for their Southern Medical & Mobility, Inc. share. After the merger and transactions that occurred at the same time as the merger, there were 642,176,000 shares of the Company's common stock outstanding, of which 620,000,000, approximately 96.5%, were held by HASCO Holdings, LLC, the former sole shareholder of Southern Medical & Mobility, Inc. Prior to the merger, the Company was a shell company with no business operations. For accounting purposes, HASCO Medical, Inc. has accounted for the transaction as a reverse acquisition and HASCO will be the surviving entity as a publicly-traded company under the name HASCO Medical Inc. or together with its subsidiaries. The Company did not recognize goodwill or any intangible assets in connection with this transaction. Effective with the reverse merger, all previously outstanding common stock owned by HASCO Medical, Inc.'s shareholders were exchanged for the Company's common stock. The value of the Company's common stock that was issued to HASCO Medical, Inc.'s shareholders was the historical cost of the Company's net tangible assets, which did not differ materially from its fair value. All references to common stock, share and per share amounts have been retroactively restated to reflect the reverse acquisition as if the transaction had taken place as of the beginning of the earliest period presented. In January 2011, in connection with the sale of the Company's common stock, the Company issued 2,000,000 shares of common stock for net proceeds of approximately $20,000. In February 2011, the Company entered into a placement agent agreement whereby the Company engaged that firm to assist us in a best efforts private offering of the Company's securities. Under the terms of the agreement, the Company paid the firm an upfront retainer of 150,000 shares of the Company's common stock as compensation for services. The Company shall pay 2% commissions based on the proceeds received by the Company from the offering. The Company valued these common shares at the fair market value on the date of grant at $0.02 per share or $3,000 and was recorded as stock-based consulting expense. In March 2011, the Company issued 9,000,000 shares in connection with the payment of accrued management fees of $180,000 to HASCO Holdings, LLC. The Company valued these common shares at the fair market value on the date of grant at $0.02 per share or $180,000.

- Definition

The entire disclosure for shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, if any, including other comprehensive income (as applicable). Including, but not limited to: (1) balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings; (2) accumulated balance for each classification of other comprehensive income and total amount of comprehensive income; (3) amount and nature of changes in separate accounts, including the number of shares authorized and outstanding, number of shares issued upon exercise and conversion, and for other comprehensive income, the adjustments for reclassifications to net income; (4) rights and privileges of each class of stock authorized; (5) basis of treasury stock, if other than cost, and amounts paid and accounting treatment for treasury stock purchased significantly in excess of market; (6) dividends paid or payable per share and in the aggregate for each class of stock for each period presented; (7) dividend restrictions and accumulated preferred dividends in arrears (in aggregate and per share amount); (8) retained earnings appropriations or restrictions, such as dividend restrictions; (9) impact of change in accounting principle, initial adoption of new accounting principle and correction of an error in previously issued financial statements; (10) shares held in trust for Employee Stock Ownership Plan (ESOP); (11) deferred compensation related to issuance of capital stock; (12) note received for issuance of stock; (13) unamortized discount on shares; (14) description, terms, and number of warrants or rights outstanding; (15) shares under subscription and subscription receivables, effective date of new retained earnings after quasi-reorganization and deficit eliminated by quasi-reorganization and, for a period of at least ten years after the effective date, the point in time from which the new retained dates; and (16) retroactive effective of subsequent change in capital structure.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30, 31
-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 4.E)
-URI http://asc.fasb.org/extlink&oid=6228006&loc=d3e74512-122707

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB TOPIC 4.C)
-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187143-122770

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 129
-Paragraph 2, 3, 4, 5, 6, 7, 8
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 5
-Paragraph 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Article 4

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section C

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 4
-Section 08
-Paragraph d

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section E

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(d),(e))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 43
-Chapter 1
-Section B
-Paragraph 7, 11A
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 20: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 21: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 12
-Paragraph 10
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 22: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 23: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

+ Details

ZIP 25 0001161697-11-000838-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001161697-11-000838-xbrl.zip M4$L#!!0````(`#<^+3^XT=_$(E@``'-C`@`1`!P`:&%S8RTR,#$Q,#8S,"YX M;6Q55`D``UE#;TY90V].=7@+``$$)0X```0Y`0``[#UI1XJ7#DNTD%$79S)-$1:*]N_D&SH`DXIG!+#`CFOGUK[N!N7AH9:WDLF/6 MKFUR!D>CN]$WP-=_^Q0&[$YH(U7TIM;>:]68B#SERVCVIO;^MM&[[0^'-682 M'OD\4)%X4XM4[6]__?.?7O]/HW'=_>7TYH*IB$W$G`=3IJ;L6O"/\)>>*AWR MR!/LFNLD@AG8/$GBDV9SL5CLQ=U/$QWL>2IL--Q8#@C6W3O>.V#YXU@K/_6$ MCY-T6NUVH_6RT3YB?V?MUDGG@/4N;4L]K+"#'F%>WG21A4 MVB^ZU+I]?'S[&AR_!VM-]I']VW4J.P1=8A2L/-C?U$-Y-E+)K00FCIN0X/ MP2'0E['7N/`3X\U%R&_$E!$B3G#$-S4CPSA`7-.SN193&!:(WLBHO/?)^#76 MM`,!"`)BV\M'P]-HM#M` M3@O1MM$+X,Z4EX9Y$]C$4OGG\,P0=%O?/AJ\?W8L9%M'W@8:0K\-L/S=H\'" M)YL`RT=>!\O"7*;EQC=_""3[I`I89?1UL,:P/RK0X(-'`]%N-?Y9G1Z'*V8= M1(E,EGUXKGDPC'SQZ?_$DJ;?^.;1<+1:\*C;/CPZL-!L''T-+!6&*KI-E/?Q M=LZU,*,T(;4&JJX,XSW-]EZV6JL`<]-0TT:NF0X"A*`%9?/!K"=V"9C-BEU>IU-@2]7H:M M.HL%#E7"29^;^7LC0+SH?FH2L`OT!;2T@F3;R\="6>:"LQ4.:+>.#P[WCU\W M[P5K,^2W/!!F+'C8B_QA--4R'Y M`BL]V+;25F6EK0>OM'/P\K"U_P<66B)UOI[J,P#[7IGS.&ZKSE&"Z$+^EDH? M-M`9:+Q`&0#YK8+]WU=@B>GH2B5B#&"CU@:"ZSZ_>G%\,^JS6:S9^[_6;S;'S&?GDWOKQ@X,6P,6Q](Q-P*'C0;`ZN M:FR#13V^L:9W&SN[CXVDU'//3\!N;#1^G"6O_OPGA,*7=_B%N<_@&"T#L$!_ M'IZ-WYVPHTXK_E3#!@[BVP2H+^8"%RS8:#'6*Q%#/_ZC!N3 MAM@O@8&<2F$+&03$$S)*87CHPF;*#8X\M/XQ6 M.)$!<#0V+0^:J/N@9-+`'#$8_;!LEL;@KX*SJ04WV,B@1`"0P(^=)%Q&^(S[ MON,SYO%8)O`O-G!81"0I9M(8-3"3@$DM/!R:>[#C+(=NQ,Q9JC,,_Y8"^X$: M1Z#\^_`%CF-*]&$+I3_2JAQ$X%()1`2L!*"%)5$_'JHT(ES^L-]JU<$@VPC* M)8_XC/@`.B8`A<$U\01X(T[PH^;2B#(BIBDVF@!3<,(_9W$Z":3'E`8NDG=H M7:OI5.`2-T[Y\QRLDLK:)B*0X@ZP[V"_DR7Z(E[13@`CA@CL2"8

Y4`'8N MD05Z8^.L[U;@";'`\Q['J`B+%#&]1D^65I_,><($+,%+JIM][_Z-#-($S/RJ M+*$F99&4?7%R_G.$_7WNG%`+[?#"YZX\$9/+D9__HE=<`P8N=BHD&T+)TDL;;X.Q6@ MHP(;X.*B;\5+P/5,F(09]&;F\!YD456HUED`S`.2YX<#$B-VA^2O21[#)L-& M5I5$)%=!J.&X$W#(29+"_L27/DAF>.^+$)[L?6$L*"LH2]"35/K?[O$KT`P2 MI'>BM,G7V^X>//."'R4Q'KZ52P*C8N_*C6;Z_4V>RLJM>![W3VG!=Z'/DQX8 M-:#1LJ5##WBB4^%?.&TAA7'Q,QLN?'C[IUK;T4'WY='1Z^8C0/Z2:VUO76O+ M!B,?L-;#=J?SLO.$2[T!TPF,!^@+E-^TMDT-GHAPW>[^R_W6^F(V3?FTT#\% M*3H'^]W##:1X`/2Y873-);C!?6=1$N";WST5Q@_;[?UN&>C-TST%O$^!XVZG M?738^FQXC1$N;F4_/A'V#@\[Q_NMXQ(T-/KO3_X4J-@_?MG&L.[OSUW9!^4G M3\5$[587!.XJ*)M9_7A(VV3\^?GGX((!.>?1Q=">TK_G4D:GZZ*G(!6S; M+2"JSK$*DI%F-+T&.P;`Y(,=OY2R2X)CS*'&2!GT3=7?8R_L@` M.[=CS:`=#WX9-WH7P[=@U/X[-8F<+E^Q!_@B;?`]KGKC]S<#-CIGH^LL#,5Z M5V?L]OTE#/$KOKF%D8?GPW[O:LQZ_?[H_=488UC7(\#=SZ5GJ""#!R$[%=R;XR!UMN`8"O&4CI6FR)B,V"5'+Z9U#'L=?33KNRU, MYL_<)C;NPLX#I:7/;9@L"["H6-B!*"@6:W4GG:/'?1`&B329RS*S8($,,;!M MF1'Z3GK"[+&"@N!749P*H:G&J+PYCV8(+@BT"'-*X#EM0-*S$F5D4=7NU!V` M%@`,B`8"44#!L2)`ATBX52E&A*(,3+M8_,,NE8TF9>2]O;RLO6!QJDT*\BQS M#<'W"W-2]&9:V(@:(O0ZX#3'I0!'6[.?B"G M`;B%J`[T/`,O<(&^9L8QN"SR/]D"7/I@V5`+=&A-.C'2E^@/5[W@/?8^9ZK* M4E;A?`!`Q+PA]D.V!?P\&+GUS4O>2HN)\)#'[ETDX=/NA94(Q\/GH=UH3$K! MUT2AP0G]#P[VZX='AQ0@H*'-]M""1UECX%A2E!$3G^Q.08F`7:3^#'!HLN?= M0[UIXK@AM`R`A"'=QSVDM+$A4N5Y:-D`6A)J;&C+RY!B[T7O+-RZP+\.]SOU M]F/0IHI$>QV[+$!*S=EAAV)2]&(-9!:RR"79FADNPP-Y@;P,8WJ M"@N9`%$5YX)Y?<(TC@.)NLX&^#8#0,DR\=9PT`)+ M0*OJ$U=HAZ0DX<1F=DP*N+O#B045>SC#@Q)%(*IA9$QW97Q:F#1D-50@M``2 M[\\$89*XFK)"F:C/B)9O!A_H$ZD$\W$*G(__"#93RB<`$2W0`E032&`Y"5!8 M646]I6G3+)];N3`%:E5=W90)O!\B9EWAB:0ANT)>,48 M"DG+@@^?V7@$NH(H``ID^?0RSNH6!U:GHL5EOU&Q`H@8#APS$2*"$<"'Y\1" ML`C,K!%_8TX_%S.;Q0228[JFO[#<).$?8>0XX%YY*T[$3$94[>$>"*[1#$@0 M/JE0]5,X2_A[CXAB?':/S'_MVB(0]@Z/1JS(F'N=V4RTLG-PVGP54A_"]\]S M(0+6GR,C?,#D);3N4:D_+_OWI>*0E:&(9:HHJ2>A1[J M9`R!1OF'F$Z!C:,(C!UDU*(XA]@"[2LB!'(GQ@PEUN64(?D998<"$K-NBRV! M+@8V-5(%62LO%N&DN+/#*3+R089JT",(@IO=VO?^&FYP#)@X!J.2@A6H[PD* MBE=F&.6P\VP0AEP%#JPQTVI!-;>VHCE;.EJ'W&HEK.RAJ:8I;`AG2X+,!L-4 MF[F,J6*G`/N.DLFYM1AF@.9VIY4U*@5'!FS\F$#QI<'TCH^N,!FZV$N`.F53 ML7`(*X1^KO,,!AZ%7\60J\=25,R$\60JH`$5"$(4=QCAV5G87E898(5/I!;, M5T#4?(85@ZY&G.=M9+P:V_Z2F5B@E0$&G+&DLHIY%6_.+(*RRE4#H3ZS>R_3T6L,175(2,D$='.< MR:P):B-`F6^_6AHCK^12B(P.O7Q>T;P&K8=ZPMBJJ@)EI++C^=*03@ID*&TL MWS$A;09'&1BK\*I@&%]+NZ<7Z(>BM."A1&EJ!PU%."'5![*`BB,RBA4#6VR1 MZ$9.!*D+\HMY0F--'O.D!F/'VG0@4R;*&1?(G"!&1#`M3TY.P@9`@4"9"U=W M=1_!6(U`+%_\)=-\KAL3+@B M7^M5WH%$QV53%:%UGB8B`B,/E3=J<5SH>^!0P!(QLF%G6+1I#4:8Z4,V0&^* MRMZX8..'7NU%6:KVIN'O1[C9..2##\E'-`-HE%*DKE-`"=LBZQC:4Z MQP%QW@_*2FJ@SXV86_OS,U-X\'Y'8"T!( MW`G7GV#/F#(3_G:JJ56/Q"(2F51&T-?/1%#6^%3J9-YP!3SL2J1:!6KF/-Y_ MIWI)!J```X;6TC-&`1_;=5T-^[T77UA4Y(&:7#49%:1.+"C::AYL=.!$/(5I MMSL1-_.7DKE6Z6Q>[%F*T2`%G5:AH%ZN"L"K`8E,INX=L<4P<16?11"+V:!W MA!K2)3>`EN!T`HK_0P7%J&T=QT4IRAZ<932X!/Z,T***B1%#'J533F5'VA3T M.GD*#"?(WM6.C?'HFCJ_8N>CJW'C=OBOP0EKM^*D!CP5!";F'IWN;=GO,;*G M_5X,J[,QRT/`"$4+'XC@)_,WM<[^)ELT\?]8T\.CSN^T;2:Z!&]YB,WHJ*%[ M(F?1&Y`^<6T%I"H%KGMG9\.KMXW3T7@\NG3(+)'E%8I&/1%%BFS\*B>VY#8!N/; MUF5OW:LE\XS,FUC%:<#!II61I-VF?!&8%;%XIOR9P*0HR(,^UQP:NCC47"\- M[N*Q6D2E"%+?&DRVT5@M5<+9+1]"=XSZW[B. MS7S_-2QDQV_?D&`$GS0!8ZZP#(=8ZATYF_,52IL=J;^S=>Q$R[=!IZ]MLHWB1OXYE<0IL51^>IZB\YSQ"KO\`( M-!7S#R-SL,(LC^5,0!LPL(%13,[2(W"D,6=&10XA_TAYY+#PTPH;L^R[6Y@J M,Q;3!4MG9.)AG87(SUQ.`Z5T=<+\4.%<<'!(%89^*+;N`@-HQV)\&M/96%FD MP6GEVGW3`([)K4ZZ%"<(2M'CDJ4#Z&2,RP"EWFFB%,6&Y45!O]B%Y@W'$MT>,"=N5V:1(0N&X+G>VV( MK>`7WYX4#M4=A9QM+'2E2B$4(@]P8PC56*[+=DZ,@1!:2;5@*$VD#:QS2IKD MYZ(%Y@AYHNS"W3<;UBN&+Z''1G`PQV=/#^.NP3AHK"6&P\YLJY[/8XJ?#_(H M[$^UL]Z@]LQQ+)@B(X/-(J_'P#'!A(2=:(4Y$*WMN>8\\V)+86UH&H91"V@; M*DS9FF13G"N+@D._6":4WT6!@2'_S0R*KG<>G*Z[=(!-!%OW6VX)@-,)9O') M$W1:,2N#2M,Z:O4L-)(I4JYR)74J'PTBG'.(@J+[K)?W^,Z=J+KVZ#35RZZM+`_&R&F M4[P_,W>L,)(ST?PCW1_Y,%H_:]YKO<8[,"HOB8IL,7<:R=]2D==$%L>>5+PQ M$50JF<(;SS[2"4?Z4.1O]M@()[%QZYME5*I/KHRUVB^#+2E=E$H'9RB";)W8 M99"?PL M*.V#F@^+1@,L&K9G.D8Z@"6J.KO@>@;_9.=9[.T->#-'7W&3-$_32`1!W>7Y M8$;&IU.8GY(C&T<>^#.QP`K[.KO&0EY/!;8X;>3Q(#LFDE\H8`2>."@5M^)5 MLK8>M3BN4#H;([)K4VWQ?$CW?+C,C`C5++M?!!.U+MUY!?MLOG9FA9*M>(XP MPK,OF)QP%=4$X3W9O1*LNYK97=+A^]-@>%Z*KHF@RU9F=&:8BEW)-M[9*=_9 M.G9V\;=!IZ]QDT#?!IV^<@G$F2GN["R9-.A?A'2^4B^+4Z$\`7?"<[>/H#C*Q-"' M7G[S2Y]\F3WFKD(-EJZ<;+&],=;FV7/D>.<370N>W3>4W324^5KXF!T>-+A' MO^H0QBFY.X;NG\'C^B--UZW1F:'E2OTH:^]ULA\7809_CP.O`U-X<8OG[JC! MWS3TT\`=WHX%W2TSQ0M,`"&=%MXU2"#1H5=N[]1G81HDLCA]#+#$@$0,JGJ! MC*179^WN?D-&V=.)P%^F:'=:#:RELR?P`Q?1M0BQ+6"EK<8$B_I4*!%")`89 MH#Z6U])/9=`A;#R3ZWZ;9-,UCF-[)C?#I:<:&3K_O[UO:VX;2=)]WXC]#U@= M=X0=`4H$[_3L=(0LR6W-V)96DK=G'B$2E#`F`2X`2M;\^I.7N@$$19`"(,I6 M[_:T38*HK*JLO%7FERIV\2WPR=GG@J^LWW@43J?>C>W#(@IN MW9EU"MOF)XM$?)Q^FWS+X<@%=]5GA(H++_;<:'0K60`_^PK.[`+\UZ-;?SH& MYC$XJ[@(#]O5T,+!DS.UO`Y"7J M8JQWY,X#GQY\XTP&MA?-,)DUX412V%#C6?ZUD4)(/`EG&Z$>(Q_S&`7&&>?# M8O:K44,KWXC72T!.\GE'Y-0`:B+T\.S4:81*:*DP&S'+X!9RJ6()1$ MV8,5^3>W2:RH4'.2V=;JY3KU%C^6(0Q!E7H(YD>`9%.))8.5]I[5;?XF8R?P MF@GV(`HX&1F3C6.@"]F(L.?&(N8A\-]P3)D:H@=-A6D0LH3P:G+FG!]-H3,9 M>0)X!M--!9Z/1;W^6!!CG$L!5TALD@5R1+49M9\47!&"=2$5)N4>2<_1(F:Q M+%8403AD$'3,4H"*\5DL2YR^M>A_YL)^##'\2+`]0`*CXSK.>C"<#,'I"G)Q M4I+[,(T)\II+^QK6^G7,O^5#HVNUN3])&'M&-80F^T$.<90<+HP- MC&,3SLD/;%5NEWX%VTX2#@W<4,)NRD-0,L(),!KYQP**5>^30H2]]PSXM!6N M`EG(7&:%!EV`Q9B(7&\@TS*"5,6UC_AE7I>*#;MLU-^[0I-*35NH"X71MB5+ M56W=:A>!"X9&0N#0Z_K6:K10U;W6IXZR832FA`9R06^\`,';\&2,1MZ<@*(, MC%\X.^75I_'!Z>[[TCYX]:_ODFR_D!Y5(8<2KA`OLZ M@$7G^",\!E9^XW_HL4/PZ="I'S2:;1SPPKN1`;?+QC]RT)'7+\TX)#]>EC]K M=WV)1@QUP:-4FDLUKA3&$S-EF#.!-IH[DBBOQ3P7/Y`A0M53EE%^-:RQ]J%A MF,##;!&,7G$F!`'4S@TF-#983&0LHEJ8:V&\%`41XW3BU/#HHVC#[0U<^9MWB6T+8O$9H67]2^2D,,/7":.I!_#?`F"K.T0MFM3 M%AMSS"+RL.!$(8#.$;$NX!Q,O6.H`%P_8$Z77/3W55C4C/\G.]#8UMZ]A_^[ MB/?VK;/(V@/1B9U'@%I_:L;]+G']N)H5"3J1[2K@31(@4+U:?(`0@X=4SZ\# MQW1`),9[JGT$I7BY4RYBU;OL85EL('6R7N1,'^5ZY.(WKC@_B1,"=(SK%(DL MSU3,/9?#')!..B,[<+GQK6D2TBI`IV9$3P5 MO#.>40;;QY^:8.KX][%J8"JP<7$B%/]:\1M1I2\@70GBEGD*VV#(7ZPB!*&C M"8D8'\(071##7\:Z,S?_B-:2<*`1F7*4++1E@9BMT[&$W!8(G8@SH%9HWS)Z MGQD+!\O/P2H8F@2!E-,4T<2X%LV"\#'#Q74R64SEW@HP>J[*%^SA!S`5C);R M=XO8PQ],_8DGZMA1EK!AF&Z!0<,9&TA1.S0SW>F(`.4MPNQN(/H$=VN0>)35 M6U5\TBZ\$2*-*CCFN@[AD8B52X81!X8V:Q/#)%+TBY4-29A+Q&+B`E/E`<>@ M! MO[D!]GK6BH+4;'.0AKUPQR&)P(^'EQ\LT)G6H-4$G6C,Z`LX.""$A&D!QT1W M5H[WP`H4/Q(=W59)IQF_)=L"@JXJM7URC<;WOJ0#101XE#Z(+VIJP;CYE.CA MJSL'XV4"GIK:UA![>3]$;YS"1B_);"'NI?0@E:-'F1GKP>FO:3(GD3OS[L/H M.Y''3^,H9N,+EK%T>V2(>?<:O#\VYU:,)^YOQCJ+&I9*[S"NF6Q]P)>O8"K" M/NLCLMQ%09_8>2@O"M25`)`MI+MM72\2>CD3KJ[/-/T5'[?EF5+&3YSI*,)7 M+`@N;T#$DP%+=UO[`O(K3)?AK!F?B(D17,>^#*/HA;*1IRG"#UR;W*-9F M;O0=7H0PTN2GTTEA=6SL'JEF8.ZQ!F2RE_=/V1H&]VGUEGBC6TJMCV6:\P^P M$?^=XM7P&H,5=+GB!_.%.(QX&9Y]$/`O-_&SI&,B2 MO?];A*@!Y*F-1%S/XOXJXG/V6;G[!09,A5X+(U.M/4]X?&?VN)(+C_*F_"ML M0>:8M9[SF/'!$>Z1.'-AE*=ES(!Y%(77HJ_O]8,\E*`JW5]\9U\/U[-O0>9P MM6L_7-]RCLZ$H`BQOBYAV,88-%*28(//"'UBXP1)O/H-JY) MY9D0Y<`S3/&A\R%>-;H-0VZ/)M["M:;FM9>*^EBFI\P7&3XAG*:B(/G-6CW5 MUL^,EXC0Y$3T;15XN-1<;4(WAKET5+O#2#TVUZ3QC9AR+BEF]A0>9%N%5H@4-LV=10/24M MIZ[HOQC?`H\TZ()]AC=J(H<[$9YS>OL3:F@N9!'=`6$SQ8@"XK6%C2FX;UUP M_U]UV7D4!B/*8I?1I",0B'YB7?CQ=S-@6<]=TX6Z@A`M8ZE5LB_R""^,;BL%1*>80ZS* MW5,=Z!C..4MD)/IL82PL9Q%DK01UJLL0%:1NF=382T-QW]/,CLHFP%)(R#L@ MJ855D([W//+\V?4BBCE\EMIQV9`ZTT3(_EAF5L^G M;A#;JE$Y35OV*J_V:*YB]9#QA5#,P893-%P&$F&A,FG@^C50'T-S).9R&A2L: M8@O\;-\UBX#P^FP4^?-LY<75K5AD6L*1DD'BA.%MI\S2B%?4&Q`[8$4+;#H" M];,.(^-%WC2#306F#MDAHL6C0&@OI1@UG?1%MEW4G/.-4HT8K M)GQX^&:$KQY1I0=PYFP^#1_$C0^Q$""J?]OEQMTR0L9]@UH M343B3S:G1KV&;JWP0,+A$5=6?WJBQZ.Z"V(T?W5[C1O&-HW((F+VP',N"#5& M$]=0>//":H1OU5GDBUN'2@447873R<6?[UO M'?/%'-4W4O:1SKSBSL1&6H+Y;B^X\Z,PD+!K[,C>>^)F"DP\:58;"1BT1V+S MN)P)]DOL."L^845F[4TA9/THESW2,M@4%@>:L]/B%\45>F=,/)\I(^%!<#Z8 M6#!J)J6$O?.I;BB"X\;7ZXA>IZZ/4IE0\D2Y=ZX_=:DMR*4H;..+)L[3 MPM2U'^*8D=M"TMEBZ8R"CDQX4]'*W5D$8L'YQQE&$$K";`.JUH486'[*:AK& M?I#\C8ZOR?JA=B$B_\;GQB7RZ(F$@.S)3![F(MU7MJL6N7'FR2>Q$OK<')9B M"'15/!*M_<"']N&@>8'/K6WE:<5M\.[3/AI[B;$V<*1WG9?^@"R%@$89PK/" M6;];D&R*"'/"\*XW3K]G#WH=FN,;9]"R!\V^F:T3^S\P")+M0=(^4),-4R$XN+NV=F1Q=*MZ4?9TZ: MON)&,8R5GQG379X4#]V?R>I1W^U;9]QV'L01?&MZ(>('J0[3,RQ_2@]E4^<0 MW@@I>T8/F/KK9S;$->HGU8`9%R1[0H51'>QQ5Z3XH&7PZ&UEQ?Z.+LCN6`UK,N3 M(^N+*":.EQDH&NOMOK_%Q'H/S6]J?.VA1)$P@4&*NRCM".,+4@.:"7`!1YT- MZUCM+.+UA2,J0Q%;QY:A2&?ALZ-:8?FQD&68%HG@$Y@KS+$S[>ZI')8XQ^&K M.NXKE%AE MD7>H.LWKVQ0_N`OU;F$$]L%+>-=T3$Z1(%BFW=XR/'\CQ<1OU"X/MK/S]]T[>LL'EO;/+=)A0*D MN<]V*H548&'THO(0V=C,OO5!+!NLD/L`$]<:&@\/>8TH`!'Z,2()_R"@#OCO MX/5\AU]AER)_X2@UTWXK[U7-^2RMSGXTJIBR(7C!689)`QV?NF+B,612@%=9!EE?T2 M7W%=@"R\3Q6ON?>NS[<4%/X@#@LGA"`CC!TLLXB`%UC#"*M82EXDQ]C838!#RO;3>?!>;>\R(ZQ-4"\!B'&[6 MN9?\N0Q5`>F(BR/Y`8O,?=$R[8.^JA`V)IT!*E-1V=HFGD3&^=8[GO+K;(&! M,@\E-B^R"#HZVI?EK'\>RE9@ZOB9@/]18!WK,E%-&`IYRSM!;5_7-8FZ8*8_ MG!@7S,9=2%WX1)B$ANR M$,OO['5ZV@Z:3UU*C\,"#WR01R&"K!%?%]'M8Y*]`D6H(P4YL[S;TKTF=\./ MS9]8_-=%I!7N1V],*N#8HRQE(QA\)+"-J0IK[^/QZ='>.PN,8YC;FU:7>@#N M8VE8`;0%L/P0AG'N"W50 M#9:3H8;&O+CUG3?S^C%^Y/ZQ2G(^YM[;DZ";APFJ35I5Y:\;NX"FB5'0-%J: MCC@?M/-TGF-*-YVYD4]5YB(*E9/2LNI67%5(BFOQ5:=+2PB8Q=0?/8B*>?X< M]QX;=R)A]FK9DLE+D%:`Q-EFW0#&8"CJI.AFU%P08_H4VQ$B1`_Q#,9`N M0M*.3)VGDNMCF4VAC!AJ,ZSOJF3;W#5^35(DO\#FNR9E`=MZ?66V%EKRJ#O= MZ:I0(3GD\"\Y]N!L"@](\:V<(]9"B:`021CQ=^V6"A-4ES<:K,36OIN;!U:5 M9#B4ZWJAUS63A;"A:-@XA>$P9VN!/Y:`-.B24N(QB$,>IT^YX=&2RT+>AKS8 MS%YXF@%YOB[-BTN@4P;LB4&IZ\2X9<+8<+O9MIU^GV/#[5;?[@W[Q1-?TB'A M?>N++GDUSA`?H9RSDV,^W\K1%.ZU>_"*J. MF_..&@=R"0\TQXG-8S%EHF:NP_4*S.1O)I1BJ#,[\I@RRQ%&"7QI?J].MTN)2\QZZ[=C!>DM+E#0P%/.6X)N#=N&:RF'A)YUF\;*/.AO4 MBM93_BF6;SU+Z#O\GWR]>F\UG'X&C%?]B]_PSV5L M:^L57D?T\QS?#:E:>WRM5ELO7UIW4)\'^G6KO3_XK3:2:SK9FY*U[F076LEV M;[]7VTH^[Z%?)Z&J._3^^.",(CE_J/#+KOL--9_GYGZK&!<^YZ&M^606/9@O MX_0]@\H]%V5T*B^"3^%+5L!K?<.=4='=WG[S9:OH6M:Z%%'1'=9H#KUT)9XG M,EI29%QAI_57!_OI+.DTFT\Y_[^(\[V#2UG)\:X4`@F_Y,274PER33^M(4]. M#8B7P$UO"&6#V_@V7?DM,`VROR'E49JX,`OM2 MDOQ-B`#CE%Q/5*'1 MT_+DMB'I/!=2WT3Y6"H()9P0-XI\EB(D&B3ZR!C+ND22-"$M8`]?7.K&%*L0 M68*H@DV=O:*`_N\8T"9A.'\/$UF/Y3M%I69>A2KF.2T2!=%&9RDU\LQ+;L/Q MNJ'-LJ8P$/EIF'R/O4]BD;L@Y0@[Y2=DOBBH''LQYP+'$YD MYIC#-<)$F;]4CP!+Y,X(1)QSPF(3AF3LC;!\3A?0J/H@KKL4BT"%H51! M170913>6485K,D*-D M2=GG,+AI?":DGT.:\'/(84Z]`X;`$OS&E*@1RT\HB9IBW`TL%RRR(WZ`$4O9 M5"U91K%+2Q%S6^"TBV1$L3DV90IFBS%6UJ0+8'Y!-/(R\Q$)G<6,2D=E,M8B M0(Q]I`MT:J/1Y4#G.-*AX(1`F4;HB?)E_G2&\*=3_[M'E4]P`I"G.,=PRMF[)D"# MRR`.1(`DC#.HE;B5&N]4)RY*:T`#>9!>4H@GRA,F%,/O1N)"8L^6)><)/!%90I;2A]"1UF9IEKM9[@@;-%S;+9\\GEA9$=3-#% MQ+;EC3CQ#)R,*RJ&BV#5Z7,NB5)\A0V>=@.GW>!I`\E8))A>L"2E2R2SJ>1A MB6HHS*?\?HF'2SMGM@HBEB95D.2-).!5;A#63[90[39_XVWS;\-PS(^S#\)' MFW='%JX2+&Z(1+;0%I);UD]6)%!M2(7CBSE>+R MRA!/+JYC$(\:8B==FJ)?16N4(.J$HLUX9[(\B2`DP\F+UE`^`G["6FV#V+'7 M*$!O'G[RVCF85$G#9%E0@$2-0YW/KD%?`H,V5;AA-`FS-=@N0SD'[E0@!NM1 M2+0PKH.0BK;9T4@$21#QP<^V74Q5Y*F63+F-R9;K,]2NSEIW M+,F69@-[6UK92D&,NCO&AA)&&T,!5J$Y5!;#C%<*I@`2C5IEGHGCS5`XC4)"PF#DL"@ED<9>0S'X<+ZH&_S$8 M#%LF6A](@QT9+1/KBUOK&L=6L]EAZT%7?1]J87"I;),/(?R'7#H$E;+%DFF$ MJ:MP[H^LOC-XGYH3(DK1=%,?!B;PC)$K/C`%CBL?DY5H=36L@)/O4X' M&\%'\G*:4:8AY%*VPPU\D32(!S.NFA+R*G`3/Z:W=1!,B'F!/EL&-7BU2Y:OHC)18\AA)** M0='UDVA\*@B7;Q/8&OS:?7&VY42@MJT*4A`FB451\HH*L=-184RA4HD M``70:-%RF:I/;YLN(9,O7YA,+*J\,DT)F;U3F!5355O&;*<7V]Q4(_KZ8>J. MOC6B?4UDQ;#Y;>` MR3BD"C91`E)'JH4,VH@@/Q*,\$<41N2_X?9S(P(,_.-%:!B)_44P4#QAB?J$%I!!$,3T.90+9IR!,()EWL$$9`D!;-]ZYJBI)J:$@<(SJ)2_Z#C1 M5`D.A5#D)+(:L00OEH*00]+$FLSH,O&:FIVC22DO1#C23+COY+`DW)Q)@8A* MZ9%%:V%)[C%\5&0P2KKW/#=J2&':@>[C@(99,V_VH.%)T!V]`>U.F$@4:A^C M:RJN!#4\%1LDJY;A(=:G&IE_^4<(W?"#H.+% MU_1^7]W'"'P$7#`P):XY*D.H#L9;:NSO[1%;G[+!:1BGL*)!B%&Q6MM)2UA[ MOH#Q6'61&>PO4:C-YV\$/$&&[[>]=^E6R^8L1!X(,#`PO8"8P1$B3\:T&%-? M]H*B4G^&5#2PKJ6.TVWMZ:WRJD2UJS>/![J$6*'"I\M4!13GO<\2*B+*"5ET M''4IWE2:P(.SZ$FJW0".1JI"6(3&#S6VQTH8O9&&/S.L%[44CW9WQM46-C[B M$UNHIE9'.-@>U=>CA/8D@S1H^FI$:_(:T*"<"L:11I(F)Z,?%%:(XB%3#?+N MN"LC,!>>O*9*`TW'C&$0)(^Q8"PT/,.+XX4`D)Z([GH4'Q*7M(@G`FQ:FS`X M<2.,AL36V\]A'+^SSF$MR%NJZ_`K`N;:&!'^$UU!3D?B2G\A^YZP?Q=+0"`W M)2J0T67XSMZ3KJ(!C8H/Y%X5<,,,O-)2C=D8^)=`B$PJB;S5L<14\I#<@;-V2>&Z.K=O_^`+OG9 MY)R9F9;Y,!A?:@-7:]=S8<%>@4GY80IS^/T__\.R_EN^"1%+X:?X'P.W]#`Y M$G>\W%_1'_]UK]"3^X-6V+'(%WMD?OD_ M@&EVLM-$;TD<-OK_)-STZ#G]WMK-S*>GWJEW5TV]F9KZ!MO==H;#82E3!]7E M,[KA5([/CJ[^>7YBW2:SJ77^[GJR^?+3CLO=LDF;\_.+B_O]^_;^^'T?3GY>G5)NK.F/D1G*F3T&=FA MM@3'*2>:AI,)!F81>(MR6`E8%*S!PZE[[.LQH_3,`*S6IKA M]V$#'*T[K\'9KVI&8@QR/+T?/88'YS*^I*`GL[CYZ(0OC:%M?2_*3R9'B',F<4?VMSS:.5U$YFJ]=Z10H4667@C3NRB?`VLHQ1785=7JWB^>'Q\>G7 M/U3I;C-3*?X72S[Q^>3C5>:CB],_/F4_4V3P6+77$0K.V>59%BK(%6R]>_.H M!-%@T^.D_FVW!?$*OJZ.$OJ:8+4V)"N7]5/QS: MS:'=:;]*^>>7\B6R%D)B((3[U,OGK2HTP)L=(GC;P]!O._:@5TRS_CP<7QA: M9./RP@O*6.5R<0+P?^.T!G:WWV5`B"'\N=G;'&&B/@2)4QG(6N[C)KL8<-_4 M'[(EY9L!]8;CM*1/;CP*K4_A%#W[V+8^?SXR:][A[5_<:'0KWIY^FA^F&`Q5 MR&#FEU%5I+HWIN)<1O>W,,)64SJ;;JG#$-&!_ZH^0[9U&HSVK;=[EU^^8%+Y MU=)[:"#1G4;T9\DAFQN;4Y]JS)28++#;I,Z?2#4BPF8MV>YUHEUI+'*/526? M:E2*\\D9%F?YY0N&+HES6LWFH*0;UDR7/^=> M1)D6*L2_YKGM[DOEK\W[B_;>[_!4TTE/:0P9#XL M*6N&5KN?2V5>9D)!RLI(>Z$EW("R.#F;7(BV4$R6\0G0U'KD;KRS3=9#JSWL MM(==DT)CQ$W):S^2F=#9)C/!&0ZZ@[34?0)YY>>,#`>=82JSZ2GDE9[7T6D2 M@<7($RU<1;_H^$C`;A"A^=^5='J[W6;+S#7*'RQ-[;%WG:Q*,%GQW6MF22%' M,I-9TK$:%O[A$ESR?QY^^'Q"7D1-N24?!/:.68X$/?P;VZP<*,'_&"8=EYE MZK39\UG4`U+Y0VB]Z;;L87](Z%9A$'@C@4DBW,N,,\8EY&,/(;1@P#OOUA\I M2+GT*->8/9+VF5N_Z6+%.25>!(N9PNV+O9%LV>Y:4]]CLN^.L MSAE.0?0@0`7519@H0HE!-N\%N]IOG*[M]'ORU3FM=9_X^H'=;(J03,ON(J_4 M%V$YD\[Z4(1YV*\700H1D`_6!S?XKG+@)4XL0LD2KIK,,3)J0:Q#]>7$'7&-RL2CD?9;W=\HIB7P%!': MB7E8_UR4GOV)+'B91`@S\;=P$6&[7$2G]:@TEQ/I02+^)M/Q%U37)L>3.$!S MUQ]+3DV1F&T,3N=S$D:T`+#YWCA="TQ4=Y!^\S7ZCSD<+)+>X96$D_C&$1N@ M,2`$Z>E]J)QUOK@/EM.V<$S0L*Y6#HR@[\@PK">(IX"6XD$$6"Z]*93$2Q3 MG;<_8KPKG"$;6F_QH4,M^-[9LM9`0PB]:=N#+JV-+4H$J70Q%1&3A0@3EJ*1 M0"B@TMMT<10>88TYJGA:`5-B*2A5NW-$<#D*&-.4LJ\UA3?PX64YRLA+C"0/* M#7I\Q*]APJ<35%]32+6WH/O%*69$3$)Z\\8$=\9'BJL+%<2.4+&@J?E7!KR7 M.[[#RC3&N[@/H^^HK@0([CMCI>'5GT`OH/Q*$&7J,K*IMO'H%L$KW2![B/&( MDC$5&X!4B05*2:*$LAC(LVW2"%:Z]!YFT'+L%DI4+*_R`CR'UN'B!KP-"ZP0 MU@4X$:?5%',KP/:RR.`ZU_L(J@ MH#/HM?M=&;B;>_;1WO,;%MXF+]Q&Y\NKLZ._6V?G5Z=E7Z_SSX==M8^,; M9Y]]4_`ARSA\)EX#P3#:C#3(F!A_6X`E0`'))OVO\@QUZ"8%/W'/P3%$K!*. M'H:?"%Q68'9[TX! MKZ/0%T:L,/QWYPGLT#,Q[MN]T\NS>.^=C(,JZ&91OJ@LGTL1\^^T6G)\BG!B M]%)>T!V%8YJ4,QQ@?#HA'#'$"(L\QDHV0W*(LL905 MR-NWN"-,8`&Y#,9-ZR6A$,6",``-!44^>*4F#,*KXL-'( M(#.3&B`8SV`ML,T/WDLX\N"8FR_9'7G@YB;R;@1M'06ATI6%Q1(J3<&DKCAU M8,R_P>2OOK&OS-.X0K$$?D-(31'6I%9)-G79PM!*ZK")VR1Y%'./G"96(;W@ MR1=MZTPP7%Y[26&O0R1*)%-$H*8.:>S>].SFH"GP2=U\=%+D.6K=`.=M:B9Y M8A$Q(]DHC-+W8GD4GV87RE>R/J1G3GR16CN[A5V*+X<&N_ MW?ZM6A:[-$4V@@K>T6U,"L3ZD?1A@A*;84?`?S,VWT]4@6WEQ*?;[>)UU4ZS M>+EV>X,:[.)O'?:+OW507FEY'84?L\TW:55XI71R%D ML5-NYJB"<;"4RK'UVF[EE1S:$A:P2#%?P9*XIU,S7--R M>M5NDF%8VTZV#"%6Y**@XBN?0@?XZN0?5XW3K\6ZU>YM*'?O`'>S9/ MNT8IZWPV2B6CBL-7Z@FK:.QMSU/)J_\\!Z8R95C@+)T(PZ/8:7I.15ALJW]Q M!5@_6=6>W%[JM7KV:`2/=]:",X5+S\?0[U$NZ(N5W);&Z$B M>E[=ZMW8AI]=XXL[:A'-YQK/1-Z'X\WN#DGI7]01?U79KU[\VFJ\:0WMEM/"C"TXOMB"C@]X)CE.'.IJ,[BN4BEK(F=*YF3%!3)U M'U^0GR&3RV3\S;.H!AND?&W0H*.YKI?&=J]MK2N@-NJRBT]LV*LBDVQ8?`E: M&[QU':WKG8G2HK"=0<\0G(-2DHRD!V+$'FE6&R83%5:+>53O6*2GM/UJ.>4G MA8_']*LUZS;5N?M9M')2S$,@*:7-Z@6^?;INZ];E.N@Y*'Y+UU M*FQ=`O&7VJ+6&FM_T\S80^$67Q#J$5J<1R%8T>XHP2*CS_ZDTN/5>@%]NS]9XI3?LE MV`QE7#=M),*,?DEU%T#\(ONQM?'6WN\.K']BF6I=M.9:9KLD9S83_L\E9UZ` M.BYA*[84,[7=9.9:13\#,S^V@K]2J.I)QLG+G,H+V)7-KUW_8HG?T`=+KL%S M6SH_T=X\S69YF7.IV*:IC=NK-WU^)ONFOFVIU`S:$5MGYYF\J$E41H++MN"F M3X/I2^,&_N$%7N1.$6%S//,#/TXB%Q'13D1'4L0%7/-,%4B:CM-N]SM&OZLU M-%0QJ?)[4,$_W8[SK),J'7&SU6JV^F9KJ&>85.D@G"WX9]!N;3NI*(SC\RB< M^-SUROA[)6>EW1KVN^99T>-M0ECY_-[J]7O#UI,)*Y]G.]U.J_=TPLKGNV:G M[[0'!0@[#4;AS/L,WWZ$,?'2U0\6?G!S-OF8WR]=]JV3?2M<_C79GV!KLCIRD%YYC4S>]N.HS MR;@_8O]]X$__NI=$"^_)?/QC-@WB]_#.O^9`BK>:3>?@'U\^7XYNO9G;H$88 MP0@&/5A!O;`//X#Y*$V(%=])K5=L-D65X#/.IGQD_.Z@LZ0+ED9>(CWRP`T^ M]OB_I\'A:(1=4^(+;^3Y=]SNDN>Q]L$J).4`++Y!:E)KR:AVAN7+E$ZKW2MW MAB@U@@2DC!>OF)KQ1"4.1+O9:[8?W3>#@K*G4X'8;[;;SK"DZ9QA(TRA((*; MPSCVDE7SRGNTDO;:_>[PT>GE$;)NGN>1A_U&C[V)%T7>6(@A4'?TLD?G7>2G M5:Q#UW$>9=HB=#W_LI2O67J=9K?L=6'KQPQD93ZKPL]M]YQ!:H=3(VY#8NDN M70NFW2V5Q-*/2:\_:+=+);%TENUV>\--230,:?W!3EO1K',>OGK2V-0?`-W- M[**Z<2.<;*K)@<6''7,E]1B;D>.L)*?9<%J-ME.`G'ZOW>T5(>:S[U+[9=#' M((:H(IK;^<7L7A&!ZQXJ:0U[O=:PTS3TZ[IQJYE*&>O?&0XUC,Y$JWF M,[2+C\MB7J?9'9H:?7FD[0DLA9V;O;;3W("^,+BY\J(9]F_\&@8CD\;SJQ92RJTVUU4Z>M`*T@/X[<^/8\"N_\L3?^\/`M]L:GP4<_ M<*F!\2'WBI$>2/''JU"_G7X'_C&T6W%RZIMU^4Z8TW':O4&KLFESK*WPM',> MKV*S&_WNH&GJO.+DU#?K"KH\]H9.97/6CFRA.><\7LE.MWNM3J_57#OM''KJ MFW8%SF6[/1R6,VL=2)<3TY_4<6V:&G!3ZJJ^''P2<95?@3V)N@HB?KVNTRY( M'M@4P*]GT;D;)>(OAR,P?[F/ZD?_AS?F$`A]&GECAR>Q^>\JR:D`@]ZPEK:@ M:FDY0GE4>\KC%=R9S/RW)V6_U!FMN71GH*B:5X9H-FL[L!A4KEBR5F MX;_T:34)MH-NTPP=+(VZ+:D5I,WVFQW36BZ-U"KN!3N#?A6K6KY:;'>:?3/% MM2BI&5,EY_-*^+73Z7>:.=2NLEHVH[=TIAWVX?'*R"U?C76&[4&W,GK+UUJM M8;MKANW7$ZQOZC+!NMQO2E):[4'3O%?/'>JI=)82]S;=\J)4KH@FK_BNK,N& MH=,=9&A=%U;>CMHRUK6=#BL7IU9X)LO&X'/XP7&Q#PC>:3@LU5,+1NP+DA*'7.MX/RD`]7;S342>3-T?WKN1F?198*E MBO^+,-OG7D35BCS50H]NITKDK\TIMO=^AZ=,2ZT8!=5/<`OM4]<$Z8'X<)'< MAHA*/LZ96/:1+94_O25/I9I*]?&1RY_(-G9!+1,YC>/%(Y/@KTO2"EI+.) M)-+.[4-ZP:NZ39J2-&A0$N)&$LC`+`VX[ MPO-9\U0E.>R#OI/6%FN(J&IF%13V-)O#7BDS,T/N2Q,ROZPD;\GI]%.!ZE6# MKZ;_`OB5+>RSR:-S6?5@-5&`X:#;RI_6*CJJG6(%?DZWU^Z;D?NM)CGQ$Q4) MU7^M++V@DR)7C%:X^#@S_;1P<'QU;'UCT]7 M7SY;H(ZLJ\@-.&_`G1X.>G30CH%"=@79NL\H!/Q1ZN MXR42_"E?CW)W$"&@#/9M7M/IPU!#_W>IK-ILKILR)[]Z6$%RJN2I=Y M#03@2?.())QO*,T^+/PIQY)F\RB\ M\\AH+L8A930LV%:B.=U&>TC=/>LC-H_6'<,^+0$ZO<0NO$^GIK^&A5>!@O:: MMN/4U\WB!:#B_G25*U&CM@3WL M#VOCN)]*K97O3UV`OG"G):BU^EPI#"2W>]8L#)+;Y_6F*M!N91BYN\#>.^%6 M.7:WY=C]WFL_M5>FJ\UCZ_0&=J_3>_7;=L-O^U_OUA]-O?K7O]9W[%YW>W7VZJ^5JLZP']<"-,9+\MB>JMAVP55;>[W\ MB]C5=:S#MLJQV[:;@_H,[Q>@&U^YMD:NW38>ZMB=0?O57=P-=[%^NRQ?K^[" MEKRZFS_+XC\A@#IHV4Z_]>IPOC)=70YGSVG:_5Y]=](_E48LW^/\[,7Q>\L= MC1:S!?5_ML;>//)&/K5G>U[OVZ=5W?2DB;9=]U[>.[32;]J!7GR=0)`O_ MW>ZL["N'/4VMONWT6O9PN/W=01F>YB;\]>H1[C*KOWJ$+WKQ<_743S?+5W?R MYYEEKM[[Z6;YZHU6K@]>/<]G]CS;8`^/P\7UU*O.,36UIE5W=A8IB?R/-@1:DEGKR8TL2]NX++0 ML3YZ7J5#G0;6%S<"H8W<8),\D^+19WSCH0VF!/YKQ01PNTH,"JA!%('N:!3A M3V=Z'A,/?@E?@>[@EX&X_71X>71F?0H)>06TP.?/1_N6*:#O$`QWC&\'=30B M'$U)A)LPGIKK1S!,]!V./#UMP2/XQ1@."XYW`VR6X--O@,-;%AQ.?H,%*E+2 MDAX4M58.999[`W*=E"%HC!EH"!@`1S(F28_0GV"-_N8&"Q<4`"YL29)^`QF0 M%3:)ZP?>^,2-`IS1H;YV/?8F_LA/A(Q9]UA)0K_1<3K=KMFB8_W0UF_HPQ`P3M`WFD<^^H*@%(7VL4Z#21C-V%=DA\^+T9OU M8]#3QF@3X85&DM.LZP?K>A(R%XT4OI^%\XZ5,C&JY8\6"+-N:<[^6F.B) MO>C.'Z'[>..%H.?G0`LX;)X+G^#W,_=?0,%H$2?AS(MBUO(S+[D-QT3;V&-% MCD/;4XR!3;^7WOX ME]C8$$EO`^8"!A6L$`'=CLF3AI6[9LMH=.M[$\O[X8T6Z-K#9!#K*++>'IV< MO1-&U\D9K/.=[]W'QD3-C<`EFR^B>2@8);U\!C'FXN'G^>M&H^:/Q'3`#*X? M>-.`-@Q;C&$G_!$\+(Z-^9LYV*(>!4G\0`0#1KQPXN0EGMI(S19$1>3!:[RT MR8T1"#OUX(E+,G`+Z*:,TD-;_@,> M3R31`XN8MH7T7.Y7E6":]P<#H\%!_L!/I[O\5JK-9K^S(=W8QN`6_"(0J!C; M2!Z8YJ6/2VN>W$YU)E@>:'OZ2C'[V[UFK]-Y"H$8$EQIJQ5]^M5BV\9BZX'% MAG#Q5__'\98'RVG9+($YTO#%&Z.&L<&V&NU;;_?HT[UW&/.8 M3[V$8R#90/,E6$F@1@+Y:[Z$P'^M+R%UZGR0+[S\\@7>-C?L0WP?ZADEX@]5 M[`(5`,8O\9LO7G2#&AN?V!-_44_"*]T9K!A/PK9@%/KQ$F&'FG"F"`PT4$M3 M]QXC,:,0M'LD3#]4X6"-A=/I0R.\1R48+Z[!M/`QE)+61ON@@N!@+$\E2V5,/>DP$W;K*#]T*C6[P,D8:]'VU`#@U6K=5Z.$D$ M-\R8`7!C$B-,QO94.*+.P&,90HQQ.Q(?]R0V?DV&&7`GF3R]#I8K;;%LH>X& M9NL+LEZK*8.JP#YS\&I^$!3]],$:]O:[O]D\ZJTW)6,T)QIIBVX2T0P#FN%T M>T:IUB,%.S22XL985VU0PIJ#10LSG5HC^1E&E(-0NXJ&X5PIM6@^&WZS]#KL M7"&-IKIXV!LK7]=@-XNFAI9T%*=EMXXPW_LP;^$M@3Z_\^]P8/0WL)4(_GZ^ M`,=Z!'("WHS&O%RDA1)]`?)OBD(FD!;^QD,NX"7UP;A7^R/8=$3 M('@4WJ`O:]V$X9@(Q&7!^X``./G&QY8CPE7(O0D`E\E8A6IW[&0RX6MC?0TA M%UQR&[HXEPF\[.*R MHI`0(;%ER'-U=5*,2"'68&.2,"+^D+?O^6,''@C&]$[;0G!))AG[L/"1/FK[SX8R&&,XN<,RUYZ'/ M#S:?*S,8(H\\]C%'?R93X*T43Z4.,6S'9.G,W[KP8_<[O'D^=4>D4L0Z7WLW M?D"Q)O&!YT93.(6)\-9U*&%_E MV!N/#?+<7'0NH^AC2BF^87U9+4/!>7OOF[1ZM! M1I#4CV_<&QG/F?C1C"*T,;:&LA8BJG.-K.!-8#&`0>>1?\<7F,#@!L\L+W_L M@34#'(GB?(4YK&A+SP@;3+(5@02!N;^8PR$.4`/0Q169$4XWNW4%Y)5+?]=1 M#=Q@&:Q-*QUX+8IG<(A:O]$[@&?(4DM%7!5C@&[RX*3J")T,JZ+PH#(=+%E"P+D6%5.3^_WNR7%)8L&H;A6,^/ M:Y#L[S%J1$$_H;0?Z=2M>?[SBU:>79YV6 MTW\/3VSW9M68/?U^6!]_[(G/4C_[NIBAJ1Y&ZLM-B:)?'#SV1F.X8R\(*1/C ML0%7+VUVK.77R6^-&:]:-1%YHX4S`YV#AM.5P;;4*K*5GYT6WS9,?.1F[,OL MI3HW@[3?OPGO#HY._[[W._"WX[2=7K\K:=(_SM"?&DN,Q&;'TOC4!3KY71.O M7BZ^2;_9>(O\2*Q$D<4Q(Y$O;G&0^+(7ITANQTM8J1BCL\<@J7_7DY%OT=]E M?N0%8^,GYO+*;TIXO,YN+.^*"Y27L*+&T1;$5R;WFB^.W5*+4ZG< M>RR'["6L5.I@-C>7>\UJY=YC-\4O<7DWE7L5+:\\VLWA"Y9[DO@G'&W^!/[P M_P%02P,$%`````@`-SXM/Y!1%:=L"```KEL``!4`'`!H87-C+3(P,3$P-C,P M7V-A;"YX;6Q55`D``UE#;TY90V].=7@+``$$)0X```0Y`0``U5Q;<^*X$GX_ M5?L??#C/&)M;8&JRNR29V:(J,Z&2S-:^;0E;@&J,Y)'D)/S[T_*%&&)`$.38 M+TDPLOKK_EJM5DO*YS]>EH'UA+D@C%XV7-MI6)AZS"=T?MGX\=`;#NNVW0&3??"^M-RG4_MGC7ZEK0,"/WY M2?V8(H$M0$W%IP42WF4CU[UZP);8)QZ"IIZ2TU)].OT.*):\I`#XJWDRW53)6]#P',G;NL.A\-6_&W6]$W+?+^=5@:\`:I85J(,9P&^QS-+ M_?YQ/SZHB&K7NF%>M,14CJC_A4HB5V,Z8WR))-@=L,0=+SB>06_013-3WGX1 M_O_B)S[")&LH5R'P*<@R#'##:KT7VS6C@@7$1Q+[5RA`U,,/"XRET`+FL:DH M&]@$<;#E`DOUBC;*$/$2@#Y(^*FH%G>SNQ#SF&)-4PK&2D9XC<3B:\">=0%Z M,T,`OR,9<9PW&0R5AVBY1'QU-WL@M"G+$2A M(>Q_,4`#%O8PI\K0Q#^*]CEH9`C9A#.PIURIL/,K(J%B70M3R!$VQ323&$;P M"DT#K(6%`G6&L-PR1#,L]SA0HP-BBUQIX0I"'KH&C?0>7&U#N)07:<(0TC?E M0@^2>3_O0C7$)C`M:,)AIL;_-5LNB8PCJN9D!.U-F0;/%9!['#*N@J2>;3`W M157>>Q\YC#;DZ4=&CD-IRD[15.!?$9CJRY,V<2+"3X?Q@"@O"N()X!8^9^V) M#.`%QVE;36L]!)G3`A"3CFU.6%N:1[#L66)^`\L!061.]^&%,19W""V;1@W=4QK;5:?Q3BXP+YKE MW>[`7$:[0VK9/.HHGQ+9J3J1.37L@=,S%TES@L[,UUO<&5'[2:W%.B2GPG=& MO75"Y@[*8.I5Y$=P5JQP74)D3A&U<:`*A`L6`':1E"S!!'US4]XAZ:>7,`HT M<=L]@ZJ<"%[?&37IR3ST@`%J$_D9G3]BOKS!4YD?:9VVN?5ML8TX7Q$Z M_QL%$;9[W:&YW%H+PCE&ZB%ZUJNE8VU2M6&ZMZY\CST,.L%J_CN6F3&Z`X.E MC'V2R^15UP)U"3=CJK;K&%^!&O;%T#4W>^8EENR=Y;M/-P2$7M@Q^T7+R4*3QEMOUZ*^?=!KDMJ^`!K%O&(T1(BP)C0 M&4="\LA3YXHSE5Q]%O;W5@HI1RA4E^0PE_KDQKC;;G?,Q;5"F:40>%C;NN1Z MD,/.,,!/"EQ),BYSWZMU+?)"=3J9T9P&O4&G,`Z> MI["U):UTSO:I6Y>9;.3[))$_@87CF%ZCD$@4V%V3]8X=0DLG4$/YNLQV]U@B M0K'_!7%*Z%R,/"]:1O$1L1L\(QZ!R(VU2H0GR=@5@_V7$H^\"0-8YIDKJ+1/"'O3;YC9(-D2= MOM7SVL=7<%("0=-]/#<*9!>S*SN0+]D1:K18#>5.OUHJLZW&0/>WUSR^Q]DJM)^F[K5"C% M/[":>W7<-_JXCM,V%]7VB:X*W=KF*=R%^[BI6WN$CX6(U(5JF"Y?:TS@R&VC M.ZO[Q5>%_*/L5)=]O%VS5O[2)F2Q3EEAOAA!%5U`QUIUN4.7UVM#EV&O9_(, M4['4*K*]RRIU*;=/UKYZ0Y1%J"_LH7-AKM1>(+`RO.ZW16'EO:)S]PYS)"6A M-^8P5[G3Q_&.)6E*VR,;>;\BPO'.(U'V\,+@N79]'`8=7HOA;8<_SG)OEZ<5 M'029>E\9SX?L2?S?.\$Z.#W$T.L,S,>[`R"JYA)'V*QBY<@3KK],,,!4E72. MD<`W./FMBK3FDIQCD)P>&W>X1+K%L.42%T:WM#1QG&,@O(_E]?^G. M?:2I#D2>"N;('VFM`[EJA0Y^[-SQ2;]0/]2_CH8G_P=02P,$%`````@`-SXM M/[/(!5.$.0``"T4#`!4`'`!H87-C+3(P,3$P-C,P7VQA8BYX;6Q55`D``UE# M;TY90V].=7@+``$$)0X```0Y`0``[7UK<^0XEMUW1_@_8,N.F*H(297O1^\V MUUF2JEM[OWX8G@T^`.AM?,?UGG_]\/W^='5_?G7U`821 M[3GVUO?@KQ\\_\._6O_]O_W+/YV>WH[_]Y>[Z]/3Y)]).6!\MCR;@NSQ2Q3M M?OG\^8\__CC;C7\\!MNSC?^:_;H+?&>_@0Y`&4>#X?!TL#@=SL'_`L/!+Z,9 M6'V+4VY=[_=?\/\\VB$$"+47_O)BAYM?/Q2*QP_\5^BX&QLEW>!Z/N,R![,Q M,BS.A`$X49:-X/ Y1N,/T<_Y@EQ?65*OAC3-(.E\OE9_)KFK26LECN^',* M_`,R!8#8F,#?PCOX!/!_O]]=M1J"TWV^\#?[5^A%*\^Y]"(W>K_RGOS@U8[0 M>T=82,$O`7Q"I:$B3E/CSWZ$SO\@3QP;NFG"Z'V'OF?HONZV\`/XW!7;N>^% M_M9U[`@Z7^RM[6W@_0N$4<@%;.,_AKJ!W=H!>I!NLZ0J_N M>;-1]>IN`Q]]QN@=-]V_[]T=?G-BN4.;C'#4/N,WKEP;7?!;JCP)77!-5*$"[.($T88.:HH=!_YF]_7.]S$ M;I&T]H_AO#O>_2J+M^X/URXAV_R>)[L\)&X9_OP]-FV=S&0K?T( MMY_M'VYX`9_L_;:JSP67L58`1O@9;J,0/\&EA:>Q.SL\'0\);$JY_0+WX!^D MY]OUB[M>K-SW+[K$RQBW`W9-^@;V#/;[M:8.]O&0:AL)"TO.5:D6S0I/.X1G^E*=UH MBY*2W&`P&()3D$X[%/^T/0?$H1`>7^G5K/Y\-IXO%\FPX/)NQ.\80;LZ>_3E0NN8P/56Q'?I"^W=+[704IRJ?`?^4#&?DHG?U82;?X`/P`C6I__8`&/#ND M`P%Z9[]^&'P`^Q"!\(DKGD]GV,&F]BW*DU-)BL^;N),_W=9I@Y)0K:J\>!I6 M!AW*$'(GIEQO`$-_'VP@F69#U>!92>B=?K__`%R'7J&5/0#XR;]\SA&VT^9\ M'^`9H:]NB%CZ-V@'J(?`O3'Z.,O!H"<&L2KI1B8!Z"FOF%E&`Z,YUHA;-=^: M*K>2'T'\*\`_(XUT`$X@QL0F55P]AE&`QFYGX\%T/*6QDCIDXBJS&PDE4:>$ MY,H^'(XFPZG1!!6R0S5A1^^HO;NX#_2'/]')9V'BZ/D]TW)//P*RE'W[S@*]RFI)G M-#X*%C.0ZQ)B>O4Y0Q/G(4X`2(HNE,1.2/Y-1TH(F=71)QV;@-/)6,@Q&AT1 M%2NX]1*Q7'F-AL2'[4#";*8M&XS,>J9@J89^"-@&NDJ_=6`6C7#V%5;R=@A M^0V0'P'Z58IV_NNK[Y$=%/E';D!Y#^(D.R._CLXND:+[JQ7XD?->YK8$NK MH`^:M4(N\ZR:?&#VF((-6@_7*#6G;,M_`OBW&MV*#Z[17_PKXR-P"K)-T.CO MXN9HD&PT!^4M\/S+XJV[Z<77Q#<;?^]%Z1[;E>>@)\$>.M>N_>ANW9 M&%C>9G:%-F,G;6:;YY-K*G=P`]TW7.X-C-*J)XO11'DW0JNYG[;`9U.5^]1< MH[G9LWCMX'7U`DP$.8'S)"<`)>HH\HU?6:FH'XBY3-6FY9H3_3!\:9?/`*W* MW`@EIW)0H+('11GL.&[\WF]MU[GRSNV=&]G;L\ERV+;*UH&\]$H[\I;7DHRR MK`R&CY0;<2N7V(;*K?Q'@'\%K@>2W_LEI1I%/00IZSI*SQ`W^^E1$C/'KD<] M6U`46;I+6+J18FD8PBA$Q8Z7;:LL'5A)*NE(0A;0C'1Q@L5\:O9L=`FGI#%>/7)7J3-1*=E*-_FU4ND\J.<5RIHISZR/#US"H@#6Z5I6J$P\K/2LI M[VDE)>1*N%RVG?+NB6I]=H^M5E")ER5'3?88O#`Z;*WJ5JZ[JG(=G3/65U3H MHVGD(L-CJR7'#=SL3<7-P#7Z;PP(UOGWN[O+FP<@[\[=H/=4+7PT5[@>P*BU M#T+RV%+F)"4'&G9,CH"43.1Z5))5?2:4>8*.6MGP417*I7:",D23FF,\F!V# M;C9@URB=;!36]?KFM].'R[MOB7[^(L;/+[;W^_H-!DY@/T7AV70T43>#5ZZK M&Q?;<*<,K*1;C,TF'0VN:C&DU&GA9R!_V`NGE"B=!D[55*V2CDRC'Q6M4L1: M%(Q>MY4]DM^'AT-PKSP'_P='!GZSMT@@PU5T;@?!N^L]_]7>[N'9=+)41S\N M"-U8*6EE%O(*Y;,]9X/^`_/LL?-M]OZ\%N1:R-N,P<(_DSVE.`$HI%!)9"5] MLW%$KL=NX\H^'!J^)T#$#-4]OP"6G.KDCT+R$V!'(,T!2!9!]N>'-Q,*(!=$ M'=$KM77D="OVC+[5E,.)X6SIY5?4J^,";?_SS#,8)W=@#><+)_!L.3P6"0_G\0 MQJ?*[7WT@E[O/Z#SSV`^G9],%[.3Y7!`-'0^F9U,QNC?@V6:W"54)K_Z^7GT M$X!^V\%-Y+[![;M@H+;S/0+\"H,+N/-#-U^5F@T4;@!D5-J1][R6Y(%>Z1F& M"].;0"-PY=K;5+N5_@K2GR47S-N^IAHA/@0OZ[+,>L&CT=+P=:0VZ'HDNAE$ M3E$G22#'S&LWC&Y@=#8>SNAC+GIXUDKV?KC%QE(E59H2OXSA<9"I"EF7P%7J MS7F#?\`'['KB#6=<7SW$J4?KK20=+N(78O;)-S9H?O9TB\/+1%#F$3FI*>FS MU3Y>M5,\))&8W5J2.MN'.8EJ6TRT7AF_( MI>)5+9BT2JWXH?2&6\8'4B*$&HA5T[M*.K)"9?9Q&`9B+:I&K]NZ?UB?__G? MUM<7EW?W?P*7?_E^]?`WP8VS5QZ"!<,H"4=7Z*@4QG^C5]J->-R&I`QD99BB M]FLT$9N!JQ:[QMJM]-D3]CV,97(X"%86=-%5@;5A$^:39)5KSDGE1B?"B&$SQ:#J3H' MKE!1-S8U(D[)5$PT&E82`/9INN]D& MW3+%I"5@,3( M[!VM@I8<6MW+ASWN[J!FBY:Y`E%4UO75 MZLO5]=7#U>4]6-U<`-J"D723R$^)+-0M>O=]618/?@JA\Q-$AD]D,3%K5.I2 MQ45-EEP-:OAFRCUMU:1K]*9+ZQ='XS=44>OVF"OU5Z*6]C&/40T!.%EHF<#H M-6ZD@#EL9N8=SL+P>Z9:L>O7QS(`JD[VX;DROJYJ5U4S69N\45K$SO&Q=>,U M]+H]3@:.+.YIP=<4W(-4J*2P$WXQQP?2U*MJ7\GI21BEZ3&R-$6N1T,;,73S79.B;_P(ALEN?'RGJT*7E5)C/V1L MMJ%*Q5+JZ7!N^!"*C5J75-:KMLBC_`B1]'"^Z0,JU41-)&3J82DU<88,GYUO MPJU5"VD(RGP4XV"QO/-L*F:JSG6D5-B-@5P6I`2D)49MVNR^F`U:M08R:ZY* MH-2Z>=.74R)_6KE7$S]:8K)(8?9XI0FV%NEK`)#04.J89+'84YU+$ZQY9:9V\4;#2#PL)B^L%X:O98OQ&W1B6L55[2 M0GG_L^4[JM9#371L$L7R-IS1_,E"W>V/C%I[ MH"*7*24R4G(LEH;'+FD&KD4=6;4G\MC],%'KYU0GD=J929?)>HZXJ1M^@J,5 MNSZI;$!1YZD8/6\1Z2`JTBG>'#F:+=5MA:?4V(V6?":DE*2F'@X,OT6@`;5J MF617;64_]7"_:.-75**1>HE8TT9*ZN3F3+,=R$;<6C2Q"4&!D^3:4?"Q=NWH MN.G*4<_W(.-2T4_"A-[9KG/Y8P>]$*X\I^#U9CWG!`W&5"IM&X+.A))OIMN6,I,WP[ MJ9`=NCH%;D09_6&<.@[>XQ/^IR=0;)Q3E/W^#@;1^RT"&"$$.$C*#E^7B$.M M+F<3=2M4335WI;N(33G-&W+-QC/3G>U6].JEO`V"E28Y`211%G^*)),(#LWU MI15I]D'92Q'IAEQ$0DSWT#GP:Q+E=B09D0F#86(CQ0HM@F$;TFW^V98T=P:O8^1Q$SM(BY`""KR'%')A[L MO;V%X0.T7U&O<>5Z3X$=1L%^$^T#F-ZI/:3I./U^[^;2NG%5&&G*TY:,9#74 M[+D/3@M4BS$?#(LD`S@=0`E!):6XP\S[X?-E=>,YFD/E(RD.\8+?KMFW&W#; MP$]4QT?ZAKQ4&QO6,V%S0"V4)8.\,S6DK;H-YG*VUO\W9TRVF9B]>9'7!"W] M/B>8(EGQ2*[*5>'AW#UJ71`WLO735]>SO8UK;V_Q)>7HR^07?@[4;7OD`="1 MXS(F9CSGR8P=,M/)+F*'6TRQ=& M4X4WUO1]L0>7`3F'ZXD'"\-/4+)!JV$C,39J`1]!/APVN_XD'#:5GQ^9TU_%!]?H MK_AA^5F*T8VP:00W0+:`4Y")./J[2:,_Q@WB!4;NQMY^8KXK[.OZK]#!J5QO M]L[]U]??8^\.E3@.B!V.63#RRT, M[O'N%1SY<:INAS,'@FZ-4\[$M+%RY1[,YF;W)P)6J.Y@^*%8<=)TYQ]*C5YQ MW/*<>!\@0#D`R2+6XPA10LGTMEFLKPUPN7+C[&8O4XJ8H66@*P`H97\8LS_; M70AVB/-A)\Z3>L)5MB?Q;+H8J=N-W5!Q;Q1OMXC"[%JFX61I]H)-.WB-ZDU' M4!'M.!'(4_5/6M7ZK)^T37)[<0#7[?\LH!49+>V?[LC?^-S"_A+ MJYM49%3:,V]9EC`YFV08#L;CH_$::,BU2VRI>JJ^RIV':?ND>H15!SG;!35] MQT@$9F9?5](&_3!"6@9!%U&W#XZN\],RZ/..MNJS4(#&TMI%-`7CTJJY>\[7I;>O=8-(YLX$7#?QCEI2"ARZ\O2^/R M84CFO,5R,E!Y_(0'0S=JR]I)/V[;,+DY'IHMUF*&J-9M(33U`^,]3AL+$D3# MD7(C&D++N?/FB"`P@U"TM= MH#O..=.J3:9GT(=7-^W,KK=_,K/L:2)RD@&HRG9N^3X[3@$`ID):]XOKTV1M7.:2YNK4Z['3NK$A(.I M-`4,4ZJ;9K'EMW1/FK9T9S^@VI_`>@<#:GKIWJ9$ANYPVC] M=`??H+>'R$]3>)5SJ:JNJTF-J//EHV*RX=SPN`HTN.I7-VMU6O@9IFSR5'3Q MDO9I%*U6*B8493VR]+:0YBS,'A32`6M:<:14G7$KQ$=RQ9AU`7D3Q) M[TQ5(HB'8VI-*1ORX,T&9@?S:@>O14%;8908*T;1-%12NNZ7G^E?*KRNB55K M-W[RVY*RDYD#*8'A9SG:H*M6T9;ZK2R:7+990CK@0.MW52*B!^)H34'9+QJ[ M4F;W]:W8M>AG&PKK!D9@ZXMB MJ7:J,"8I^B6F%G'40LQ6@4PSD&9N]G;:-N@'$+\WNT/D,4"VH7"BL)!4) MBUE.EU[`I(;/2G36"#[7=+)[;!BU*S(NFQ&Z[E%20U8$?AM_L MX-GUD/IO\$5:.,@O59GIX8CK)71D(P^BC('UQ,/1>#`T>TMV`VKEVLFLVB(_ M@?@WD/S8'YDX`[+K9%,]\'H]-8D+CMZ/V1M.&W'S4ZI;@/4F$%1R"491;_J4 M?)'3=9*KWEG6$L_CMV/VV+D)MIXND0T@8=4K^?$$3W5+:M9MX#_AVX,F"N=P M"A7UP#H6XA+;DD3CR=AP'ZP&5DLW6*PQH5+\J#N#U`P"5#*(KE=QHMCM-'SM M@XI7GT)5:D[XM)/@TY6'M\I>H^Q?T1<[][W(]?:N]YQOB?T"G_P`QND>[!\P M_.9ZY&-<><@,&.);_\JEQ+&?O\'HQ4>_O*$D9)\M%E*%Y]\T6M*M01SVE:P:!0X`E( MBB*P3L#ECRBP$7UP54$7T.RL1!]^PB]HBTN/@5]!/JGI,/^__K']A`/`8>CV4#= MO`>CUCXXRV-*F;64'(/%PNR!;0MR/9QE59^J*OH]758%'Y,D@A=LMW[3R4_$ MSPDO0JZD:U%M0IS\K))DO# MKS&@P56M890ZR=&A\EBYCRM-Z=],S66FRJE6O\&TG([LTC)[ M4FK5!=H)$LOW_'AL[#W'^=,>:#$?*I0S5K4=^<9O348]9I;I8&GV?$P;=.7R MUUR_5?P]T\1+J7%#^X=5L@1Q,)K69O>969(96K-OP.)`KV7FO!U'S'[W` M('4*!:>VF97D$Y:C^4B_M/8SWRUA72N'\ZRSA>&',KEM.)CX5H`TJ[#T;#@_ M#?0*LVZ2\PMU:;EB;O;N$7XC#BO;53C6FNAVLBR9SE&&GP2C-JS3RI)J\++[ M:*(N9$.MOF[LY8&?TI62=C">F^WW,C&KUEQ6Q5;V0SIO*>@R-'PQ)?*ICW`U M?:RE35POLX^(-*#6HH#L^E.'-6.@G--:JZ`0ATCAU<+,:GLF)-L:)B^+\:OF M9D^OMV+7+HP5`!2!E/8\V[^M'LG4Q=1V!2UOA#%[)J`=_&'TM`JCP-A44+LZ MD:LP.8&U?KJ!41+_-B1GWJBS`?13>)S%]LU*7NQLDM)+0(["4"GNB?),%-787$D_'([.WOK!!:W-%JC47.%G: M#-,?^=0.\G20CRVM>>)DFN=('&0:;KV224&0[EHFIS?][!R((!/QND)]&>)L ML9Q/U$DAO=*.C.2U)&,E(\/4]'LDFX$KE\:FVI-U*LK2;+^T5".2AZ!E72P9 M&;!3-#9\NK8%NA[);`916DD5(V4VB$`=G;HUTW[&0VRL*<^R%,BO,7M9M()4 MM<"5J[/D)I!J[U^)8BGB2DV3\JDW/(EL=N]8PZI%=:JUDGW+TC"9*P\ MYYL=_`X+`^:SX6`VF2I3'G;%W?@E9%!*N89,\\G"[.F75NRJ):P-@)4D('%B MLR1R9]-XOJX2\3LD76L*R>MGR6%W\#D$TW>C=W?24\Z(E+<93LW>'RAFD M6LRE4%EI+I!D`W$^/&D>9P&%/))WBTA324E_*B=CCBE=4@&3:'&G)($. MVO\6>J_0L?=V"C!Y@S](WY/Q6+S4M=/N,Q2 MD?'K@S\BZ#G0^=#>XE?.?^Z3Z,$/_AW$K'&WL!2UYL''U=P&_IN+ROSR_CV$ MSI67;>)9;2+WS8W)N\J'G':8BHZ2VX70^-CN4@TJS57?V M"K%;A;)QN+*L=%`/;89^)B*4U@(>W\%'7!%PO4\@WP.:5R8]E%7:))2X&__% M9*7FNZCA*.IV#;_F5ZG=6CPAE194Y27(Y`4?4MCB:Y_04_SW!BO+KJ@L^U19 M\EV3=E:1X(`>PU]Y#OX/OOO@S=YB1*OHW`Z"=U3R7^WM'N_67,8A"Y4X'EP8 MNC5Y63/31LR7'P>(-OS66#%#^)L98J+K8QP2&*_(1L660D8WG M;M8^G+1]H&=DX"'>3O`(Z*L?G*/!#1HC!==N&.%S]/,I]7(H>@P`5CG=":A8TB)M,S5?W1NPZM+P)0*S<9)H,)0%I&D`2]4T\SH@KAV)>/:8**P^) M[H'>G_DJV8*>GW[=HJ:T0VDDHF!4E/9/7;N%QRPFUF_:8>69S.(7:/8>!0[T M'$SLX_:==B161KVM*WKA<:'T>]3SAP_0?B77FSX%=A@%^TVT#_#<)?G2U$7$ M5AXVEML;+T714VC:7`1YV68?C1:V16-?S@6H(JDD#\"9`,H%RMGP@IIJKHMW M_T:1O=$]:"PC[>7,7BN2L.8`[@,G-!'NGV#RR[L8G/01=SF,8G^C2])81MJU MFC\K+6B-?I>%$YD5TSW"=,>3@"PUX7\Q MO4KB5_V;GY+X-2^(\RM-IH;[/T)V\%/_#0:/ONSN%Q%,I2;0D??9]=LPO+5= MYVPX6"ZH<\?]7MP>U]:-S>W0:_>T)RGGRYG9#*4#5JW"U%K32(;D,<#/>R*8 MDNT=>@A6V[)12XG7>\R.*L*"++!X)K_7CU%YRK4(_R!,L]*2VY6WVFS\/5Z2 ML]_Q);8(^<<]=^=+=D^][9=#96M]]"#E-GSO;R'@K,EBEO.!X;3W]Y MNS0(L30XB[+_`J\OIR6`I(C8;X@+`852M#8[57W`L34[6H6P>7G0U-@Y9_/!^8?0I#R(X#=!I,,,S^ M@MS&5`BH0_(H;02Z!@0';P4\0P1:`63OWV@Y/K91;XLM!QLX-.-*+B2S%1"_ MM'"':M,Y9\]$HK8)-)O,VPY*I0PFXZ/SE-JL.7374(?$VT'TN(S,P1Q=0PJ# M&@O/L**QE+'9>_-ES#G4P*(-6-)W]+C8>QO`G>TZ%_`)!@%TDKN75IY#:DH< MC.ELJ6YOOARFOAN*W'M@-QFN\H;C^;&MFPG8I;_/X0?'ZGV2$M*;\H,D*YY\P0NXQ[9*R+3BT!I?0U233ZM56NDCJ9-AE(^B:%)'*9$HLS*E]S2: M#DV?I*3@U32O4J\YXY0@G<)P;Z.7L7ZZC_S-[\B7_7<["&PO"G$\!1B\N1L8 MKH/SK>V^AF>3Y72H3KA$H'0D9#>K,\:*%3,QG,_BUBB73F%(5IJ%7(R&,Y%A M5YH-/.%H-TE&@`/ID:PZVHP:C3:]S=157J@8LM_$\%5;*8/T]!,RT*SSY!Y. MTGA<5`1T2+,)DPQBC>4&1K3K1[ZZ'D)6NG[D;#%5N#.4'T>W9M+%WK2-")0Q M62S-7IP2MD5UGR(*B(2?;K@Z*\M8N#I+>1-1$[C=X#92#]HN4`AQDLE9B*V\EQ9O<9P9T*/ULI^[#?O&V4]@DOS!\&X2\ M4>9T.15D,GV/]/&$#@13,K8YH@96&^7(E(7GFZG2P2LMX1QY?'`_W"=^F M##`CJ/V5X$D&!AI\P"Z,:EZ.NNU'_#B4M!\N>UO:#:T,Y)R;/9\F;,N!NB$F MH+;>)\O8]\BGB3):1SXFM!'ND0^M$")O1^FV-5ESR)%/`ZY\Y)/U:*&60#?C3 MF=D[867,.61GT@0L'_9\W*>-I+CT4P@0HKS!%'T4[7L)&O#H:D!L^\4;4LDK M/\JI-@ZCS.E]*LADNJ&^!T$\!#MPSW3P!M:AIRI'5?I9.JR:58;U6U5\M4$0 MK;\2'02A5XY*S8=@GI,M0EU%\#4',9F.U%VEP0VC8^N1MS9K--Q%#"?+N>%- M1=06Y7V0("`KR5"8:,-[J//-!B23?&H_!_O^%H.C)\?D#8 M&#W]AR@LW$A.2=>!'GLA[BI\3[*?6`>W=A`E_UAM_KYW0Q<7]]7]`9WX6#EY M&D`'KP>.Q@K7=\01]=(^.KZ"2E,1*VTRGTZ/H&KEX^B9Y(R2V$$T8W3TI:F_.8M8#@P/$R.F"&JA5H(C96F M)B>&/Z89R,3J)Y#GD0HV*,H0-9)N9&.HJSWW9\-1$9\O!7'V/4*BP M'\(W6E#E=C'Q='8DJEX'K4O!:S7G:HUXF/W6'_74"K`6[K&%M9`Z)A&W1I;R\@')!COQTMAND>4X`R75"'(7+;HZ"`&/4BKB! M380M^>V%)'?9F[V<)&..YNY!`%H^T]*7,UUPYO,(6G%4+!)'ZVPY':F[3+JU M^HX-0MRZK!FT9IT-%X;W$)PF*.\8^'!8I0D44(QMF$1I(XE5\5O)XJKK["4)`!)BI[IJ5Q_-=*S46U+.<[,_]P-ID!6]!4VD%'_,,:&3W">`\(,^DM!UH MT'@CVD&+[K,_&-8MPUD_J4!P&(VT.63TQ&H87RS MC6U\+^6>+`T/:2!@Q:$4OPZE1>Y[FBMII816J3\0[;EEOCPS@&=:1\=/_-2. M@TH\#9%5H/S'79*1[//S"/EEYU^>W.C:#_'=WM.!PFU]646=F:>79(AJ4O33'8N$E')^+FT=ORZ=+45B?7%=H`# M'Z/TUG$QVA:=U?H\]6"@,$1B4]7=>"MH5$K'^]AES(.E0F:\?M?/\MW]BQW` M+W8(G7/_%8NZC;_+V6PY4S>NI]?9C@(\U3Y:>?AZ[7F;O8F^#KL5_;0%AD;V](&;G1IZ=$=)9 MK,+K)QQL[RL.TYJ'XEL.U47":ZJY(U.%;,KXVI@+O?2%V=,&7/B5ZRD'".O< M]T)_ZSJDA\]R$#>`!'PDN:3#GY)V@3?"QT'6Q@IO?BQ6U96RC:!SCA:3319+ MP[MV"ESU#*S5F4AE_+`/,JGILQ63J=Y!EY+AJ*MF+Q%1\>KIBBDU6U]M-P!O M]G9/#M&$N+<.J\=I@$LRD2E2>[,)\-^OMF<_$\4#3U#TIH[[_6ZW)9GM;2JP M5QXJ_I7T_85>3N&F<4X0'4DL:VE&;\X"Y@O3.W8A0Y3KJP@:JY@Z[]Q!(8-\ M/R]($#6B;6)3J"L];P%X:N;G:`RI*7KZ!S%0Y5;AN.%FZX?[M/M(;\L`;EZ" M8-CS%CSD(@_;=;[Z009M/)C2HY[;X8:0?S`;#PCU\1.)&I0V`3Z+.)L#K3`R M=#%[0V,'JP[<9S1`X^E`XDN<4'Z`"E#5G30RK-JU''^;$>U"6)_0]`&JO%4F M="P-^*Q2J]#8?PP7/UUCR$WJVH.8O0C>P2K^UN#XFSVIHKXBH;`G6?+T)+^4 MNY)?"GW)6:T!%1];_KB5YYS[SY[[I.[P7&?XFTQKO=\ZV_=C0O#!U3\ MERV.YC*#A6+(4$ M/2N4`_*"0%H2^`]<%B"%"7J@_3!2R33'L3?3FCO;K5@\`SS^B=MI8I\6%[K&XNP/WW;]]6=W_#O]Q?_79S]?7J?'7S M`%;GY^OO-P]7-[^!V_7UU?G5Y;W@A2?!L^VY_XB=CFPY,\9>-&7]E-QR9V_S MA<[\1L+17%T(@5X@=FN\BMY2=N%*+\43#IE]9*]?0U7WO[VB[:-I-\T)B;OQ M1.;`<#!"COQ%-G>+_O';&E=ZOKXYO[R[P?^]O[I($3/?.AX,^Z_005*'$FS. MT#_B=_^;CQ3O'+,G(&_1=@OZ7$`N\C2F)?J[=-'\>TE=A,0*<2I/'!D M)B0S^W(.`2M4-VQ^*%936Y">HA5A`^\ZZ"/FA16!XB/RN3N,J43=[48GOTC9 MW9I!1RO2]B!4#/E$9B]F2]FC6N5E0%E9IB+IRXT#9^PP.R)'(;Z5.=,;0FWZ M0OP;F;WR(&6/END)&62-WH\.UG,Z/Z;3ONX0B7\-L_=L2-FCRR&2`6==/0%\ M>2L$;@AL$.Z1VV-[D8OW.>$SV,!^]/?H?SV`8*&B_X12Q5':<"P5'$C%]?80 MV#CS,^D^-DGW0;;0@@#:(?I>^)#@#J*OZ>`Y^LC%$5N>H8<\K^WV'25[AW80 MA\A"8,"CO26W.H0O$$8`'SOX=))NNX*_@(_V)UP8JAGOR47U.6[LOY$[3M[( MT81G]PV#"=R0!'W!I=IA",.0[./%^W\9EN*4/9MZ`CX^?B(%[_PP='$"^/0$ M-_$)BG"_>:$;@?)M/A6V'R-`$.]?CM MP2OZZ=DFRR!/R,7U`UR5\RF'A]]U;&]:++Y%)O:245)80;7;XEBN']TL]DX` MMP@I>M&[P`]W,+[A]"F=/"INE/L4W][T\>E3\6GA6P1PX[^ANI,O@=[T9HN^ M)#$Y?0\X#=(,AWQB]"%?2/J7-/M'9X- M>_@;F0F[_,OWJ]MOESZ\4OQ&J1RC<2"QZ,Y&>@&)6G+?-4H^X4+=Q0@2*(M[S&=W: M!FC%+(X@9+2H-0=K%4Q(5N7FP_+%AZ7I*^EANQQ[5(5Z,KK)T&)!"14S'9N] M>4C*'BVC?!EDC,ZE1Z]O4O7Z;M8/E_?@=O6WU9?K2W%GCQU)5\#)PS%<*!/B MD_%HHJRSH]?9K8WRVI$V1D9Z0@:S5Q!;D*ONEYJKMTJKA\@(]0>Z/N!]RC>]J M2OR08G@X:9^$56!QCP7]LB;&PDA+>1T70\319NL?;5D)-

.G/;H'RAFQ.( MU4A_:9>%GP:\RWF&L):R;,?(RW(+S8X.)V&-MB4[86@6R9+>&8/)78XJ2]O" MU`_/:3T;YA`U;HT8XWMW?;K9P-\,*GV\X;N7),PYE*8W8*JT`#;_Y;2T2V@OF])]/,8OFU)PAP]NY;$@35[.1H(W]'+,8/Q,KY/Y5,8OF-)PAQS MO)\:-@'WIR#_?6[MF-$F^?L;:^,Y_SZ'VHSR2J.`$;\'UU)ZPNY$]S MW=U:L*A=I5LF&O)A^IB]8,UI@6H7C`^&%=.^V^TYM5JH#7^PF*O;\LF-0P6K M^(`P_T,N208(NZJX*,;!ST2X;X MRL`"]K,TC]08+8,385A))]&C][6H>E_W#^OS/X/U+8YY`&ZO5S?BCA@Q:TV^ M.#Z7(>V1Y;C63\6K%!,7]=P/HY!^=*3A:I[SWY@6K6F+']*@Q?0ER*@HGQ-%=[FV!&=IL;(_6J$ MFR.CY.5P:O:6A'X,-*8Q-J&T"GTLOBVU4$XVXT)*.@'%RZO3TKH<8^F+GVK. MN_P43;=^@*9SR4C!?^[&FYJHQ='N"6R]1^W1$U]6/?'S];=O5P_X:+)$%&)D MY:L;$3.D_>]"&2L/O202RQUZ.)([]0"NPCO'A:!T4X6.5J<2(%8,(9C9>V;E M#%+=.TNAL@I-2]HG+M1,';&/1HN9CO;0^^R1L&$4RM/GFB:&1[/D,T`CI=DH MK$*J?N9(>3^[$C_0!#[7O+BVC$A,IF;O)>6T0(L/QH>E*,W].5?#06V:\_(W M$E'L[O)V?8^SM8"P*KQ7'Z!N5(5O6^:+M0-`C@0]$M>/A-91*:N=D[F MAJ^4<1NAF]I,)%:2$F1)>UHT%F&#FN5BHPA?7R+FR8UUR.Q=VR)FZ%D6Y@=4 MU_<>G:9AU6DJG^UYN%O=W*_.):_)*FY/?`AL+T0]4J=+LE@%%CT0=6%=VVKO MUD[%;4O;:&M.0B2S]]MRVZ"Z2^(%8K$;BK3[Q:J;)@[+Y5P_TWOOG#I9W,9_ M:CRT^=+LX8:X,8=J$4Q$5GE_>3%//UZ;#&N4.&]&MY.:+R=2"%$YLX\CR9BC MQ;>3`-;0F_3H[-5N1;W__N7^\B_?L7-Y^5>Y15R&I! M1;]'W;XB5JT=QUSOLE:I,Y+*H6\HQGAN]H:<6NFZI5`%:>`,0INLQNM7]=-7-:!R-K??Z* MG0=K@^$3M:W@]!\A8``"E.`0`5`!P`:&%S8RTR,#$Q,#8S,%]P&UL550)``-90V]. M64-O3G5X"P`!!"4.```$.0$``.U=W7.C.K)_OU7[/["Y+WO$GI'!'[TO.^*BJ+<>?\;?C7QS?BXO;N0\1LL"L?YPB!H@B78 M<.3O;\MIKB#D>W?$&?D-@@T?#0]R& MPO,_;?V_O4]T%1CA%YV//=:G;>SV)KCA[B[E;0(M&YJ&KCI`OU=-U=+`Z@T` MQZ9B3(.O=MV,+52$L7P##OD5:B[W*JJ!T96#_R2JMN>;^1X@3\644-H0ULSA M1+7?GDSX@Y9!;<.(P9GJN`C$(<.NLG)W.Q5]S#X5_>,>/\*,3<880T@BP!MZ(74OL42,>)L@2#&T_D@8>=WU]@3 MK5/QM$+&PZACQ\@Q5*^1E"4SB'3BV.!]4?)E[M!<9 M@G0)7Q(COH@54;)A.SHK$UHY4/L^WQ,76^!I@9(=R,K_)W"W,QPOHE).1OC[ MK*`!6\+($NPA(D&2#AN`6*DJ;KUKA+U-U>@C(P)[AQ5.[JL-?GS\\>`1L/Z6: M/O?@IP,L'>A^>AOR;T(M^):IO@+SRPW^X/_.#3I^M1V$]I`%.)-Q?$:_R8ORHH\3.,LMIJP@<9OX?N=#@QO]4'^<>LO;<3; MGNCQC3\Z&IB*O;A!C%'(Z@;!W478.C!'4(AP(H)7AS?<'AD0X8&Q^=UPKHU9 MA5[TC+)G%6D)"SM>"P7?N-M[R?>M]F:8^K'X^!M4FAEC;G7"\9.I;C''HY%2 MD6J.1FZ#;K)%#90C\8+0-OV$,B\`9@N+K3_@$$XL2QA4[$)'%-J@KWS1`[WU M6J@W7^`EV!I$3LN9J3N/]YY4D=K2"+1!:[F"!TKKMU9I$SP*4LTIGHU__A5\ M>,SW*M7:"87VJ.VY!;J;>(B,L238>/\ZS>@HGBP$"I271:1-FB/"H!` M@8,6*C`4/Q+@"7]B>QE450$S@T8;U$NUYT_7D0!5A6('&E-:JS%2[X*65X1;O>$Q M[;GK>#N-AK7U)*EJI9U/KCWZI`8E7)4+S>CWU[O4(E6!^I7$W7*'/23\[_C> M$A?LTW''.XCTQ:OJ_>I! M[MJW6U7=^X8+3,<./SFUX.!C*@;*E[G&MHW1B02118&9),>T*O&]4MHY5%Z85B7V7$`3H15G2]Q)6PV:.\(M>>RX^!/D8F()Z'BQ-U(D M=E,=/2=-V499L+HW-\9;2D*)1T-YP,PZ4@@V904YLC=5^6:J[P<7K&&LL^#( MT!6172J?3;@I]5-"T50AG:D93"W\"\!V3JP?RRWUF9E`.M&FU$\!05,E^(:3 M6E&^EJPV9;H>"".I3B%J,M](G)156IKL316O"]HN=%23WG8GKNW`'4`/8$\6 MLS'!%7;+L0RB3<4M"@R::K1@&K?FSAM`:?FYV!^Q6\MF4&U*^30@-+7U6)7V M"\!6L)R7'3I3@._>6B\F]@Q:VHGDHC2LI:25)%VU,UUN%>?AZ63]J#!^S!.L MRZOD>8+R(T'NUR)+,R9^-FD\$OY*,H9BV>()*M)`8E?T9+"'"FDF]A#,B'Z4I*(,4"PS.TMFN`=@_@U8FF>G[4D]C5O=-IMB10 MY`/2R6*XWP21GNRQLX0LJN53FO"L,CG1Z<0/+,^`PRN#OLQ,EG.4*[%M>A6% MMDP+1O?6=V%%Z!0S?M"7&&[L9%!M2/TT('1R`1?6!9\-VS/UGCA04NMBZ2=* M3WZ](>V=$Z*34]!*-8&]!NH.1ZJI86V0BB%R-7*C1RB_2*_$\Z,UI-,"(E[) M,K1$X3H1CD1)ZK$+RJDT&])_OOS=7(T&.76\RX2TES`LLJ90K'J!05,X/EU5 M9"'0O0PL+NEQ9TE\5364V3D^#0=-VD11A#J9JJ5BAZ461_5NP#0:'/(PZ&0N MX$^#IYN.Y')%QN6&REINR+5W.)$C?Y&5]3M.[BR\VG(F*D(?AK7]NVJZ@)?[ MZ6N/:AHR:%BH,-G)5==A]5(4F^[-@&%G]1)H``.`HSS.\<,NA?Z(87?A.NIMO^X%Y/CU\]$*6! MPJY,F$*Q$C_(:\6,Y=%G)>[>9!N[_"@H#XUZJ3N^U93.3JC5JMQSHG9SCM5U MP^=[@1>'4VNB[@T<+/D^RX)(!M%:-4TA>"<#]A(XJF$!_5%%EF%M[;&FN3O7 MV^5Z`!M#,T@/ICAD5P3-9Z!6.RB(QY4D/,5L(@,K-JEK58=D4KK"14EFV3W/ MJ%\^%_U#EU*.Q-=:#[G\TL(>_:6%W/\"BXQ3'VX[#\W&IY;,&#( MYL@CJ'OYU@(@[WY-7ND++%O":7BHQ+DONN6N.%;=6WP<8^!?OCIVG3+3$KP#RR47"XT&[!I`0RJ5."8M[M%^1E+$[E6%)M#&D2J0E1\( M#&]%.2+5B$HSA>UD5>,(HXI4*AL+%:$1KDWNP@0CXWUNK/X'] M8EB>Z.$[".1VEJ-1_"Z(%^"\09V<H2:[5W:00=ON$\96UTQ MO,8LBVHC,S<-!(V]4,UTFOT',+9O.*2-WW&.L@4S=_<*T'R3V(Z(7OR6&6[7 M%.6F$6.Y!++0B,1.&1'](HU-NE/-TC5C`O<3\V!`?CCTSR6RRMN.J%5BWF64 M<_J07IKT+2^BE\W8,N$B%YBQBWR99&NV`?H"3!R/;M;>R=4!2?'YD<+PE%<& MT::M@`*+[FV6KH!IDGGP1U5R,_\.268W;S02;=IBR`#HA.3@1?@87A,LE3\OK.L`P" ME6.\'R;"85]DU\N30[PIQ?^@!(I M%&E>T^<,.(?.,?+<0>K^;/J+#I3#MD;1%%)W!2R9,?&(T>NP5%06ZNPZZHL.QDP/*Z MH5]4M#6L(#WS,K)4^TG/0Y,C5*+SL_WH1[W%IY[(F$=#ECGTA(!J@P?@_SVU#JN)X+ZXR-,';/N@*/FXJ,7KA$;R>0A> M'O3Z=8J99*&JK?+2>HVU@Q7#J\U!X(*^L!,0PLGR)(FB`.\<2Q$25+8]804X*2] M-D4'7E>/LIP%(W@@8C@8"+4NA5*8:/&LGHM9R_<>*\\#'P*RJ2^3D:Q':2`[ M/,M4BZVK,*8M+R:6;G\%#BG_+!!\-W2@WW]\LX$^M8*[C;#?:8[Q[L7M6-,@ MPUM$BO-3/K7$1#0`=.__S=X!TI&X\*^BSO`^3AH=JVD$K M4'5T2V91Z-IQ^Q)Q MI)!8/G200[YIDSD;57,!ZV2])BL%F4$'A)4L?C00ZIJ&TSEHM>'0P-;)"LT% M@#*[!:&V:9F>%C^2_15UTT(W[46I=T:4`;'EUYZ4NU`B'E*.PH@BR^PV8;*H M-FTK9R-N%CPMKRZ5G*$/D\N#06"T=)M;!TM+\A`T/_ MDK-,#!E>_E6X:"&"J>X!7>`M3M<@M<.3>MSWY"J\,%8;; M0O2,L'2<8DH_=9R"(+:Y\MB`,]6:RS%Q)GI:)/=2VB!TT\Y$G<#F@=CRR:ED M`AL$EB>(XLG:(CCS_@["_<#>J(;D)8>+IDTI.RX7@:_E"6_%<3EJ8TC%E5V' M7G%^RH?EL?[_;G!=[1HN@09Q:FR"H\L5U[`H.KWAD-W1*!8B=K MM;3[+`KGLF(M0Z M<\C`H,V+LY*WB$4OQ!T.UD7P*`RO#CI'N1)[*"9:\4"09D7=,Y`+->>J]2**>5F1R=G;"H@V125+H[BJ0*1H<:63OXB5=)WU20+@@7` M^M)/NZ/)%?@]=@(68:6^2).LD)6&[$HZ&8O5R.A`9%(8J],CQC@4(O2!HY[W MECLO]_V-!#:24?%0HP\D2GO%06IY@V)@_'O/BS$HR*G:!=J9VE?A`FR>C6V9 M"R1?E2T,TG6T6_HN\&@5J&ZOW/W>]"!4S1#"J;6!:*<>O7\N*@P//U`RT>`: MI01,W>RRA):&Q8_69I9^6%-,,:X1E'U98M>?Q M%JJJH3]!%&U&"'+Z_7GI]Y\5IU"-890-GI1A)0^9[A72F.YLC3JUX9B*7_R* M?_QO$WAV:.GC'42.\2_5O^V_%W1_,`&$AH5*O*\>6TE[/($*V2MPSG>`7F'! M7:]WP\:LXXCT`-U79^.:X4TSO#*0F1[,R:3>*E^N]$*H'=#`_8<34S5V-E\7V%H5H58N4([*PWUM6\!M$P-9:YC MZN1:@"GN;)HXVY7AA<^X^6O+^&-^HBR)#(_?9Q)N?UA,]K=2HMCR&D[9EM;P M$1"@3^".B.UGKP-EP*Z/*9UF^VTGN6;/!>]*-@N+!6Z"'T&-Y`VJ">PU4'S!LS80V3K7Q#[/Q^MORD9L_ M^!6WUY>QLO?R/^LIE]GTZ?I9#Q;<^/)9/YMMI[.OG*+ M^?-T,GU<)JCK6H%&U/1,U'^IM4BAMI\$\P_JAF](!5-0A+#HW"5L%B^ ME$8>+K3GFS@EHI9SVEAC!=R;Y"X^L3]@^`S'):Q5$IH864\8K"J#_BJGM3Q^6,_+V:/H3AK7B\^@K)S@3.+`'RM(_7N4'<*AV.LH<\ MFMM272KCT/S;M^GBY7&V+NZ3X.E!*;242)X9*A""N5.'H)K<8:4LK!]DG=O)]85\S7CRMN M,?YM?/_\6&*%D'G=90&O)G>+1TQ%65A/8E<-2:=Y20?C:ZK-#<0>N\O",XA6 MXI2T2HD:#7,!^*0^)Y_ZW/-\/#OX'/YY^?@\7C\^X$_P?%O%?=@3P%S M#S.RDB^_DCSPY;U`=&AS#*+Q!-J.[35"OI)&R/"VV-CB1F:XXKR(MPM6IK1T M[^-TXU43F6&#TX7<5;/4K=AJ#DOB"I'_I,%&.0TVD_G+RW1-2M$E]H?(HV2& MWR19.L3$QB!W<4!OLP]89*LOM5S"\);%0JR4#R`Q,JE3HB2-V/7?GR=>B?M? MJ-%#2RP]3)_3F44AD3D\?B6>C%?_E\NP5^ZK#7YW,=G']XO2[-.!XLIG M>-PF@^H%T_')B/%V0$5@.`EGT:VH`YQ6.]&5430X=,P3@_\A?Y#2`?[DWU!+ M`P04````"``W/BT_GH(,8P4'``#-/0``$0`<`&AA'-D M550)``-90V].64-O3G5X"P`!!"4.```$.0$``.U;WW/:.!!^OYG['W1^NGL@ MAM"T32:TYQ"288[8'#8WS5-'V()X:DN.)"?PW]_*/\`X0"#Q34B/EQ;+VO7N MI\^[*VMS_G4:!NB!<.$SVM(:1W4-$>HRSZ>3EC:T:X;=[G8U)"2F'@X8)2V- M,NWKEU]_.?^M5NLWOUT,>K5:=IGI0CJ#D=\>#( M9>'\;L29%[O$0R!X7&\T:O7/M<8G]"=JU,^.3Y!QD\ZG:"J`;X(J00QI0RB26L83*4#4:1 M3\"5X!')-@2*9C[/T8JXD3`N[T+M4#DIP!,6>B`\4C] M&`ZZST:O!#`3RY@3:VR!Z0EJPJ">'88ELHVV-32=KGF-^E:OV^YV M['.]_)RR";$@GD6_)+]+42H3SF9L$ESHWTVN3-[M)>!,(AR1/UHME MHSFQ*N%;&Q@&_/&P)-X%#E0VM.\(D44VN6PDJB13O7X,_+$!V"3QP^^B%2@S M`Z5V'#BROQSI8[!&WA&I1$J$B3"OEC/-[3F#?E^R[(\#A_:`0V'H2[5TRY$% M1JO-4Z?E/-6V;FZZSDW'=`[Y9A]XL'AKYV^SL,9M+.ZN`O:XQ`[ACJN-(2>; M8LC"',3&2!F$$HL.K-E;UBRJY"7:,%8M;3YL3YN%10?:O#EM+ID;JY6!+50' MMDIRUJ5CQL/$YP)A/$PJ34+U=+.4/;SX$U,/I9:@@BD'IKPY4ZX9;*3AM78) MI^KM]KT5@64"6^YJBY7CG28]A"KN> M&1X%9$`"%?]AIR%G!9($$8\:U;+DI,R2GF68-NH;M\9%KP/7@T[/<#J7,#)P M;@\T>7.:F$R2YUER7"U+/C[Y0&2PI,(.R"%=+C`^KB#$/'PQ'ZE2L<"(B&-2+2.:94;T!^H;OG.;?+_O_#WL]M7WD@,U MWIP:Q?3A<"@^L%NN2CF)9*7T:#PYZEE*'<@90/5AM`\UZ7Y0Q"83%3`&)&)< M'0<6J"'`GFJI42]3P^Y*1 M(/Z@!,!Y;[!%67 MH!^JJ@#1E6V9ZYHATX[.'G,371M$U%4MEZNIH5KCN-9L'$V%ES=$[6C%G&<[ M6I'+O<2*,1:C1%TL:A.,(SUM>&V`CK5F)":L%-1)($4^4ENH>ADH3SM/M\&E M+*50.56H-#Z^UHQB,^MNIC!JOMR:(M1*G:AHD1)=+UFE(@=/DBM/;DW:7$`A M<;+;(P5QCR;L0?>(OS4$91GUX]7,5(N89AA*)FJ3NIWW`>=+4NO(H!+46=8: MGIC2TM21_!#"XQ7C[1BJ&2!3SQ?%C/9]_13J!X'ZU-;2)(]5-:QZP\]&:=]0 M2W,YI$Z9#T=`4^8Y2>NI%_/LP%!`)I6^C-75-6=QU-+2Z;XDH8;23M5T)&24 M2,QG7;BCU*QM8U_=^KT="#8.B'`(#@WJ=>F88P&NN:I_U"1R-2C/B/PT(!76 MOH1%^/!F1`WF$]\VB?<7?K(_'W5S=6OQBO\@\)!B2OMU;O7\^]C M'\+3;+'_*"ZJ.FYQR%1>!+`_+CB^FUCUD"1_070F\T?\![BL.;->\1(\/_6= MOP+K'%RL_4J*["+U#AFRYKAZ!4&>G?G.^;'&O\WTV$7H';(CZVBDD\XT(E00 M88@L0UACJ*`&Y('0N/C71]^WEGA?"6:I=O8WU-O/3?PY2DX[CJ)T``=Y]W:A MC%1#?>RK3<>*0/(2X7<36Y*/<>E>&*[^!5!+`0(>`Q0````(`#<^+3^XT=_$ M(E@``'-C`@`1`!@```````$```"D@0````!H87-C+3(P,3$P-C,P+GAM;%54 M!0`#64-O3G5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`#<^+3^0416G;`@` M`*Y;```5`!@```````$```"D@6U8``!H87-C+3(P,3$P-C,P7V-A;"YX;6Q5 M5`4``UE#;TYU>`L``00E#@``!#D!``!02P$"'@,4````"``W/BT_L\@%4X0Y M```+10,`%0`8```````!````I($H80``:&%S8RTR,#$Q,#8S,%]L86(N>&UL M550%``-90V].=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`-SXM/UJ^QX'R M%@``*4X!`!4`&````````0```*2!^YH``&AA`Q0````(`#<^+3^>@@QC M!0<``,T]```1`!@```````$```"D@3RR``!H87-C+3(P,3$P-C,P+GAS9%54 L!0`#64-O3G5X"P`!!"4.```$.0$``%!+!08`````!0`%`+\!``",N0`````` ` end XML 26 R5.htm IDEA: XBRL DOCUMENT v2.3.0.11

Consolidated Statements of Cash Flows (USD $)
6 Months Ended

Jun. 30, 2011

Jun. 30, 2010

Cash flows from operating activities:

Net loss $ 161,624 $ (261,837)

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:

Depreciation and Amortization 186,375 1,823,666

Stock based compensation 17,880 20,074

Sales team and infrastructure, net (1,635,045) (258,604)

Customer list (1,095,649)

Purchase price adjustment (20,328) 19,541

Changes in operating assets and liabilities:

Accounts receivable (80,478) 4,236

Prepaid expenses and other current assets (5,118) (16,405)

Inventory (2,306,038) 303,319

Other assets (37,599)

Net cash (used in) provided by operating activities (3,624,620) 1,633,990

Cash flows from investing activities:

Disposal (Purchase) of property and equipment (758,056) 11,691

Net cash used in investing activities (758,056) 11,691

Cash flows from financing activities:

Proceeds from note payable 4,147,491

Proceeds from sale of common stock 387,100 150,096

Repayments (proceeds) of notes payable 209,852 (1,563,778)

Net cash provided by financing activities 4,744,443 (1,413,682)

Net increase (decrease) in cash 361,767 231,999

Cash, Beginning of period 423 28,217

Cash, End of period 362,190 260,216

Cash Paid For:

Interest

Income taxes

Non-Cash transactions:

Vehicles acquired through financing $ 21,759

XML 27 R7.htm IDEA: XBRL DOCUMENT v2.3.0.11

GOING CONCERN CONSIDERATIONS
6 Months Ended

Jun. 30, 2011

GOING CONCERN CONSIDERATIONS [Abstract]

GOING CONCERN CONSIDERATIONS

NOTE 2 - GOING CONCERN CONSIDERATIONS

The accompanying consolidated financial statements are prepared assuming the Company will continue as a going concern. At June 30, 2011, the Company had an accumulated deficit of approximately $3.9 million. The ability of the Company to continue as a going concern is dependent upon increasing sales and obtaining additional capital and financing to support its recent acquisition. During the quarter ended June 30, 2011, the Company secured a working capital line of credit in the amount of $400,000. Management intends to attempt to raise additional funds by way of a public or private offering. While the Company believes in the viability of its strategy to increase sales volume and in its ability to raise additional funds, there can be no assurances to that effect.

X

- Definition

Going Concern Considerations Disclosure [Abstract].

+ Details

Name: hasc_GoingConcernConsiderationsAbstract

Namespace Prefix: hasc

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

If there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date), disclose: (a) pertinent conditions and events giving rise to the assessment of substantial doubt about the entity's ability to continue as a going concern for a reasonable period of time, (b) the possible effects of such conditions and events, (c) management's evaluation of the significance of those conditions and events and any mitigating factors, (d) possible discontinuance of operations, (e) management's plans (including relevant prospective financial information), and (f) information about the recoverability or classification of recorded asset amounts or the amounts or classification of liabilities.

+ Details

Name: hasc_LiquidityDisclosureGoingConcernNoteTextBlock

Namespace Prefix: hasc

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 28 R2.htm IDEA: XBRL DOCUMENT v2.3.0.11

Consolidated Balance Sheets (USD $)

Jun. 30, 2011

Dec. 31, 2010

CURRENT ASSETS

Cash and cash equivalents $ 362,190 $ 423

Accounts receivable, net 334,840 254,362

Inventory 2,382,394 76,356

Prepaid expenses and other current asset 23,963 18,845

Total Current Assets 3,103,387 349,986

LONG-TERM ASSETS:

Property and equipment, net 757,309 147,769

Sales Team and infrastructure, net 1,635,045

Customer List, net 1,095,649

Other 38,019 420

Total Assets 6,629,409 498,175

CURRENT LIABILITIES:

Accounts payable and accrued liabilities 1,753,877 612,282

Overdraft liabilities 46,023

Customer deposits 55,026

Notes payable 227,857 18,005

Other Liabilities 69,158 30,000

Total Current Liabilities 2,105,918 706,310

Long Term Debt 4,300,000 152,509

STOCKHOLDERS' EQUITY:

Preferred stock ($.001 par value; 3,000,000 shares authorized; none issued and outstanding)

Common stock, $.001 par value; 1,000,000,000 shares authorized; 757,586,910 and 746,436,909 shares issued and outstanding, respectively. 757,587 746,437

Additional paid in capital 3,611,432 3,217,602

Accumulated deficit (4,145,528) (4,324,683)

Total Stockholders' Equity (Deficit) 223,491 (360,644)

Total Liabilities and Stockholders' Deficit $ 6,629,409 $ 498,175

X

- Definition

Customer List, Net.

+ Details

Name: hasc_CustomerListNet

Namespace Prefix: hasc

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Sales Team And Iinfrastructure, Net.

+ Details

Name: hasc_SalesTeamAndIinfrastructureNet

Namespace Prefix: hasc

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 20
-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 19
-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19,20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 3
-Subparagraph a(1)
-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 4
-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.3-4)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 31
-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.30(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 7
-Section 03
-Paragraph 12

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Topic 210
-SubTopic 10
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
-Section S99
-Name Accounting Standards Codification
-Publisher FASB
-Paragraph 1

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Concepts (CON)
-Number 6
-Paragraph 25
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 18
-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.18)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6801-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Section 45
-SubTopic 10
-Topic 210
-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765
-Publisher FASB
-Name Accounting Standards Codification
-Paragraph 1

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 9
-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.9)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AssetsNoncurrentAbstract

Namespace Prefix: us-gaap

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Carrying value as of the balance sheet date of payments made in excess of existing cash balances, which will be honored by the bank but reflected as a loan to the entity. Overdrafts generally have a very short time frame for correction or repayment and are therefore more similar to short-term bank financing than trade financing.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=6743817&loc=d3e1243-112600

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 43
-Chapter 3
-Section A
-Paragraph 7
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Current Liabilities
-URI http://asc.fasb.org/extlink&oid=6509677

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_BankOverdrafts

Namespace Prefix: us-gaap

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits are not generally reported as cash and cash equivalents. Includes cash and cash equivalents associated with the entity's continuing operations. Excludes cash and cash equivalents associated with the disposal group (and discontinued operation).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 1
-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 95
-Paragraph 7
-Footnote 1
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3044-108585

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 95
-Paragraph 8, 9
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash
-URI http://asc.fasb.org/extlink&oid=6506951

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 95
-Paragraph 7, 26
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash Equivalents
-URI http://asc.fasb.org/extlink&oid=6507016

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The current portion of money or property received from customers which is either to be returned upon satisfactory contract completion or applied to customer receivables in accordance with the terms of the contract or the understandings.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CustomerDepositsCurrent

Namespace Prefix: us-gaap

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Carrying amount (lower of cost or market) as of the balance sheet date of inventories less all valuation and other allowances. Excludes noncurrent inventory balances (expected to remain on hand past one year or one operating cycle, if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 35
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6386567&loc=d3e3927-108312

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Total of all Liabilities and Stockholders' Equity items (or Partners' Capital, as applicable), including the portion of equity attributable to noncontrolling interests, if any.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 32
-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.32)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 7
-Section 03
-Paragraph 25

+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 21
-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.21)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year from the balance sheet date or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year (current maturities) or the normal operating cycle, if longer, and after deducting unamortized discount or premiums, if any.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 22
-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LongTermDebtNoncurrent

Namespace Prefix: us-gaap

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 19, 20
-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19,20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_NotesPayableCurrent

Namespace Prefix: us-gaap

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 17
-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.17)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_OtherAssetsNoncurrent

Namespace Prefix: us-gaap

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Aggregate carrying amount, as of the balance sheet date, of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered and of liabilities not separately disclosed in the balance sheet. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6911-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6904-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 20
-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 43
-Chapter 3
-Section A
-Paragraph 8
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 6
-Paragraph 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_OtherLiabilitiesCurrent

Namespace Prefix: us-gaap

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 129
-Paragraph 2, 3, 4, 5, 6, 7, 8
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 12
-Paragraph 10
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.28)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 5
-Section 02
-Paragraph 29

+ Details

Name: us-gaap_PreferredStockValue

Namespace Prefix: us-gaap

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The total of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer, and the aggregate carrying amount of current assets, as of the balance sheet date, not separately presented elsewhere in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 8
-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 43
-Section A
-Paragraph 4
-Chapter 3
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Section 45
-SubTopic 10
-Topic 210
-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765
-Publisher FASB
-Name Accounting Standards Codification
-Paragraph 1

+ Details

Name: us-gaap_PrepaidExpenseAndOtherAssetsCurrent

Namespace Prefix: us-gaap

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Tangible assets that are held by an entity for use in the production or supply of goods and services, for rental to others, or for administrative purposes and that are expected to provide economic benefit for more than one year; net of accumulated depreciation. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.13)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 7
-Section 03
-Paragraph 8

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 13
-Subparagraph a
-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 12
-Paragraph 5
-Subparagraph b, c
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The cumulative amount of the reporting entity's undistributed earnings or deficit.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.31(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 12
-Paragraph 10
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 31
-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3

+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph A3
-Appendix A

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30, 31
-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section E

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 4.E)
-URI http://asc.fasb.org/extlink&oid=6228006&loc=d3e74512-122707

+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 29 FilingSummary.xml IDEA: XBRL DOCUMENT 2.3.0.11 Html 9 85 1 false 0 0 false 3 true false R1.htm 001 - Document - Document and Entity Information Sheet http://www.hascomedicalinc.com/role/DocumentAndEntityInformation Document and Entity Information false false R2.htm 002 - Statement - Consolidated Balance Sheets Sheet http://www.hascomedicalinc.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets false false R3.htm 003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.hascomedicalinc.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) false false R4.htm 004 - Statement - Consolidated Statements of Operations Sheet http://www.hascomedicalinc.com/role/ConsolidatedStatementsOfOperations Consolidated Statements of Operations false false R5.htm 005 - Statement - Consolidated Statements of Cash Flows Sheet http://www.hascomedicalinc.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows false false R6.htm 101 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.hascomedicalinc.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingPolicies NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES false false R7.htm 102 - Disclosure - GOING CONCERN CONSIDERATIONS Sheet http://www.hascomedicalinc.com/role/GoingConcernConsiderations GOING CONCERN CONSIDERATIONS false false R8.htm 103 - Disclosure - PROPERTY AND EQUIPMENT Sheet http://www.hascomedicalinc.com/role/PropertyAndEquipment PROPERTY AND EQUIPMENT false false R9.htm 104 - Disclosure - NOTES PAYABLE Notes http://www.hascomedicalinc.com/role/NotesPayable NOTES PAYABLE false false R10.htm 105 - Disclosure - LOANS PAYABLE - RELATED PARTY Sheet http://www.hascomedicalinc.com/role/LoansPayableRelatedParty LOANS PAYABLE - RELATED PARTY false false R11.htm 107 - Disclosure - EQUITY Sheet http://www.hascomedicalinc.com/role/Equity EQUITY false false R12.htm 108 - Disclosure - STOCK OPTION PLAN Sheet http://www.hascomedicalinc.com/role/StockOptionPlan STOCK OPTION PLAN false false R13.htm 109 - Disclosure - COMMITMENTS Sheet http://www.hascomedicalinc.com/role/Commitments COMMITMENTS false false R14.htm 110 - Disclosure - SEGMENT REPORTING Sheet http://www.hascomedicalinc.com/role/SegmentReporting SEGMENT REPORTING false false R15.htm 111 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.hascomedicalinc.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS false false All Reports Book All Reports Process Flow-Through: 002 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Jun. 30, 2010' Process Flow-Through: Removing column 'Dec. 31, 2009' Process Flow-Through: 003 - Statement - Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 004 - Statement - Consolidated Statements of Operations Process Flow-Through: 005 - Statement - Consolidated Statements of Cash Flows hasc-20110630.xml hasc-20110630.xsd hasc-20110630_cal.xml hasc-20110630_lab.xml hasc-20110630_pre.xml true true EXCEL 30 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\R9C1F,S,W85\T-F4T7S1E93!?86-D-%\W-39B M-C`T-#8V-F$B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-%1TU%3E1?4D503U)424Y'/"]X.DYA;64^#0H@("`@/'@Z5V]R M:W-H965T4V]U#I%>&-E;%=O#I7;W)K#I3='EL97-H965T($A2 M968],T0B5V]R:W-H965T3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\R9C1F,S,W85\T-F4T7S1E93!?86-D-%\W M-39B-C`T-#8V-F$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,F8T M9C,S-V%?-#9E-%\T964P7V%C9#1?-S4V8C8P-#0V-C9A+U=O'0O:'1M;#L@8VAA2!);F9O2!296=I2!#96YT3PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^,#`P,3$S,38W-3QS<&%N/CPO M'0^+2TQ,BTS,3QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$2!#;VUM;VX@4W1O8VLL(%-H87)E'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA3PO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!A;F0@ M97%U:7!M96YT+"!N970\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6%B;&4@86YD(&%C M8W)U960@;&EA8FEL:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\R9C1F,S,W85\T-F4T7S1E93!?86-D-%\W-39B-C`T M-#8V-F$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,F8T9C,S-V%? M-#9E-%\T964P7V%C9#1?-S4V8C8P-#0V-C9A+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'!E;G-E'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\R9C1F,S,W85\T-F4T7S1E93!?86-D-%\W-39B-C`T M-#8V-F$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,F8T9C,S-V%? M-#9E-%\T964P7V%C9#1?-S4V8C8P-#0V-C9A+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M2`H=7-E9"!I;BD@;W!EF%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XQ.#8L,S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'!E;G-E3PO=&0^#0H@("`@("`@(#QT9"!C M;&%S2!A;F0@97%U M:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@W-3@L,#4V M*3QS<&%N/CPO6%B;&4\+W1D/@T*("`@("`@("`\ M=&0@8VQA&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#L\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$"<^/'-T"<^)FYB"<^/'-T6QE/3-$)TU!4D=)3CH@,'!X)SY( M05-#3R!-961I8V%L+"!);F,N("@B2$%30T\B(&]R('1H92`B0V]M<&%N>2(I M+"!F;W)M97)L>2!"0D,@1W)A<&AI8W,@;V8@4&%L;2!"96%C:"!);F,L('=A M6QE/3-$ M)TU!4D=)3CH@,'!X)SY/;B!-87D@,3(L(#(P,#DL($A!4T-/(&-O;7!L971E M9"!T:&4@86-Q=6ES:71I;VX@;V8@4V]U=&AE2P@26YC+B`H4TU-(BD@<'5R2UO=VYE9"!S=6)S:61I87)Y(&]F('1H92!#;VUP M86YY+B!5;F1E2P@26YC+BP@ M86YD(%-O=71H97)N($UE9&EC86P@)F%M<#L@36]B:6QI='DL($EN8RX@8F5C M86UE(&$@=VAO;&QY+6]W;F5D('-U8G-I9&EA6QE/3-$)TU!4D=)3CH@,'!X)SY!9G1E&EM871E M;'D@.38N-24L('=E2!(05-#3R!(;VQD:6YG2P@26YC+CPO<#X@/'`@6QE/3-$)TU!4D=)3CH@,'!X)SY0 M2!W87,@82!S:&5L;"!C M;VUP86YY('=I=&@@;F\@8G5S:6YE6QE/3-$)TU!4D=)3CH@,'!X)SX\8G(@+SX@/"]P/B`\<"!S='EL93TS1"=- M05)'24XZ(#!P>"<^4V]U=&AE2P@ M26YC+B!P2!O9B!T:&4@6]R6QE M/3-$)TU!4D=)3CH@,'!X)SX\8G(@+SX@/"]P/B`\<"!S='EL93TS1"=-05)' M24XZ(#!P>"<^1F]R(&%C8V]U;G1I;F<@<'5R<&]S97,L($A!4T-/($UE9&EC M86PL($EN8RX@:&%S(&%C8V]U;G1E9"!F;W(@=&AE('1R86YS86-T:6]N(&%S M(&$@2!A2!I;G1A;F=I8FQE(&%S6QE/3-$)TU!4D=)3CH@,'!X)SXF;F)S<#L\+W`^(#QP('-T>6QE/3-$)TU! M4D=)3CH@,'!X)SY4:&4@365R9V5R('=A28C,SD[28C,SD[6QE/3-$)TU!4D=)3CH@,'!X)SX\8G(@+SX@ M/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P>"<^06QL(')E9F5R96YC97,@ M=&\@8V]M;6]N('-T;V-K+"!S:&%R92!A;F0@<&5R('-H87)E(&%M;W5N=',@ M:&%V92!B965N(')E=')O86-T:79E;'D@"<^)FYB"<^3VX@36%Y(#$S+"`R,#$Q($AA2!&'!E2P@37(N($-O;FYO2!PF5S(&EN(')E;G1I;F<@8V]N=F5R"<^/&)R("\^(#PO<#X@/'`@2!E M<75I<&UE;G0@=&\@9')I=F4@87,@=V5L;"!A2!T;R!-;V)I;&ET>2!&2!A M(&9E9&5R86P@;W(@&%M<&QE+"!A<'!R M;WAI;6%T96QY(#0U)2!O9B!-;V)I;&ET>2!&2!H879E(&5A2!&2!&6QE/3-$)TU!4D=)3CH@,'!X M)SX\8G(@+SX@/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P>"<^36]B:6QI M='D@1G)E961O;2!P2!S;VQU=&EO;G,@=&\@:71S M(&-L:65N="!B87-E('=I=&@@9&ES86)I;&ET:65S('1H"<^/&)R("\^(#PO<#X@/'1A8FQE('-T>6QE/3-$)TU! M4D=)3BU43U`Z(#!P>#L@1D].5"U325I%.B`Q,'!T)R!C96QL#L@34%21TE..B`P<'@[(%!!1$1)3D"<^)F)U;&P[ M/"]P/B`\+W1D/B`\=&0@6QE/3-$)TU!4D=)3CH@,'!X M)SY4:&4@0G)A=6X@0V]R<&]R871I;VXL('=H:6-H(&]F9F5R2P@=&AE(%1O>6]T82!3:65N;F$@86YD('1H92!(;VYD82!/9'ES#L@34%21TE..B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU,1494.B`P<'@[ M(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>"<^("9N8G-P M.SPO<#X@/"]T9#X@/'1D('-T>6QE/3-$)TU!4D=)3BU43U`Z(#!P>"<@=F%L M:6=N/3-$=&]P('=I9'1H/3-$-C#L@4$%$1$E.1RU,1494.B`P<'@[(%!! M1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>"<^("9N8G-P.SPO M<#X@/"]T9#X@/"]T#L@34%21TE..B`P<'@[(%!!1$1)3D"<^)F)U;&P[/"]P/B`\+W1D/B`\=&0@6QE/3-$ M)TU!4D=)3CH@,'!X)SY686YT86=E($UO8FEL:71Y($EN=&5R;F%T:6]N86P[ M(&%N9#PO<#X@/"]T9#X@/"]T#L@34%21TE..B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU,1494 M.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>"<^ M("9N8G-P.SPO<#X@/"]T9#X@/'1D('-T>6QE/3-$)TU!4D=)3BU43U`Z(#!P M>"<@=F%L:6=N/3-$=&]P('=I9'1H/3-$-C#L@4$%$1$E.1RU,1494.B`P M<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>"<^("9N M8G-P.SPO<#X@/"]T9#X@/"]T#L@34%21TE..B`P<'@[(%!!1$1)3D"<^)F)U;&P[/"]P/B`\+W1D/B`\=&0@6QE/3-$)TU!4D=)3CH@,'!X)SY%;$1O2X\+W`^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#QP M('-T>6QE/3-$)TU!4D=)3CH@,'!X)SX\8G(@+SX@/"]P/B`\<"!S='EL93TS M1"=-05)'24XZ(#!P>"<^5&AEF4@=F%N2!I;F-L=61E(&QO=V5R:6YG('1H92!F;&]O2!O"<^/&)R("\^(#PO<#X@/'`@ M7-T96US('1O('-E8W5R92!T:&4@=VAE96QC:&%I M6QE/3-$)TU!4D=)3CH@,'!X)SX\8G(@+SX@/"]P M/B`\<"!S='EL93TS1"=-05)'24XZ(#!P>"<^1$%%(&EN2!- M;V)I;&ET>2!&7-I8V%L(&QI M;6ET871I;VYS+B!4:&4@97%U:7!M96YT+"!T:&4@8V]S="!O9B!W:&EC:"!I M;B!C97)T86EN(&-I"<^ M/&)R("\^(#PO<#X@/'1A8FQE('-T>6QE/3-$)TU!4D=)3BU43U`Z(#!P>#L@ M1D].5"U325I%.B`Q,'!T)R!C96QL#L@34%21TE..B`P M<'@[(%!!1$1)3D"<^)F)U;&P[/"]P/B`\+W1D/B`\=&0@ M6QE/3-$)TU!4D=)3CH@,'!X)SYH86YD(&-O;G1R;VQS M.SPO<#X@/"]T9#X@/"]T#L@34%21TE..B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU,1494.B`P M<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>"<^("9N M8G-P.SPO<#X@/"]T9#X@/'1D('-T>6QE/3-$)TU!4D=)3BU43U`Z(#!P>"<@ M=F%L:6=N/3-$=&]P('=I9'1H/3-$-C#L@4$%$1$E.1RU,1494.B`P<'@[ M(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>"<^("9N8G-P M.SPO<#X@/"]T9#X@/"]T#L@34%21TE..B`P<'@[(%!!1$1)3D"<^)F)U;&P[/"]P/B`\+W1D/B`\=&0@6QE M/3-$)TU!4D=)3CH@,'!X)SYS<&EN;F5R(&MN;V(@=&\@86ED(&EN('1U#L@34%2 M1TE..B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D#L@ M4$%$1$E.1RU43U`Z(#!P>"<^("9N8G-P.SPO<#X@/"]T9#X@/'1D('-T>6QE M/3-$)TU!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$=&]P('=I9'1H/3-$-C#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D#L@4$%$ M1$E.1RU43U`Z(#!P>"<^("9N8G-P.SPO<#X@/"]T9#X@/"]T#L@34%2 M1TE..B`P<'@[(%!!1$1)3D"<^)F)U;&P[/"]P/B`\+W1D M/B`\=&0@6QE/3-$)TU!4D=)3CH@,'!X)SYA('1R86YS M9F5R('-E870[/"]P/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=- M05)'24XM5$]0.B`P<'@G('9A;&EG;CTS1'1O<"!W:61T:#TS1#(T/B`\<"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,'!X.R!-05)'24XZ(#!P>#L@4$%$ M1$E.1RU,1494.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU4 M3U`Z(#!P>"<^("9N8G-P.SPO<#X@/"]T9#X@/'1D('-T>6QE/3-$)TU!4D=) M3BU43U`Z(#!P>"<@=F%L:6=N/3-$=&]P('=I9'1H/3-$,C0^(#QP('-T>6QE M/3-$)U!!1$1)3D#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@ M,'!X)SX@)FYB6QE/3-$ M)U!!1$1)3D#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X M)SX@)FYB#L@4$%$ M1$E.1RU,1494.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU4 M3U`Z(#!P>"<^("9N8G-P.SPO<#X@/"]T9#X@/'1D('-T>6QE/3-$)TU!4D=) M3BU43U`Z(#!P>"<@=F%L:6=N/3-$=&]P('=I9'1H/3-$,C0^(#QP('-T>6QE M/3-$)TU!4D=)3CH@,'!X)SXF8G5L;#L\+W`^(#PO=&0^(#QT9"!S='EL93TS M1"=-05)'24XM5$]0.B`P<'@G('9A;&EG;CTS1'1O<"!W:61T:#TS1#8W,CX@ M/'`@#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>"<^("9N8G-P.SPO<#X@/"]T9#X@/'1D('-T M>6QE/3-$)TU!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$=&]P('=I9'1H/3-$ M,C0^(#QP('-T>6QE/3-$)U!!1$1)3D#L@4$%$1$E.1RU224=(5#H@,'!X.R!0 M041$24Y'+51/4#H@,'!X)SX@)FYB6QE/3-$)U!!1$1)3D#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$ M24Y'+51/4#H@,'!X)SX@)FYB#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>"<^("9N8G-P.SPO<#X@/"]T9#X@/'1D('-T M>6QE/3-$)TU!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$=&]P('=I9'1H/3-$ M,C0^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X)SXF8G5L;#L\+W`^(#PO=&0^ M(#QT9"!S='EL93TS1"=-05)'24XM5$]0.B`P<'@G('9A;&EG;CTS1'1O<"!W M:61T:#TS1#8W,CX@/'`@6QE/3-$)TU!4D=)3CH@,'!X)SY-;V)I;&ET>2!&6QE/3-$)TU!4D=) M3CH@,'!X)SX\8G(@+SX@/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P>"<^ M36]B:6QI='D@1G)E961O;2!H87,@9F]U2!&6QE/3-$)TU!4D=)3BU43U`Z(#!P>"<@ M=F%L:6=N/3-$=&]P('=I9'1H/3-$,C0^(#QP('-T>6QE/3-$)U!!1$1)3D#L@ M4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X)SX@)FYB6QE/3-$)TU!4D=)3BU43U`Z(#!P M>"<@=F%L:6=N/3-$=&]P('=I9'1H/3-$-C"<^86X@;VQD97(@86YD(&%G:6YG('!O<'5L871I;VX[/"]P/B`\ M+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=-05)'24XM5$]0.B`P<'@G M('9A;&EG;CTS1'1O<"!W:61T:#TS1#(T/B`\<"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,'!X.R!-05)'24XZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[ M(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>"<^("9N8G-P M.SPO<#X@/"]T9#X@/'1D('-T>6QE/3-$)TU!4D=)3BU43U`Z(#!P>"<@=F%L M:6=N/3-$=&]P('=I9'1H/3-$,C0^(#QP('-T>6QE/3-$)U!!1$1)3D#L@4$%$ M1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X)SX@)FYB6QE/3-$)U!!1$1)3D#L@4$%$1$E. M1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X)SX@)FYB#L@4$%$1$E.1RU,1494.B`P<'@[ M(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>"<^("9N8G-P M.SPO<#X@/"]T9#X@/'1D('-T>6QE/3-$)TU!4D=)3BU43U`Z(#!P>"<@=F%L M:6=N/3-$=&]P('=I9'1H/3-$,C0^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X M)SXF8G5L;#L\+W`^(#PO=&0^(#QT9"!S='EL93TS1"=-05)'24XM5$]0.B`P M<'@G('9A;&EG;CTS1'1O<"!W:61T:#TS1#8W,CX@/'`@#L@4$%$1$E.1RU,1494.B`P<'@[ M(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>"<^("9N8G-P M.SPO<#X@/"]T9#X@/'1D('-T>6QE/3-$)TU!4D=)3BU43U`Z(#!P>"<@=F%L M:6=N/3-$=&]P('=I9'1H/3-$,C0^(#QP('-T>6QE/3-$)U!!1$1)3D#L@4$%$ M1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X)SX@)FYB6QE/3-$)U!!1$1)3D#L@4$%$1$E. M1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X)SX@)FYB#L@4$%$1$E.1RU,1494.B`P<'@[ M(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>"<^("9N8G-P M.SPO<#X@/"]T9#X@/'1D('-T>6QE/3-$)TU!4D=)3BU43U`Z(#!P>"<@=F%L M:6=N/3-$=&]P('=I9'1H/3-$,C0^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X M)SXF8G5L;#L\+W`^(#PO=&0^(#QT9"!S='EL93TS1"=-05)'24XM5$]0.B`P M<'@G('9A;&EG;CTS1'1O<"!W:61T:#TS1#8W,CX@/'`@2!V971E2!T:&4@;F5W($]R;&%N9&\@5D$@365D:6-A M;"!#96YT97(@:7,@=6YD97(@8V]N2X@)FYB2!A;F0@861M:6YI M2!O9B!#96YT M2!O9B!&;&]R:61A($%C861E;6EC M(&%N9"!297-E87)C:"!#96YT97(@86YD($YE;6]U6QE/3-$)TU!4D=)3CH@,'!X)SX\8G(@+SX@/"]P/B`\<"!S='EL93TS M1"=-05)'24XZ(#!P>"<^36]B:6QI='D@1G)E961O;28C,SD[2!&'!E8W0@=&AA="!-;V)I;&ET>2!&6QE/3-$)TU!4D=)3CH@,'!X)SY(:7-T M;W)I8V%L;'DL(&]U6QE M/3-$)TU!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$=&]P('=I9'1H/3-$,C0^ M(#QP('-T>6QE/3-$)U!!1$1)3D#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$ M24Y'+51/4#H@,'!X)SX@)FYB6QE/3-$)TU!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$=&]P('=I9'1H/3-$ M-C"<^36]B:6QI='D@1G)E961O M;2P@:6YC;'5D:6YG(&ET6QE/3-$)TU!4D=)3BU43U`Z(#!P>"<@=F%L M:6=N/3-$=&]P('=I9'1H/3-$,C0^(#QP('-T>6QE/3-$)U!!1$1)3D#L@4$%$ M1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X)SX@)FYB#L@34%21TE..B`P<'@[(%!!1$1)3D#L@34%21TE..B`P<'@[(%!!1$1)3D6QE/3-$)TU!4D=)3BU43U`Z(#!P>"<@=F%L M:6=N/3-$=&]P('=I9'1H/3-$,C0^(#QP('-T>6QE/3-$)U!!1$1)3D#L@4$%$ M1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X)SX@)FYB6QE/3-$)TU!4D=)3BU43U`Z(#!P>"<@ M=F%L:6=N/3-$=&]P('=I9'1H/3-$-C"<^4V]U=&AE2!L;V-A=&5D M(&EN($UO8FEL92!!;&%B86UA+CPO<#X@/"]T9#X@/"]T6QE M/3-$)TU!4D=)3CH@,'!X)SY/=7(@;V)J96-T:79E(&ES('1O(&-O;G1I;G5E M('1O(&=R;W<@8F]T:"!I;G1R:6YS:6-A;&QY(&%N9"!T:')O=6=H(&%C<75I M2!O9F9E2X@07,@36]B:6QI='D@1G)E961O;2!I"<^/&)R("\^(#PO<#X@/'`@"<^/&)R("\^(#PO<#X@/'`@6QE/3-$ M)TU!4D=)3CH@,'!X)SY4:&4@86-C;VUP86YY:6YG('5N875D:71E9"!C;VYS M;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',@:&%V92!B965N('!R97!A M2!54R!'04%0(&9O2(L(")W92(L(")U M&-H86YG92!#;VUM:7-S:6]N("AT:&4@(D-O;6UI2!T"<^/&)R("\^(#PO M<#X@/'`@6QE/3-$)TU!4D=)3CH@,'!X)SX\8G(@+SX@ M/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P>"<^5&AE('!R97!A2P@=&AE('5S969U;"!L:69E(&]F('!R;W!E"<^/&)R("\^(#PO<#X@/'`@6QE/3-$)TU!4D=)3CH@,'!X)SX\8G(@+SX@/"]P/B`\<"!S='EL93TS1"=- M05)'24XZ(#!P>"<^0V5R=&%I;B!A;6]U;G1S(&EN('1H92`R,#$P(&-O;G-O M;&ED871E9"!F:6YA;F-I86P@6QE/3-$)TU!4D=)3CH@,'!X)SX\96T^1F%I M6QE/3-$ M)TU!4D=)3CH@,'!X)SY%9F9E8W1I=F4@2F%N=6%R>29N8G-P.S$L(#(P,#@L M('1H92!#;VUP86YY(&%D;W!T960@1D%30B!!4T,@.#(P+"`B1F%I"<^/&)R("\^ M(#PO<#X@/'`@F4@=&AE('5S M92!O9B!O8G-EF4@=&AE('5S92!O M9B!U;F]BF5D(&)E;&]W.CPO<#X@/'`@"<^)FYB6QE M/3-$)TU!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$=&]P('=I9'1H/3-$,C0^ M(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X)SXF;F)S<#L\+W`^(#PO=&0^(#QT M9"!S='EL93TS1"=-05)'24XM5$]0.B`P<'@G('9A;&EG;CTS1'1O<"!W:61T M:#TS1#"<^)FYB6QE/3-$)TU!4D=)3CH@,'!X)SXF;F)S M<#L\+W`^(#PO=&0^(#PO='(^(#QT6QE/3-$)TU!4D=)3BU4 M3U`Z(#!P>"<@=F%L:6=N/3-$=&]P('=I9'1H/3-$,C0^(#QP('-T>6QE/3-$ M)TU!4D=)3CH@,'!X)SXF;F)S<#L\+W`^(#PO=&0^(#QT9"!S='EL93TS1"=- M05)'24XM5$]0.B`P<'@G('9A;&EG;CTS1'1O<"!W:61T:#TS1#"<^3&5V96PF;F)S<#LR.CPO<#X@/"]T9#X@ M/'1D('-T>6QE/3-$)TU!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$=&]P('=I M9'1H/3-$-C(T/B`\<"!S='EL93TS1"=-05)'24XZ(#!P>"<^3V)S97)V86)L M92!M87)K970M8F%S960@:6YP=71S(&]R('5N;V)S97)V86)L92!I;G!U=',@ M=&AA="!A"<^)FYB6QE/3-$)TU!4D=) M3BU43U`Z(#!P>"<@=F%L:6=N/3-$=&]P('=I9'1H/3-$-C(T/B`\<"!S='EL M93TS1"=-05)'24XZ(#!P>"<^)FYB"<^)FYB6QE M/3-$)TU!4D=)3CH@,'!X)SX\8G(@+SX@/"]P/B`\<"!S='EL93TS1"=-05)' M24XZ(#!P>"<^0V%S:"!A;F0@8V%S:"!E<75I=F%L96YT2X\+W`^(#QP('-T>6QE M/3-$)TU!4D=)3CH@,'!X)SX\8G(@+SX@/"]P/B`\<"!S='EL93TS1"=-05)' M24XZ(#!P>"<^26X@861D:71I;VXL($9!4T(@05-#(#@R-2TQ,"TR-2!&86ER M(%9A;'5E($]P=&EO;B!W87,@969F96-T:79E(&9O'!A;F1S(&]P<&]R='5N:71I97,@ M=&\@=7-E(&9A:7(@=F%L=64@;65A2!F:6YA;F-I86P@:6YS=')U;65N=',@86YD(&-E6QE/3-$)TU! M4D=)3CH@,'!X)SY4:&4@8V%R2!N;W1E+"!A<'!R;WAI;6%T960@9F%I2!O9B!T:&5S92!I;G-T6QE/3-$)TU!4D=)3CH@,'!X)SX\96T^4F5V96YU92!2 M96-O9VYI=&EO;B!A;F0@0V]N8V5N=')A=&EO;B!O9B!#"<^/&)R("\^ M(#PO<#X@/'`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`U+3$P+5,Y.2`B4F5V M96YU92!296-O9VYI=&EO;B!/=F5R86QL("T@4T5#($UA=&5R:6%L&ES=',L('-E2!I"<^/&)R M("\^(#PO<#X@/'`@65T(&)E96X@9V5N97)A=&5D(&)Y('1H92!B:6QL:6YG('-Y2!P97)F;W)M2!A2!P87EO2!P87EO2!R97-P;VYS:6)L M92X\+W`^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X)SX\8G(@+SX@/"]P/B`\ M<"!S='EL93TS1"=-05)'24XZ(#!P>"<^5&AE($-O;7!A;GD@<&5R9F]R;7,@ M86YA;'ES97,@=&\@979A;'5A=&4@=&AE(&YE="!R96%L:7IA8FQE('9A;'5E M(&]F(&%C8V]U;G1S(')E8V5I=F%B;&4N(%-P96-I9FEC86QL>2P@=&AE($-O M;7!A;GD@8V]N2!A;F0@=&AI28C,SD[6QE M/3-$)TU!4D=)3CH@,'!X)SX\96T^0V%S:"!A;F0@0V%S:"!%<75I=F%L96YT M"<^/&)R("\^(#PO M<#X@/'`@2!O9B!T:')E92!M;VYT:',@;W(@ M;&5S2!P;&%C M97,@:71S(&-A2!T:&4@1F5D97)A;"!$ M97!O2!T:&4@"<^/&)R("\^(#PO<#X@ M/'`@"<^/&)R("\^(#PO<#X@/'`@6%B;&4N(%1H92!#;VUP86YY)B,S.3MS(&EN=F5S=&UE;G0@<&]L:6-Y(&ES M('1O(&EN=F5S="!I;B!L;W<@6QE/3-$)TU!4D=)3CH@,'!X)SY4:&4@0V]M<&%N M>2!P97)F;W)M'!E8W1A M=&EO;G,N/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P>"<^/&)R("\^(#PO M<#X@/'`@"<^)FYB"<^06-C;W5N M=',@2!C;VYS:7-T2!R96-O2X@ M36%N86=E;65N="!P97)F;W)M2!A;F0@=&AE(')E:6UB M=7)S96UE;G0@96YV:7)O;FUE;G0@:6X@=VAI8V@@=&AE($-O;7!A;GD@;W!E M2P@=&AE(&-O;7!L M97AI='D@86YD('5N8V5R=&%I;G1Y(&]F(')E:6UB=7)S96UE;G0@86UO=6YT M2!R97-U;'0@:6X@861J=7-T;65N=',@=&\@86UO=6YT7!I8V%L;'D@:61E M;G1I9FEE9"!A;F0@6QE/3-$)TU!4D=)3CH@,'!X)SXF;F)S<#L\+W`^(#QP('-T>6QE M/3-$)TU!4D=)3CH@,'!X)SY-86YA9V5M96YT('!EF%T:6]N M(&1A=&$L(&%C8V]U;G1S(')E8V5I=F%B;&4@86=I;F<@=')E;F1S+"!A;F0@ M;W1H97(@;W!E"<^/&)R("\^(#PO<#X@/'`@"<^/&)R("\^(#PO<#X@ M/'`@2!M86IO2!A6QE/3-$)TU!4D=)3CH@ M,'!X)SX\8G(@+SX@/"]P/B`\=&%B;&4@6QE/3-$)TU!4D=)3BU4 M3U`Z(#!P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.3X@/'`@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!-05)'24XM5$]0 M.B`P<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P,SX@/'`@'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)TU!4D=)3BU43U`Z(#!P>"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,34^(#QP('-T>6QE/3-$)TU!4D=) M3CH@,'!X)SXF;F)S<#L\+W`^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9#L@34%21TE.+51/4#H@,'!X)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,30^(#QP('-T>6QE/3-$)TU!4D=) M3CH@,'!X.R!T97AT+6%L:6=N.B!C96YT97(G/CQS=')O;F<^1&5C96UB97(@ M,S$L/"]S=')O;F<^/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P>#L@=&5X M="UA;&EG;CH@8V5N=&5R)SX@/'-T"<^)FYB6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8[($U!4D=)3BU43U`Z M(#!P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.3X@/'`@6QE/3-$)T)! M0TM'4D]53D0M0T],3U(Z("-F9F9F9F8[($U!4D=)3BU43U`Z(#!P>"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`S/B`\<"!S='EL93TS1"=-05)'24XZ M(#!P>"<^)FYB6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z M("-F9F9F9F8[($U!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,3$T/B`\<"!S='EL93TS1"=-05)'24XZ(#!P>"<^)FYB"<^)FYB"`P<'@@,'!X(#$W<'@G/B!-961I8V%R93PO<#X@/"]T9#X@/'1D('-T>6QE M/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F,V8S9C,[($U!4D=)3BU43U`Z(#!P M>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.3X@/'`@6QE/3-$)T)!0TM' M4D]53D0M0T],3U(Z("-F,V8S9C,[($U!4D=)3BU43U`Z(#!P>"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,3`S/B`\<"!S='EL93TS1"=-05)'24XZ(#!P M>"`R,W!X(#!P>"`P<'@[('1E>'0M86QI9VXZ(')I9VAT)SXR,RXX)3PO<#X@ M/"]T9#X@/'1D('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F,V8S9C,[ M($U!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,34^ M(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X)SXF;F)S<#L\+W`^(#PO=&0^(#QT M9"!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B`C9C-F,V8S.R!-05)'24XM M5$]0.B`P<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q-#X@/'`@"`P<'@@,'!X.R!T97AT+6%L:6=N.B!R M:6=H="<^,S8N-B4\+W`^(#PO=&0^(#QT9"!S='EL93TS1"="04-+1U)/54Y$ M+4-/3$]2.B`C9C-F,V8S.R!-05)'24XM5$]0.B`P<'@G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#<^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X)SXF;F)S M<#L\+W`^(#PO=&0^(#PO='(^(#QT6QE/3-$)T)!0TM'4D]5 M3D0M0T],3U(Z("-F9F9F9F8[($U!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$ M=&]P('=I9'1H/3-$,C@S/B`\<"!S='EL93TS1"=415A4+4E.1$5.5#H@+3$W M<'@[($U!4D=)3CH@,'!X(#!P>"`P<'@@,3=P>"<^($UE9&EC86ED+T]T:&5R M($=O=F5R;FUE;G0\+W`^(#PO=&0^(#QT9"!S='EL93TS1"=-05)'24XM5$]0 M.B`P<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#D^(#QP('-T>6QE/3-$ M)TU!4D=)3CH@,'!X)SXF;F)S<#L\+W`^(#PO=&0^(#QT9"!S='EL93TS1"=- M05)'24XM5$]0.B`P<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P,SX@ M/'`@"`P<'@@,'!X.R!T97AT+6%L M:6=N.B!R:6=H="<^,C`N,B4\+W`^(#PO=&0^(#QT9"!S='EL93TS1"=-05)' M24XM5$]0.B`P<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$U/B`\<"!S M='EL93TS1"=-05)'24XZ(#!P>"<^)FYB6QE/3-$)TU!4D=)3CH@,'!X(#(S<'@@,'!X(#!P>#L@ M=&5X="UA;&EG;CH@6QE/3-$)TU!4D=)3CH@,'!X)SXF;F)S<#L\+W`^(#PO=&0^(#PO M='(^(#QT6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F,V8S M9C,[($U!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$=&]P('=I9'1H/3-$,C@S M/B`\<"!S='EL93TS1"=415A4+4E.1$5.5#H@+3$W<'@[($U!4D=)3CH@,'!X M(#!P>"`P<'@@,3=P>"<^4')I=F%T92!);G-U6QE/3-$)TU!4D=)3CH@,'!X)SXF;F)S<#L\+W`^(#PO=&0^(#QT9"!S M='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9#L@0D%# M2T=23U5.1"U#3TQ/4CH@(V8S9C-F,SL@34%21TE.+51/4#H@,'!X)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q,#,^(#QP('-T>6QE/3-$)TU!4D=)3CH@ M,'!X(#(S<'@@,'!X(#!P>#L@=&5X="UA;&EG;CH@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED M.R!"04-+1U)/54Y$+4-/3$]2.B`C9C-F,V8S.R!-05)'24XM5$]0.B`P<'@G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q-#X@/'`@"`P<'@@,'!X.R!T97AT+6%L:6=N.B!R:6=H="<^-3DN M."4\+W`^(#PO=&0^(#QT9"!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B`C M9C-F,V8S.R!-05)'24XM5$]0.B`P<'@G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#<^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X)SXF;F)S<#L\+W`^(#PO M=&0^(#PO='(^(#QT6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z M("-F9F9F9F8[($U!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$=&]P('=I9'1H M/3-$,C@S/B`\<"!S='EL93TS1"=-05)'24XZ(#!P>"`P<'@@,'!X(#(W<'@G M/E1O=&%L/"]P/B`\+W1D/B`\=&0@"<^)FYB6QE/3-$)TU!4D=)3CH@,'!X(#(S<'@@,'!X(#!P>#L@=&5X M="UA;&EG;CH@6QE/3-$ M)T)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8[($U!4D=)3BU43U`Z(#!P>"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,34^(#QP('-T>6QE/3-$)TU!4D=) M3CH@,'!X)SXF;F)S<#L\+W`^(#PO=&0^(#QT9"!S='EL93TS1"="04-+1U)/ M54Y$+4-/3$]2.B`C9F9F9F9F.R!-05)'24XM5$]0.B`P<'@G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$Q-#X@/'`@"`P<'@@,'!X.R!T97AT+6%L:6=N.B!R:6=H="<^,3`P+C`E/"]P/B`\ M+W1D/B`\=&0@"<^)FYB"<^/&)R("\^(#PO M<#X@/'`@6QE/3-$)TU!4D=)3CH@,'!X)SY);G9E;G1O"<^/&)R("\^(#PO<#X@ M/'`@"<^/&)R("\^(#PO<#X@/'`@ M6QE/3-$)TU!4D=)3CH@ M,'!X)SX\96T^4VAI<'!I;F<@86YD($AA;F1L:6YG($-O6QE/3-$)TU!4D=)3CH@,'!X)SX\8G(@+SX@/"]P/B`\<"!S='EL M93TS1"=-05)'24XZ(#!P>"<^5&AE($-O;7!A;GD@8VQA"<^/&)R("\^(#PO<#X@/'`@2!A;F0@17%U:7!M96YT("9N M8G-P.SPO96T^/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P>"<^/&)R("\^ M(#PO<#X@/'`@65A6QE/3-$)TU!4D=)3CH@,'!X)SX\8G(@+SX@/"]P/B`\<"!S M='EL93TS1"=-05)'24XZ(#!P>"<^/&5M/DEM<&%I6QE/3-$)TU!4D=)3CH@,'!X)SY4:&4@0V]M M<&%N>2!R979I97=S+"!L;VYG+6QI=F5D(&%S2!N;W0@8F4@9G5L;'D@2!R96-O9VYI>F5S(&%N(&EM<&%I"!M;VYT:',@96YD960@2G5N92`S,"P@ M,C`Q,2!A;F0@,C`Q,"X\+W`^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X)SX\ M8G(@+SX@/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P>"<^/&5M/DEN8V]M M92!487AE"<^)FYB M"<^1&5F97)R960@:6YC M;VUE('1A>"!A2!T:&%N(&YO="!T:&%T(&%L;"!O2!F;W)W87)D('!E"<^/&)R("\^(#PO<#X@/'`@ M2!T:&%N(&YO="!T:&%T(&$@=&%X('!OF5D(&EN('1H92!F:7)S="!S=6)S97%U96YT(&9I;F%N8VEA M;"!R97!O6QE/3-$)TU!4D=)3CH@,'!X)SX\96T^4W5B6QE/3-$)TU!4D=)3CH@,'!X)SY&;W(@<'5R<&]S97,@;V8@ M9&5T97)M:6YI;F<@=VAE=&AE2!T:&4@0V]M<&%N>2!A"!M;VYT:',@96YD M960@2G5N92`S,"P@,C`Q,2!A;F0@,C`Q,"!W97)E(&%V86EL86)L92!T;R!B M92!I"<^/&)R("\^ M(#PO<#X@/'`@6QE/3-$)TU!4D=)3CH@,'!X)SY);B!$ M96-E;6)E65E('-H87)E('!U6EE;&0@;V8@;W5R('-T;V-K M+"!T:&4@97AP96-T960@;&EF92!O9B!T:&4@;W!T:6]N6QE/3-$)TU!4D=)3CH@,'!X)SX\ M8G(@+SX@/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P>"<^/&5M/E)E;&%T M960@4&%R=&EE"<^ M/&)R("\^(#PO<#X@/'`@2!I M9B!T:&4@<&%R=&EE2!O2P@:71S(&UA;F%G M96UE;G0L(&UE;6)E"<^/&)R M("\^(#PO<#X@/'`@'1E;G0@=&AA="!O;F4@;V8@=&AE('1R86YS86-T:6YG('!A2!P=7)C:&%S M960@9G)O;2!A(')E;&%T960@<&%R='D@:7,@2!P87EM96YT('1O(&]R M(&]N(&)E:&%L9B!O9B!T:&4@2!I;B!E>&-E"<^/&)R M("\^(#PO<#X@/'`@2!)"<^/&)R("\^(#PO<#X@/'`@2!N97<@;W(@;6]D:69I960@<')I;F-I<&QE2X\+W`^(#QP('-T>6QE/3-$)TU!4D=)3CH@ M,'!X)SX\8G(@+SX@/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P>"<^/&5M M/D5A6QE/3-$)TU!4D=) M3CH@,'!X)SY%87)N:6YG2!T;R!R97!O2!D:6QU=&4@9G5T=7)E(&5A'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$"<^/'-T"<^/&)R("\^(#PO<#X@/'`@2!W:6QL(&-O;G1I;G5E(&%S(&$@9V]I;F<@8V]N8V5R;BXF M;F)S<#LF;F)S<#M!="!*=6YE(#,P+"`R,#$Q+"!T:&4@0V]M<&%N>2!H860@ M86X@86-C=6UU;&%T960@9&5F:6-I="!O9B!A<'!R;WAI;6%T96QY("9N8G-P M.R0S+CD@;6EL;&EO;BX@5&AE(&%B:6QI='D@;V8@=&AE($-O;7!A;GD@=&\@ M8V]N=&EN=64@87,@82!G;VEN9R!C;VYC97)N(&ES(&1E<&5N9&5N="!U<&]N M(&EN8W)E87-I;F<@'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$"<^/'-T"<^/&)R("\^(#PO<#X@/'`@"<^/&)R("\^ M(#PO<#X@/'1A8FQE('-T>6QE/3-$)TU!4D=)3BU43U`Z(#!P>#L@1D].5"U3 M25I%.B`Q,'!T)R!C96QL6QE/3-$)TU! M4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,34U/B`\ M<"!S='EL93TS1"=-05)'24XZ(#!P>"<^)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`W/B`\ M<"!S='EL93TS1"=-05)'24XZ(#!P>#L@=&5X="UA;&EG;CH@8V5N=&5R)SX\ M6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X M('-O;&ED.R!-05)'24XM5$]0.B`P<'@G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$P-2!C;VQS<&%N/3-$,CX@/'`@'0M86QI9VXZ(&-E;G1E6QE/3-$ M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!-05)'24XM5$]0 M.B`P<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P-"!C;VQS<&%N/3-$ M,CX@/'`@'0M86QI9VXZ(&-E;G1E M6QE/3-$)TU!4D=)3BU43U`Z(#!P>"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,3,^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X M)SXF;F)S<#L\+W`^(#PO=&0^(#PO='(^(#QT6QE/3-$)T)! M0TM'4D]53D0M0T],3U(Z("-F,V8S9C,[($U!4D=)3BU43U`Z(#!P>"<@=F%L M:6=N/3-$=&]P('=I9'1H/3-$,34U/B`\<"!S='EL93TS1"=-05)'24XZ(#!P M>"<^0G5I;&1I;F<@:6UP6QE/3-$)TU! M4D=)3CH@,'!X.R!T97AT+6%L:6=N.B!C96YT97(G/C$U+3,Y('EE87)S/"]P M/B`\+W1D/B`\=&0@#L@34%21TE..B`P M<'@[(%!!1$1)3D"<^)FYB6QE/3-$)T)!0TM' M4D]53D0M0T],3U(Z("-F,V8S9C,[($U!4D=)3BU43U`Z(#!P>"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-S4^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X M.R!T97AT+6%L:6=N.B!R:6=H="<^-C`L,3$P/"]P/B`\+W1D/B`\=&0@#L@34%21TE..B`P<'@[(%!!1$1)3D"<^)FYB6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F M,V8S9C,[($U!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-S0^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X.R!T97AT+6%L:6=N.B!R M:6=H="<^+3PO<#X@/"]T9#X@/'1D('-T>6QE/3-$)T)!0TM'4D]53D0M0T], M3U(Z("-F,V8S9C,[($U!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,3,^(#QP('-T>6QE/3-$)U!!1$1)3D#L@4$%$1$E.1RU224=( M5#H@,'!X.R!0041$24Y'+51/4#H@,'!X)SX@)FYB'0M86QI9VXZ(&-E M;G1E6QE/3-$)T)!0TM'4D]5 M3D0M0T],3U(Z("-F9F9F9F8[($U!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,3<^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X)SXF M;F)S<#L\+W`^(#PO=&0^(#QT9"!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2 M.B`C9F9F9F9F.R!-05)'24XM5$]0.B`P<'@G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#(Y/B`\<"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,'!X.R!- M05)'24XZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>"<^("9N8G-P.SPO<#X@/"]T9#X@/'1D M('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8[($U!4D=)3BU4 M3U`Z(#!P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S4^(#QP('-T>6QE M/3-$)TU!4D=)3CH@,'!X.R!T97AT+6%L:6=N.B!R:6=H="<^,3`X+#0S-#PO M<#X@/"]T9#X@/'1D('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F9F9F M9F8[($U!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,3@^(#QP('-T>6QE/3-$)U!!1$1)3D#L@4$%$1$E.1RU224=(5#H@,'!X.R!0 M041$24Y'+51/4#H@,'!X)SX@)FYB#L@34%21TE..B`P<'@[(%!!1$1)3D#L@=&5X="UA;&EG M;CH@6QE/3-$)T)!0TM' M4D]53D0M0T],3U(Z("-F9F9F9F8[($U!4D=)3BU43U`Z(#!P>"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,3,^(#QP('-T>6QE/3-$)U!!1$1)3D#L@4$%$ M1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X)SX@)FYB'0M M86QI9VXZ(&-E;G1E"<^)FYB#L@34%21TE..B`P<'@[(%!!1$1)3D#L@=&5X="UA;&EG;CH@ M6QE/3-$)T)!0TM' M4D]53D0M0T],3U(Z("-F,V8S9C,[($U!4D=)3BU43U`Z(#!P>"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,3@^(#QP('-T>6QE/3-$)U!!1$1)3D#L@4$%$ M1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X)SX@)FYB#L@34%21TE..B`P M<'@[(%!!1$1)3D#L@=&5X="UA;&EG;CH@#L@4$%$ M1$E.1RU,1494.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU4 M3U`Z(#!P>"<^("9N8G-P.SPO<#X@/"]T9#X@/"]T6QE/3-$)TU! M4D=)3CH@,'!X)SY696AI8VQE6QE/3-$)T)! M0TM'4D]53D0M0T],3U(Z("-F9F9F9F8[($U!4D=)3BU43U`Z(#!P>"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`W/B`\<"!S='EL93TS1"=-05)'24XZ M(#!P>#L@=&5X="UA;&EG;CH@8V5N=&5R)SXU('EE87)S/"]P/B`\+W1D/B`\ M=&0@6QE M/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8[($U!4D=)3BU43U`Z(#!P M>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,CD^(#QP('-T>6QE/3-$)U!! M1$1)3D#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X)SX@ M)FYB'0M86QI M9VXZ(')I9VAT)SXQ,30L-S#L@34%21TE..B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D#L@ M4$%$1$E.1RU43U`Z(#!P>"<^("9N8G-P.SPO<#X@/"]T9#X@/'1D('-T>6QE M/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8[($U!4D=)3BU43U`Z(#!P M>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S0^(#QP('-T>6QE/3-$)TU! M4D=)3CH@,'!X.R!T97AT+6%L:6=N.B!R:6=H="<^-S$L-C4V/"]P/B`\+W1D M/B`\=&0@#L@34%21TE..B`P<'@[(%!! M1$1)3D6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F,V8S9C,[($U!4D=)3BU43U`Z M(#!P>"<@=F%L:6=N/3-$=&]P('=I9'1H/3-$,34U/B`\<"!S='EL93TS1"=- M05)'24XZ(#!P>"<^0V]M<'5T97(@97%U:7!M96YT/"]P/B`\+W1D/B`\=&0@ M6QE M/3-$)TU!4D=)3CH@,'!X.R!T97AT+6%L:6=N.B!C96YT97(G/C4@>65A"<^)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,CD^(#QP('-T>6QE/3-$)U!! M1$1)3D#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X)SX@ M)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S4^ M(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X.R!T97AT+6%L:6=N.B!R:6=H="<^ M-3,L,#@V/"]P/B`\+W1D/B`\=&0@#L@ M34%21TE..B`P<'@[(%!!1$1)3D#L@34%21TE..B`P<'@[(%!!1$1)3D"!S;VQI9#L@0D%#2T=23U5.1"U#3TQ/4CH@(V8S9C-F,SL@34%2 M1TE.+51/4#H@,'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W-#X@/'`@ M'0M86QI9VXZ(')I9VAT)SXS,2PT M.#,\+W`^(#PO=&0^(#QT9"!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B`C M9C-F,V8S.R!-05)'24XM5$]0.B`P<'@G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$S/B`\<"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,'!X.R!-05)' M24XZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>"<^("9N8G-P.SPO<#X@/"]T9#X@/"]T6QE/3-$)TU!4D=)3CH@,'!X)SXF;F)S<#L\+W`^(#PO=&0^(#QT9"!S M='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B`C9F9F9F9F.R!-05)'24XM5$]0 M.B`P<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P-SX@/'`@#L@34%21TE..B`P<'@[(%!!1$1)3D"<^)FYB M#L@34%2 M1TE..B`P<'@[(%!!1$1)3D#L@=&5X="UA;&EG;CH@6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F9F9F M9F8[($U!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,3@^(#QP('-T>6QE/3-$)U!!1$1)3D#L@4$%$1$E.1RU224=(5#H@,'!X.R!0 M041$24Y'+51/4#H@,'!X)SX@)FYB#L@34%21TE..B`P<'@[(%!!1$1)3D#L@=&5X="UA;&EG M;CH@#L@4$%$1$E.1RU,1494.B`P<'@[(%!! M1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>"<^("9N8G-P.SPO M<#X@/"]T9#X@/"]T6QE/3-$)TU!4D=)3CH@,'!X)SY,97-S.B!A M8V-U;75L871E9"!D97!R96-I871I;VX\+W`^(#PO=&0^(#QT9"!S='EL93TS M1"="04-+1U)/54Y$+4-/3$]2.B`C9C-F,V8S.R!-05)'24XM5$]0.B`P<'@G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P-SX@/'`@#L@34%21TE..B`P<'@[(%!!1$1)3D"<^)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,CD^(#QP('-T>6QE M/3-$)U!!1$1)3D#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@ M,'!X)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-S4^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X.R!T97AT+6%L:6=N.B!R M:6=H="<^*#$L,3`P+#@V,SPO<#X@/"]T9#X@/'1D('-T>6QE/3-$)T)!0TM' M4D]53D0M0T],3U(Z("-F,V8S9C,[($U!4D=)3BU43U`Z(#!P>"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,3@^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X M)SXI/"]P/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,CD^(#QP M('-T>6QE/3-$)U!!1$1)3D#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y' M+51/4#H@,'!X)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-S0^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X.R!T97AT+6%L M:6=N.B!R:6=H="<^*#0V,BPY.34\+W`^(#PO=&0^(#QT9"!S='EL93TS1"=" M04-+1U)/54Y$+4-/3$]2.B`C9C-F,V8S.R!-05)'24XM5$]0.B`P<'@G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$S/B`\<"!S='EL93TS1"=-05)'24XZ M(#!P>"<^*3PO<#X@/"]T9#X@/"]T6QE/3-$)TU!4D=)3CH@,'!X M)SXF;F)S<#L\+W`^(#PO=&0^(#QT9"!S='EL93TS1"="04-+1U)/54Y$+4-/ M3$]2.B`C9F9F9F9F.R!-05)'24XM5$]0.B`P<'@G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$P-SX@/'`@#L@34%21TE..B`P<'@[(%!!1$1)3D"<^)FYB#L@34%21TE..B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>"<^("9N8G-P.SPO<#X@/"]T9#X@ M/'1D('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8[($U!4D=) M3BU43U`Z(#!P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3@^(#QP('-T M>6QE/3-$)U!!1$1)3D#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/ M4#H@,'!X)SX@)FYB#L@34%21TE..B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D#L@4$%$ M1$E.1RU43U`Z(#!P>"<^("9N8G-P.SPO<#X@/"]T9#X@/'1D('-T>6QE/3-$ M)T)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8[($U!4D=)3BU43U`Z(#!P>"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3,^(#QP('-T>6QE/3-$)U!!1$1) M3D#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X)SX@)FYB M6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z M("-F,V8S9C,[($U!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,3`W/B`\<"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,'!X.R!- M05)'24XZ(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>"<^("9N8G-P.SPO<#X@/"]T9#X@/'1D M('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F,V8S9C,[($U!4D=)3BU4 M3U`Z(#!P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3<^(#QP('-T>6QE M/3-$)TU!4D=)3CH@,'!X)SXF;F)S<#L\+W`^(#PO=&0^(#QT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#-P>"!D;W5B;&4[($)!0TM'4D]5 M3D0M0T],3U(Z("-F,V8S9C,[($U!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,CD^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X)SXF M;F)S<#LD/"]P/B`\+W1D/B`\=&0@#L@=&5X="UA;&EG;CH@#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>"<^("9N8G-P.SPO<#X@/"]T9#X@ M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L M93L@0D%#2T=23U5.1"U#3TQ/4CH@(V8S9C-F,SL@34%21TE.+51/4#H@,'!X M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0R.3X@/'`@"!D;W5B;&4[($)!0TM'4D]53D0M0T], M3U(Z("-F,V8S9C,[($U!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-S0^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X.R!T97AT+6%L M:6=N.B!R:6=H="<^,30W+#6QE/3-$)T)! M0TM'4D]53D0M0T],3U(Z("-F,V8S9C,[($U!4D=)3BU43U`Z(#!P>"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3,^(#QP('-T>6QE/3-$)U!!1$1)3D#L@ M4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X)SX@)FYB"<^/&)R("\^(#PO<#X@/'`@2!O9B!W:&EC M:"`F;F)S<#LD-#8L,S@X(&%N9"`F;F)S<#LD-C@L,#8W(&ES(&EN8VQU9&5D M(&EN(&-O2X\+W`^(#QP('-T>6QE M/3-$)TU!4D=)3CH@,'!X)SX\8G(@+SX@/"]P/B`\<"!S='EL93TS1"=-05)' M24XZ(#!P>"<^5&AE($-O;7!A;GD@:&%S(&5N=&5R960@:6YT;R!V87)I;W5S M(&9I;F%N8VEN9R!A2!V96AI8VQE3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\R9C1F,S,W85\T-F4T7S1E93!?86-D-%\W-39B-C`T-#8V-F$-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,F8T9C,S-V%?-#9E-%\T964P7V%C M9#1?-S4V8C8P-#0V-C9A+U=O'0O:'1M;#L@8VAA'0^/"$M+41/0U194$4@:'1M;"!054), M24,@(BTO+U&AT;6PQ+T141"]X:'1M;#$M=')A;G-I M=&EO;F%L+F1T9"(@+2T^#0H\9&EV/B`\9&EV('-T>6QE/3-$)U=)1%1(.B`W M,C!P>"<^/"$M+5-T87)T1G)A9VUE;G0M+3X@/'`@6QE/3-$)TU!4D=)3CH@,'!X)SY"971W965N($1E8V5M8F5R(#(P,#@@ M86YD($IA;G5A6%B;&4@86UO=6YT:6YG('1O("9N8G-P.R0U,BPY-SD@:6X@8V]N;F5C=&EO M;B!W:71H('1H92!A8W%U:7-I=&EO;B!O9B!T:')E92!D96QI=F5R>2!V96AI M8VQE6%B;&4@8F5A2!V96AI8VQE2X\+W`^(#QP('-T>6QE M/3-$)TU!4D=)3CH@,'!X)SX\8G(@+SX@/"]P/B`\<"!S='EL93TS1"=-05)' M24XZ(#!P>"<^3VX@2G5N92`R.2P@,C`Q,2!(87-C;R!-961I8V%L+"!);F,N M(&5N=&5R960@:6YT;R!A("9N8G-P.R0T,#`L,#`P(')E=F]L=FEN9R!L:6YE M(&]F(&-R961I="!A9W)E96UE;G0@=VET:"!7:&ET;F5Y($)A;FLL('=H:6-H M(&EN8VQU9&5S(&%N(&%N;G5A;"!R96YE=V%L+B9N8G-P.R!!;B!A;FYU86P@ M9F%C:6QI='D@9F5E(&]F("XR-24@=V%S(&-H87)G960N($EN=&5R97-T)FYB M"<^3VX@36%Y(#$S+"`R,#$Q+"!T:&4@0V]M<&%N>2!I6%B;&4@=&\@=&AE(%-E;&QE6UE;G0@86=R965M96YT('=I=&@@=&AE('-E;&QE6QE/3-$)TU!4D=)3CH@,'!X)SX\8G(@+SX@/"]P/B`\=&%B;&4@#L@4$%$1$E.1RU,1494.B`P<'@[ M(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>"<^("9N8G-P M.SPO<#X@/"]T9#X@/'1D('-T>6QE/3-$)TU!4D=)3BU43U`Z(#!P>"<@=F%L M:6=N/3-$=&]P('=I9'1H/3-$,C0^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X M)SXQ+CPO<#X@/"]T9#X@/'1D('-T>6QE/3-$)TU!4D=)3BU43U`Z(#!P>"<@ M=F%L:6=N/3-$=&]P('=I9'1H/3-$-C"<^3F]T92!F;W(@)FYB2!W:71H(&UO;G1H;'D@<&%Y;65N=',@;V8@:6YT97)E6QE/3-$)U!!1$1)3D#L@4$%$1$E.1RU2 M24=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X)SX@)FYB#L@ M34%21TE..B`P<'@[(%!!1$1)3D#L@34%2 M1TE..B`P<'@[(%!!1$1)3D6QE/3-$)TU!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$ M=&]P('=I9'1H/3-$,C0^(#QP('-T>6QE/3-$)U!!1$1)3D#L@4$%$1$E.1RU2 M24=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X)SX@)FYB6QE/3-$)TU!4D=)3CH@,'!X)SY03X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\R9C1F,S,W85\T-F4T7S1E93!?86-D-%\W-39B-C`T-#8V-F$-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,F8T9C,S-V%?-#9E-%\T964P7V%C M9#1?-S4V8C8P-#0V-C9A+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/"$M+41/0U194$4@:'1M;"!0 M54),24,@(BTO+U&AT;6PQ+T141"]X:'1M;#$M=')A M;G-I=&EO;F%L+F1T9"(@+2T^#0H\9&EV/B`\9&EV('-T>6QE/3-$)U=)1%1( M.B`W,C!P>"<^/"$M+5-T87)T1G)A9VUE;G0M+3X@/'`@6QE/3-$)TU!4D=)3CH@ M,'!X)SX\8G(@+SX@/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P>"<^26X@ M1F5B6QE/3-$ M)TU!4D=)3CH@,'!X)SY);B!&96)R=6%R>2`R,#$Q+"!O;F4@;V8@=&AE($-O M;7!A;GDF(S,Y.W,@9&ER96-T;W)S(&QO86YE9"`F;F)S<#LD,3,U+#`P,"!T M;R!T:&4@0V]M<&%N>2X@5&AE'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA"<^ M/'-T6QE M/3-$)TU!4D=)3CH@,'!X)SXF;F)S<#L\+W`^(#QP('-T>6QE/3-$)TU!4D=) M3CH@,'!X)SY/;B!-87D@,3(L(#(P,#D@2$%30T\@365D:6-A;"P@26YC+B`H M(DA!4T-/(BD@8V]M<&QE=&5D('1H92!A8W%U:7-I=&EO;B!O9B!3;W5T:&5R M;B!-961I8V%L("9A;7`[($UO8FEL:71Y+"!);F,N("A334TB*2!P=7)S=6%N M="!T;R!T:&4@=&5R;7,@;V8@=&AE($%G2P@26YC+B!B96-A;64@82!W:&]L;'DM;W=N960@2!O9B!(05-#3RX@5&AE('-H87)E:&]L9&5R(&]F(%-O=71H97)N($UE9&EC M86P@)F%M<#L@36]B:6QI='DL($EN8RX@=V%S(&ES28C,SD["<^/&)R("\^(#PO<#X@/'`@"<^/&)R("\^(#PO<#X@/'`@6QE/3-$)TU!4D=)3CH@,'!X)SY&;W(@86-C;W5N=&EN9R!P M=7)P;W-E6QE/3-$)TU!4D=)3CH@,'!X)SY%9F9E8W1I=F4@=VET M:"!T:&4@2!(05-#3R!-961I8V%L+"!);F,N M)B,S.3MS('-H87)E:&]L9&5R"<^/&)R("\^(#PO<#X@/'`@28C,SD[&EM M871E;'D@)FYB6QE/3-$)TU!4D=)3CH@ M,'!X)SX\8G(@+SX@/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P>"<^26X@ M1F5B2!P86ED('1H92!F:7)M(&%N('5P9G)O;G0@2`R)2!C;VUM:7-S:6]N'!E;G-E+CPO M<#X@/'`@6QE/3-$)TU!4D=)3CH@,'!X)SY);B!-87)C:"`R,#$Q+"!T:&4@0V]M<&%N M>2!I6UE;G0@;V8@86-C'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA"<^/'-T65E2X@5&AE M($-O;7!A;GD@:7,@875T:&]R:7IE9"!T;R!I&5R8VES92!P"<^/&)R("\^(#PO<#X@/'`@"<^/&)R("\^(#PO<#X@/'`@ M2!F M;W(@=&AE('1H6QE/3-$)TU!4D=)3CH@ M,'!X)SX\8G(@+SX@/"]P/B`\=&%B;&4@6QE/3-$ M)T)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8[($U!4D=)3BU43U`Z(#!P>"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,S,S/B`\<"!S='EL93TS1"=-05)' M24XZ(#!P>"<^)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,3`Y/B`\<"!S='EL93TS1"=-05)'24XZ(#!P>#L@=&5X="UA;&EG M;CH@8V5N=&5R)SX\"<^)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3,U(&-O;'-P86X],T0S/B`\ M<"!S='EL93TS1"=-05)'24XZ(#!P>#L@=&5X="UA;&EG;CH@8V5N=&5R)SX\ M"<^)FYB6QE M/3-$)TU!4D=)3CH@,'!X.R!T97AT+6%L:6=N.B!R:6=H="<^-"PP-S4L,#`P M/"]P/B`\+W1D/B`\=&0@6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F,V8S9C,[($U! M4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3D^(#QP M('-T>6QE/3-$)TU!4D=)3CH@,'!X)SXF;F)S<#LD/"]P/B`\+W1D/B`\=&0@ M'0M86QI9VXZ(')I9VAT)SXP+C`P-SPO<#X@ M/"]T9#X@/'1D('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F,V8S9C,[ M($U!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,S(@ M8V]L6QE/3-$)TU!4D=)3CH@,'!X)SXF;F)S<#L\ M+W`^(#PO=&0^(#PO='(^(#QT6QE/3-$)TU!4D=)3BU43U`Z M(#!P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,S,S/B`\<"!S='EL93TS M1"=415A4+4E.1$5.5#H@,C9P>#L@34%21TE..B`P<'@G/D=R86YT960\+W`^ M(#PO=&0^(#QT9"!S='EL93TS1"=-05)'24XM5$]0.B`P<'@G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$P.3X@/'`@'0M86QI9VXZ(')I9VAT)SXM/"]P/B`\+W1D/B`\=&0@6QE/3-$)TU!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,3D^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X)SXF;F)S<#L\+W`^ M(#PO=&0^(#QT9"!S='EL93TS1"=-05)'24XM5$]0.B`P<'@G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#DW/B`\<"!S='EL93TS1"=-05)'24XZ(#!P>#L@ M=&5X="UA;&EG;CH@"<^)FYB&5R8VES960\+W`^(#PO=&0^(#QT9"!S='EL93TS M1"="04-+1U)/54Y$+4-/3$]2.B`C9C-F,V8S.R!-05)'24XM5$]0.B`P<'@G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P.3X@/'`@'0M86QI9VXZ(')I9VAT)SXM/"]P/B`\+W1D/B`\=&0@ M6QE/3-$ M)T)!0TM'4D]53D0M0T],3U(Z("-F,V8S9C,[($U!4D=)3BU43U`Z(#!P>"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3D^(#QP('-T>6QE/3-$)TU!4D=) M3CH@,'!X)SXF;F)S<#L\+W`^(#PO=&0^(#QT9"!S='EL93TS1"="04-+1U)/ M54Y$+4-/3$]2.B`C9C-F,V8S.R!-05)'24XM5$]0.B`P<'@G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#DW/B`\<"!S='EL93TS1"=-05)'24XZ(#!P>#L@ M=&5X="UA;&EG;CH@"<^)FYB6QE M/3-$)TU!4D=)3CH@,'!X.R!T97AT+6%L:6=N.B!R:6=H="<^*#$L,#`P+#`P M,#PO<#X@/"]T9#X@/'1D('-T>6QE/3-$)TU!4D=)3BU43U`Z(#!P>"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,S$^(#QP('-T>6QE/3-$)TU!4D=)3CH@ M,'!X)SXI/"]P/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,3D^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X)SXF M;F)S<#L\+W`^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C M,#`P,#`P(#%P>"!S;VQI9#L@34%21TE.+51/4#H@,'!X)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Y-SX@/'`@'0M86QI9VXZ(')I9VAT)SXM/"]P/B`\+W1D/B`\=&0@6QE/3-$)TU!4D=)3CH@,'!X)SY/=71S=&%N M9&EN9R!A="!*=6YE(#,P+"`R,#$Q/"]P/B`\+W1D/B`\=&0@#L@34%21TE..B`P<'@[(%!!1$1)3D"<^)FYB"<^)FYB6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@0D%#2T=23U5.1"U#3TQ/4CH@ M(V8S9C-F,SL@34%21TE.+51/4#H@,'!X)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Y-SX@/'`@#L@34%2 M1TE..B`P<'@[(%!!1$1)3D"<^)FYB6QE/3-$)TU!4D=)3BU43U`Z M(#!P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`Y/B`\<"!S='EL93TS M1"=-05)'24XZ(#!P>#L@=&5X="UA;&EG;CH@6QE/3-$)TU!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,S$^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X)SXF M;F)S<#L\+W`^(#PO=&0^(#QT9"!S='EL93TS1"=-05)'24XM5$]0.B`P<'@G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Y/B`\<"!S='EL93TS1"=-05)' M24XZ(#!P>"<^)FYB'0M86QI9VXZ(')I9VAT)SXF;F)S<#L\ M+W`^(#PO=&0^(#QT9"!S='EL93TS1"=-05)'24XM5$]0.B`P<'@G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#,R(&-O;'-P86X],T0R/B`\<"!S='EL93TS M1"=-05)'24XZ(#!P>"<^)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,3`Y/B`\<"!S='EL93TS1"=-05)'24XZ(#!P>#L@=&5X="UA;&EG;CH@"<^)FYB"<^)FYB6QE M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@0D%#2T=2 M3U5.1"U#3TQ/4CH@(V8S9C-F,SL@34%21TE.+51/4#H@,'!X)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Y-SX@/'`@'0M86QI9VXZ(')I9VAT)SXM/"]P/B`\+W1D/B`\=&0@6QE/3-$)TU!4D=)3CH@,'!X)SY796EG M:'1E9"!A=F5R86=E(&9A:7(@=F%L=64@;V8@;W!T:6]N65A6QE/3-$)TU!4D=)3BU4 M3U`Z(#!P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`Y/B`\<"!S='EL M93TS1"=-05)'24XZ(#!P>#L@=&5X="UA;&EG;CH@6QE/3-$)TU!4D=)3BU43U`Z(#!P>"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,S$^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X M)SXF;F)S<#L\+W`^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]- M.B`C,#`P,#`P(#-P>"!D;W5B;&4[($U!4D=)3BU43U`Z(#!P>"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,3D^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X M)SXF;F)S<#LD/"]P/B`\+W1D/B`\=&0@#L@=&5X="UA;&EG;CH@"<^)FYB"<^/&)R("\^(#PO<#X@/'`@65A6QE/3-$)TU!4D=)3CH@,'!X)SX\8G(@+SX@/"]P/B`\<"!S='EL M93TS1"=-05)'24XZ(#!P>"<^5&AE(&9O;&QO=VEN9R!T86)L92!S=6UM87)I M>F5S('1H92!#;VUP86YY)B,S.3MS('-T;V-K(&]P=&EO;G,@;W5T6QE/3-$)TU!4D=)3CH@ M,'!X)SX\8G(@+SX@/"]P/B`\=&%B;&4@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-#@V(&-O;'-P86X],T0X M/B`\<"!S='EL93TS1"=-05)'24XZ(#!P>#L@=&5X="UA;&EG;CH@8V5N=&5R M)SX\#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>"<^("9N8G-P.SPO<#X@/"]T M9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O M;&ED.R!-05)'24XM5$]0.B`P<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#(Q-2!C;VQS<&%N/3-$,SX@/'`@'0M86QI9VXZ(&-E;G1E#L@ M4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D#L@4$%$1$E. M1RU43U`Z(#!P>"<^("9N8G-P.SPO<#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!-05)'24XM5$]0.B`P M<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@S/B`\<"!S='EL93TS1"=- M05)'24XZ(#!P>#L@=&5X="UA;&EG;CH@8V5N=&5R)SX\#L@34%21TE. M.B`P<'@[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,'!X.R!T97AT+6%L:6=N.B!C96YT97(G/CQS=')O M;F<^3G5M8F5R($]U='-T86YD:6YG/"]S=')O;F<^/"]P/B`\+W1D/B`\=&0@ M#L@34%2 M1TE..B`P<'@[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,'!X.R!T97AT+6%L:6=N.B!C96YT97(G/CQS M=')O;F<^5V5I9VAT960@079E6QE/3-$)TU!4D=)3BU4 M3U`Z(#!P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C,^(#QP('-T>6QE M/3-$)U!!1$1)3D#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@ M,'!X)SX@)FYB"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.38^(#QP('-T>6QE/3-$)TU!4D=)3CH@ M,'!X.R!T97AT+6%L:6=N.B!C96YT97(G/CQS=')O;F<^5V5I9VAT960@079E M&5R8VES92!06QE/3-$)TU!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,3@^(#QP('-T>6QE/3-$)U!!1$1)3D#L@4$%$1$E.1RU224=(5#H@,'!X M.R!0041$24Y'+51/4#H@,'!X)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.3`^(#QP('-T M>6QE/3-$)TU!4D=)3CH@,'!X.R!T97AT+6%L:6=N.B!C96YT97(G/CQS=')O M;F<^3G5M8F5R($5X97)C:7-A8FQE/"]S=')O;F<^/"]P/B`\+W1D/B`\=&0@ M#L@34%2 M1TE..B`P<'@[(%!!1$1)3D'0M86QI9VXZ(&-E;G1E#L@=&5X M="UA;&EG;CH@#L@=&5X="UA;&EG;CH@#L@34%21TE..B`P<'@[(%!!1$1) M3D'0M86QI9VXZ(')I9VAT)SXS+#`W-2PP,#`\+W`^(#PO=&0^(#QT9"!S M='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B`C9C-F,V8S.R!-05)'24XM5$]0 M.B`P<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Y/B`\<"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,'!X.R!-05)'24XZ(#!P>#L@4$%$1$E.1RU, M1494.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P M>"<^("9N8G-P.SPO<#X@/"]T9#X@/'1D('-T>6QE/3-$)T)!0TM'4D]53D0M M0T],3U(Z("-F,V8S9C,[($U!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,3(R/B`\<"!S='EL93TS1"=-05)'24XZ(#!P>#L@=&5X M="UA;&EG;CH@8V5N=&5R)SXS+C4X(%EE87)S/"]P/B`\+W1D/B`\=&0@'0M86QI9VXZ(')I9VAT)SXF;F)S<#LD/"]P/B`\ M+W1D/B`\=&0@'0M86QI9VXZ(')I9VAT)SXP M+C`P-SPO<#X@/"]T9#X@/'1D('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z M("-F,V8S9C,[($U!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,3@^(#QP('-T>6QE/3-$)U!!1$1)3D#L@4$%$1$E.1RU224=(5#H@ M,'!X.R!0041$24Y'+51/4#H@,'!X)SX@)FYB'0M86QI9VXZ(')I9VAT)SXM/"]P/B`\+W1D M/B`\=&0@'0M86QI9VXZ(')I9VAT)SXF;F)S M<#LD/"]P/B`\+W1D/B`\=&0@'0M86QI9VXZ M(')I9VAT)SXM/"]P/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=- M05)'24XM5$]0.B`P<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Y/B`\ M<"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,'!X.R!-05)'24XZ(#!P>#L@ M4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D#L@4$%$1$E. M1RU43U`Z(#!P>"<^("9N8G-P.SPO<#X@/"]T9#X@/'1D('-T>6QE/3-$)TU! M4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.#,^(#QP M('-T>6QE/3-$)U!!1$1)3D#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y' M+51/4#H@,'!X)SX@)FYB#L@34%21TE..B`P<'@[(%!! M1$1)3D"!D;W5B;&4[($U!4D=)3BU43U`Z(#!P M>#L@0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@'0M86QI9VXZ(')I9VAT)SXS+#`W-2PP,#`\+W`^(#PO=&0^(#QT9"!S='EL M93TS1"=-05)'24XM5$]0.B`P<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$Y/B`\<"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,'!X.R!-05)'24XZ M(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D#L@ M4$%$1$E.1RU43U`Z(#!P>"<^("9N8G-P.SPO<#X@/"]T9#X@/'1D('-T>6QE M/3-$)TU!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,3(R/B`\<"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,'!X.R!-05)'24XZ M(#!P>#L@4$%$1$E.1RU,1494.B`P<'@[(%!!1$1)3D#L@ M4$%$1$E.1RU43U`Z(#!P>"<^("9N8G-P.SPO<#X@/"]T9#X@/'1D('-T>6QE M/3-$)TU!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,C,^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X.R!T97AT+6%L:6=N.B!R:6=H M="<^)FYB6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@34%21TE.+51/4#H@,'!X.R!"3U)$ M15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.38^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X.R!T97AT+6%L:6=N M.B!R:6=H="<^,"XP,#<\+W`^(#PO=&0^(#QT9"!S='EL93TS1"=-05)'24XM M5$]0.B`P<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$X/B`\<"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,'!X.R!-05)'24XZ(#!P>#L@4$%$1$E. M1RU,1494.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z M(#!P>"<^("9N8G-P.SPO<#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@34%21TE.+51/4#H@,'!X.R!" M3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$.3`^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X.R!T97AT+6%L M:6=N.B!R:6=H="<^+3PO<#X@/"]T9#X@/'1D('-T>6QE/3-$)TU!4D=)3BU4 M3U`Z(#!P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C@^(#QP('-T>6QE M/3-$)TU!4D=)3CH@,'!X.R!T97AT+6%L:6=N.B!R:6=H="<^)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@ M,W!X(&1O=6)L93L@34%21TE.+51/4#H@,'!X.R!"3U)$15(M5$]0.B`C,#`P M,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.38^(#QP M('-T>6QE/3-$)TU!4D=)3CH@,'!X.R!T97AT+6%L:6=N.B!R:6=H="<^+3PO M<#X@/"]T9#X@/"]T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA"<^/'-T M6QE/3-$)TU! M4D=)3CH@,'!X)SY/<&5R871I;F<@3&5A6QE/3-$)TU! M4D=)3CH@,'!X)SX\8G(@+SX@/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P M>"<^5&AE($-O;7!A;GD@;&5A2!H87,@;&5A6QE/3-$ M)T9/3E0M4TE:13H@,7!T)SX@/'1D('=I9'1H/3-$,38Y/B9N8G-P.SPO=&0^ M(#QT9"!W:61T:#TS1#$S/B9N8G-P.SPO=&0^(#QT9"!W:61T:#TS1#8Q/B9N M8G-P.SPO=&0^(#QT9"!W:61T:#TS1#$P/B9N8G-P.SPO=&0^(#PO='(^(#QT M6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8[($U! M4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,38Y/B`\ M<"!S='EL93TS1"=-05)'24XZ(#!P>"<^4&5R:6]D(&5N9&EN9R!*=6YE(#,P M.CPO<#X@/"]T9#X@/'1D('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F M9F9F9F8[($U!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,3,^(#QP('-T>6QE/3-$)U!!1$1)3D#L@4$%$1$E.1RU224=(5#H@,'!X M.R!0041$24Y'+51/4#H@,'!X)SX@)FYB#L@34%21TE..B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU,1494.B`P M<'@[(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>"<^("9N M8G-P.SPO<#X@/"]T9#X@/"]T6QE/3-$)TU!4D=)3CH@,'!X M(#!P>"`P<'@@,S-P>"<^,C`Q,3PO<#X@/"]T9#X@/'1D('-T>6QE/3-$)T)! M0TM'4D]53D0M0T],3U(Z("-F,V8S9C,[($U!4D=)3BU43U`Z(#!P>"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3,^(#QP('-T>6QE/3-$)TU!4D=)3CH@ M,'!X)SXF;F)S<#L\+W`^(#PO=&0^(#QT9"!S='EL93TS1"="04-+1U)/54Y$ M+4-/3$]2.B`C9C-F,V8S.R!-05)'24XM5$]0.B`P<'@G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#8Q/B`\<"!S='EL93TS1"=-05)'24XZ(#!P>#L@=&5X M="UA;&EG;CH@#L@4$%$1$E.1RU,1494.B`P<'@[ M(%!!1$1)3D#L@4$%$1$E.1RU43U`Z(#!P>"<^("9N8G-P M.SPO<#X@/"]T9#X@/"]T6QE/3-$)TU!4D=)3CH@,'!X(#!P M>"`P<'@@,S-P>"<^,C`Q,CPO<#X@/"]T9#X@/'1D('-T>6QE/3-$)T)!0TM' M4D]53D0M0T],3U(Z("-F9F9F9F8[($U!4D=)3BU43U`Z(#!P>"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,3,^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X M)SXF;F)S<#L\+W`^(#PO=&0^(#QT9"!S='EL93TS1"="04-+1U)/54Y$+4-/ M3$]2.B`C9F9F9F9F.R!-05)'24XM5$]0.B`P<'@G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#8Q/B`\<"!S='EL93TS1"=-05)'24XZ(#!P>#L@=&5X="UA M;&EG;CH@#L@4$%$ M1$E.1RU,1494.B`P<'@[(%!!1$1)3D#L@4$%$1$E.1RU4 M3U`Z(#!P>"<^("9N8G-P.SPO<#X@/"]T9#X@/"]T6QE/3-$ M)TU!4D=)3CH@,'!X(#!P>"`P<'@@,S-P>"<^,C`Q,R!A;F0@=&AE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,7!X('-O;&ED.R!"04-+1U)/54Y$+4-/3$]2.B`C9C-F,V8S.R!-05)' M24XM5$]0.B`P<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$S/B`\<"!S M='EL93TS1"=-05)'24XZ(#!P>"<^)FYB"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-C$^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!X M.R!T97AT+6%L:6=N.B!R:6=H="<^,S`Y+#0S,3PO<#X@/"]T9#X@/'1D('-T M>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z("-F,V8S9C,[($U!4D=)3BU43U`Z M(#!P>"<@=F%L:6=N/3-$=&]P('=I9'1H/3-$,3`^(#QP('-T>6QE/3-$)U!! M1$1)3D#L@4$%$1$E.1RU224=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X)SX@ M)FYB6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F M9F9F9CL@34%21TE.+51/4#H@,'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q,SX@/'`@"!D M;W5B;&4[($)!0TM'4D]53D0M0T],3U(Z("-F9F9F9F8[($U!4D=)3BU43U`Z M(#!P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-C$^(#QP('-T>6QE/3-$ M)TU!4D=)3CH@,'!X.R!T97AT+6%L:6=N.B!R:6=H="<^-S,Q+#@V,CPO<#X@ M/"]T9#X@/'1D('-T>6QE/3-$)TU!4D=)3BU43U`Z(#!P>"<@=F%L:6=N/3-$ M=&]P('=I9'1H/3-$,3`^(#QP('-T>6QE/3-$)U!!1$1)3D#L@4$%$1$E.1RU2 M24=(5#H@,'!X.R!0041$24Y'+51/4#H@,'!X)SX@)FYB"<^)FYB M"<^4F5N="!E>'!E;G-E M('=A"!M;VYT:',@96YD960@2G5N92`S,"P@,C`Q,2!A;F0@,C`Q,"P@6QE/3-$)TU!4D=)3CH@,'!X)SY);B!!<')I;"`R,#$Q M+"!T:&4@0V]M<&%N>2!R96-E:79E9"!A<'!R;WAI;6%T96QY("9N8G-P.R0X M,"PP,#`@9G)O;2!(87-C;R!(;VQD:6YG2P@ M26YC+B`H(E--32(I+B!4:&4@9F]R;65R(&]W;F5R3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\R9C1F,S,W85\T-F4T7S1E93!?86-D-%\W-39B M-C`T-#8V-F$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,F8T9C,S M-V%?-#9E-%\T964P7V%C9#1?-S4V8C8P-#0V-C9A+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^#0H\ M9&EV/B`\9&EV('-T>6QE/3-$)U=)1%1(.B`W,C!P>"<^/"$M+5-T87)T1G)A M9VUE;G0M+3X@/'`@6QE M/3-$)TU!4D=)3CH@,'!X)SX\8G(@+SX@/"]P/B`\<"!S='EL93TS1"=-05)' M24XZ(#!P>"<^4'5R2!B=7-I;F5S M2!T:&%T(&UA;F%G96UE;G0@;W)G86YI>F5S('1H92!O<&5R M871I;VYS(&]F('1H92!#;VUP86YY(&9O"<^/&)R("\^(#PO M<#X@/'`@&5C=71I=F4@;V9F:6-E'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA"<^/'-T6QE/3-$)TU!4D=)3CH@,'!X)SX\8G(@+SX@/"]P/B`\<"!S='EL M93TS1"=-05)'24XZ(#!P>"<^36%N86=E;65N="!&964\+W`^(#QP('-T>6QE M/3-$)TU!4D=)3CH@,'!X)SX\8G(@+SX@/"]P/B`\<"!S='EL93TS1"=-05)' M24XZ(#!P>"<^26X@36%R8V@@,C`Q,2P@=&AE($-O;7!A;GD@:7-S=65D(#DL M,#`P+#`P,"!S:&%R97,@:6X@8V]N;F5C=&EO;B!W:71H('1H92!P87EM96YT M(&]F(&%C8W)U960@;6%N86=E;65N="!F965S(&]F("9N8G-P.R0Q.#`L,#`P M('1O($A!4T-/($AO;&1I;F=S+"!,3$,N(%1H92!#;VUP86YY('9A;'5E9"!T M:&5S92!C;VUM;VX@

Consolidated Statements of Cash Flows (USD $)	6 Months Ended
Consolidated Statements of Cash Flows (USD $)	Jun. 30, 2011	Jun. 30, 2010
Cash flows from operating activities:
Net loss	$ 161,624	$ (261,837)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and Amortization	186,375	1,823,666
Stock based compensation	17,880	20,074
Sales team and infrastructure, net	(1,635,045)	(258,604)
Customer list	(1,095,649)
Purchase price adjustment	(20,328)	19,541
Changes in operating assets and liabilities:
Accounts receivable	(80,478)	4,236
Prepaid expenses and other current assets	(5,118)	(16,405)
Inventory	(2,306,038)	303,319
Other assets	(37,599)
Net cash (used in) provided by operating activities	(3,624,620)	1,633,990
Cash flows from investing activities:
Disposal (Purchase) of property and equipment	(758,056)	11,691
Net cash used in investing activities	(758,056)	11,691
Cash flows from financing activities:
Proceeds from note payable	4,147,491
Proceeds from sale of common stock	387,100	150,096
Repayments (proceeds) of notes payable	209,852	(1,563,778)
Net cash provided by financing activities	4,744,443	(1,413,682)
Net increase (decrease) in cash	361,767	231,999
Cash, Beginning of period	423	28,217
Cash, End of period	362,190	260,216
Cash Paid For:
Interest
Income taxes
Non-Cash transactions:
Vehicles acquired through financing		$ 21,759

GOING CONCERN CONSIDERATIONS	6 Months Ended
GOING CONCERN CONSIDERATIONS	Jun. 30, 2011
GOING CONCERN CONSIDERATIONS [Abstract]
GOING CONCERN CONSIDERATIONS	NOTE 2 - GOING CONCERN CONSIDERATIONS The accompanying consolidated financial statements are prepared assuming the Company will continue as a going concern. At June 30, 2011, the Company had an accumulated deficit of approximately $3.9 million. The ability of the Company to continue as a going concern is dependent upon increasing sales and obtaining additional capital and financing to support its recent acquisition. During the quarter ended June 30, 2011, the Company secured a working capital line of credit in the amount of $400,000. Management intends to attempt to raise additional funds by way of a public or private offering. While the Company believes in the viability of its strategy to increase sales volume and in its ability to raise additional funds, there can be no assurances to that effect.

Consolidated Balance Sheets (USD $)	Jun. 30, 2011	Dec. 31, 2010
CURRENT ASSETS
Cash and cash equivalents	$ 362,190	$ 423
Accounts receivable, net	334,840	254,362
Inventory	2,382,394	76,356
Prepaid expenses and other current asset	23,963	18,845
Total Current Assets	3,103,387	349,986
LONG-TERM ASSETS:
Property and equipment, net	757,309	147,769
Sales Team and infrastructure, net	1,635,045
Customer List, net	1,095,649
Other	38,019	420
Total Assets	6,629,409	498,175
CURRENT LIABILITIES:
Accounts payable and accrued liabilities	1,753,877	612,282
Overdraft liabilities		46,023
Customer deposits	55,026
Notes payable	227,857	18,005
Other Liabilities	69,158	30,000
Total Current Liabilities	2,105,918	706,310
Long Term Debt	4,300,000	152,509
STOCKHOLDERS' EQUITY:
Preferred stock ($.001 par value; 3,000,000 shares authorized; none issued and outstanding)
Common stock, $.001 par value; 1,000,000,000 shares authorized; 757,586,910 and 746,436,909 shares issued and outstanding, respectively.	757,587	746,437
Additional paid in capital	3,611,432	3,217,602
Accumulated deficit	(4,145,528)	(4,324,683)
Total Stockholders' Equity (Deficit)	223,491	(360,644)
Total Liabilities and Stockholders' Deficit	$ 6,629,409	$ 498,175